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ABSTRACT 
Introduction: Over the past decades, several labelling techniques have been 
used in an attempt to track stem cells using magnetic resonance imaging (MRI). 
However, very few of these were able to definitely determine the precise location 
of stem cells within a living organism and monitor throughout a long term period, 
without loss or diffusion of the signal. A novel MRI cell tracking method described in 
2005 proposed that reporter genes that could effectively increase the iron content 
of a target cell would allow a stronger contrast when imaged via MR. Being a 
fundamental part of the iron metabolism, transferrin receptor-1 (TfR-1) and ferritin 
heavy chain-1 (Fth-1) were naturally suggested to have the potential to increase the 
iron load of cells when overexpressed. More recently, there has been some interest 
in the reporter gene MagA, which is a known iron transporter found in 
magnetotactic bacteria. 
Aim: To evaluate the suitability of using TfR-1, Fth-1 and MagA as potential 
magnetic reporter genes for MRI-based cell tracking. 
Methods: Several cell and stem cell lines were transduced with a 
2nd generation HIV-based lentiviral system containing one or more magnetic 
reporters. Viral transduction resulted in genome incorporation of bicistronic 
construct(s) with TfR-1 gene alongside a gene encoding a green fluorescent reporter 
(GFP) and/or Fth-1 and MagA gene alongside a red fluorescent reporter (RFP). This 
allowed for identification and monitoring of positive cells with complementing 
imaging modalities: MRI and fluorescence based methods. Transgenes were 
evaluated for integration stability over passages and their influence on iron 
homeostasis was assessed; also, integration and/or overexpression were confirmed 
at the mRNA and protein level. Finally, the influence of magnetic reporters on 
intracellular iron retention and MRI contrast capacity was tested both in vitro and in 
III 
a model organism, the chick embryo. 
Results: After analysing all three potential magnetic reporters, TfR-1 was 
found to be the most promising, as its overexpression induced an adjustment of 
iron homeostasis in Chinese hamster ovary K1 cells, leading to higher intracellular 
iron accumulation relative to controls. The same adjustment was found in mouse 
mesenchymal stem cells (mMSC), but only when TfR-1 was overexpressed in 
conjunction with Fth-1, also leading to an increase in iron retention capacity. 
However, a limitation was found when overexpressing Fth-1 in mMSC, as 
permanent iron supplementation was needed in order to keep these cells viable. In 
contrast with previous studies, MagA gene integration posed some restrictions in 
certain cell lines studied. The results presented here show that while some cell 
types are able to stably maintain MagA expression over several passages, others fail 
to survive and die shortly after transduction, suggesting that a potential toxic effect 
may be originating from MagA gene integration. From the surviving cells, two were 
compared side by side and contradictory results were obtained, demonstrating that 
MagA would only be a suitable magnetic reporter for some cell types. 
Conclusion: The results obtained with this project are of relevance for 
reporter gene-based MRI cell tracking as they show that no single magnetic reporter 
is capable of generating detectable MRI contrast for a global cohort of cell lines. On 
the contrary, overexpression of endogenous genes or integration of foreign genes 
should be performed with caution and analysed on a case by case basis. Finally, for 
some cell type and magnetic reporter gene combinations, this study suggests that 
MRI could be a promising method for the longitudinal monitoring of engrafted cells, 
especially when the cells have been cultured in media supplemented with low 
concentrations of iron.  
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CHAPTER 1 
INTRODUCTION 
OVERVIEW 
The field of regenerative medicine using stem cell-based treatments has 
overcome many challenges over the past few decades. However, the fate of 
stem cells following administration into model organisms still needs to be further 
studied and understood. In order to gain some answers, one possibility is to 
visualize stem cell spatial localization through magnetic resonance imaging (MRI). 
The monitoring of stem cells in vivo would be a great advantage not only to allow a 
specialized treatment of injured deep internal organs, but also to unravel and 
understand important key points during the course of tissue regeneration. This 
could be achieved by modifying the stem cells so that they overexpress iron-binding 
proteins, or ‘magnetic reporters’, thus enabling their detection via MRI. This chapter 
covers the basic biology of iron metabolism, which ferritin and transferrin 
receptor-1 are a fundamental part of, as well as the origin and function of the MagA 
gene in magnetotactic bacteria. A review of the use of these genes as magnetic 
reporters in MRI-based cell tracking will be introduced in the subsequent chapters.  
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1.1 STEM CELL TRACKING AND MRI 
The most routinely used technology for the study of stem cells is 
fluorescence optical imaging and there are a number of reporter genes readily 
available, such as red or green fluorescent proteins (RFP/GFP) (Gould and 
Subramani, 1988). Another optical imaging system uses luminescence derived from 
specific organisms and is therefore designated as bioluminescence imaging, a 
technology that captures visible light emission from cells or tissues. This is only 
possible due to presence of specific reporters as, for example, firefly luciferase, 
originally derived from the North American firefly (de Wet et al., 1985), that and 
upon activation via D-luciferase substrate emits a 560 nm emission peak (Sadikot 
and Blackwell, 2004). However, a pitfall commonly associated with these optical 
reporters is the low depth penetration capacity, which is essential for regenerative 
studies focused on injured deep internal organs. 
In order to understand stem cell–based regenerative processes, one needs 
to effectively monitor cell survival, migration and differentiation potential (Bhirde et 
al., 2011). Therefore, over the past years, there has been an increasing interest in 
technologies which are able to explore in-depth the human body. Some examples 
are positron emission tomography (PET) (Bailey et al., 2005), contrast-enhanced 
ultrasonography (US) (Jang and Lee, 2004), X-ray computed tomography (X-ray CT) 
(Herman, 2009), MRI, amongst others. All these technologies greatly differ in 
imaging resolution capacity, contrast used and user safety, but they effectively 
monitor non-invasively functional processes within an organism (Engstrom et al., 
2003). In particular, the use of MRI for stem cell tracking has mainly relied on iron as 
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a contrast agent to visualize cells of interest. New techniques have been emerging 
in an attempt to provide optimum iron load into the cells either by labelling with 
exogenous contrast agents or by modifying the cells through genetic engineering. 
On one hand, the exogenous materials introduced into the cells are very often 
composed of iron oxide covered with a biocompatible synthetic shell, like, for 
example, superparamagnetic iron oxide nanoparticles (SPIONs) (Peacock et al., 
2012; Renshaw et al., 1986). On the other hand, genetic engineering of the cell 
focuses mainly on introducing or overexpressing one or more components of the 
iron metabolic pathway (Deans et al., 2006; Genove et al., 2005) or other synthetic 
or foreign genes (Iordanova et al., 2010; Zurkiya et al., 2008) in order to augment 
intracellular iron load, using iron present within a cell or in its surroundings. 
1.1.1 Magnetic resonance imaging 
MRI has been used since the mid-1980s and is a well suited technology with 
an adequate spatial resolution for deep internal organ, tissue and molecular 
imaging (Cherry, 2004). Also, it is one of the best choices for non-invasive imaging. 
Perhaps the most important feature is that MRI acts without emitting ionizing 
radiation, but other aspects are also of great significance, such as: i) high spatial 
resolution and tissue contrast, providing precise and detailed information about 
organ morphology and function; ii) unlimited tissue penetration and iii) the 
potential use of a broad range of contrast mechanisms. Usually, clinical MRI 
scanners use between 1.5 and 3 Tesla (T), which might pose as problem in the 
required resolution for detection of small amounts of high-iron contrast stem cell 
  
INTRODUCTION | 4  
populations (Harney and Meade, 2010). This could be simply overcome by using 
scanners with high-field strengths such as 4.7, 9.4, 11.7 or 14T (Louie et al., 2000). 
The mechanism behind conventional MR imaging is the detection of signals 
from relaxation mechanisms, produced by the magnetization of hydrogen nuclei 
(1H), present in mobile water protons, either in the form of spin-lattice relaxation 
time (T1), spin-spin relaxation time (T2 or T2*). Once the sample is positioned in a 
static magnetic field, the magnetic moment characteristic of 1H tends to align with 
the direction of the magnetic field. The signal detection is directly proportional to 
the concentration of nucleus imaged in a certain region and decreases exponentially 
with the time constant T2 or T2* (Haacke et al., 1999). 
A few compounds may enhance MRI contrast, by affecting the relaxation 
properties of the nuclei present in their surroundings. On one hand, the use of 
gadolinium containing agents may result in positive contrast, primarily affecting T1 
time constant and promoting signal intensity. On the other hand, a negative 
contrast can be achieved with the use of compounds made of superparamagnetic 
iron oxides, mainly affecting T2 (or T2*) time constant, resulting in signal loss. This 
signal loss is due to the strong magnetic moment associated with iron oxide 
particles and its interaction with the surrounding water protons (Ahrens and Bulte, 
2013; Jung and Jacobs, 1995). 
More information about the physical properties of MRI and the use of iron 
oxide-based contrast agents can be found in Henkelman et al. (2001), Hawrylak 
et al. (1993) and Bulte and Kraitchman (2004). 
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1.1.2 Exogenous vs. endogenous iron oxide-based contrast agents for MRI 
The most commonly used method to generate contrast for MRI is to label 
cells in vitro with exogenous iron oxide-based contrast agents, like SPIONs (Patel et 
al., 2010). This method of labelling has proven to be effective and robust for 
stem cell tracking of small populations and not only is a good choice for short-term 
studies up to 6 weeks, it also has been shown not to interfere with cell viability or 
proliferation capacity (Bulte et al., 2001; Taylor et al., 2012). Nevertheless, if 
long-term regenerative studies are an essential requirement for stem cell-based 
treatments, exogenously incorporating iron inside a cell does pose some limitations. 
After an initial cell labelling with SPIONs, cell proliferation causes the label to be 
diluted by 50% following each cell division (Taylor et al., 2014). Also, even though 
exogenous labelling materials are biocompatible to some extent, they are still 
foreign objects to the cell and might be easily rejected, via exocytosis, or 
degradation. Exocytosis of the label could lead to it being incorporated by 
neighbouring host cells, giving rise to false positives (Bulte and Kraitchman, 2004). 
Another potential cause of false positive signal could arise from phagocytosis of 
dead stem cells by neighbouring host cells or macrophages, leading to the transfer 
of the magnetic label. At last, even though SPIONs have been proven not to 
interfere with cell viability or proliferation, it has been reported that in some cell 
types it can inhibit cell differentiation (Chen et al., 2010; Kostura et al., 2004). 
On the other hand, the use of endogenous iron through the expression of 
genes that may influence the intracellular iron content of a cell may prove to have 
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certain advantages over other labelling methods. For instance, stem cells expressing 
metalloprotein-based reporter genes can also be monitored non-invasively, in 
theory through long periods of time. If these genes are integrated into the cell’s 
genome, it is much less likely to undergo a loss of signal during cell proliferation or 
even to be rejected by the cell. In the case of cell death, reporter gene expression 
will immediately arrest and its products will probably be more easily dissolved by 
the normal metabolism, avoiding the risk of false positive signal (Rodriguez-Porcel 
et al., 2009). Also, other genes of interest can be associated with the magnetic 
reporter gene, creating suitable vectors for gene therapy (Liu et al., 2009). In the 
case of basic research, the gene of interest can be a fluorescent protein and in this 
case MRI contrast can be confirmed with optical imaging. An obvious limitation to 
this contrast method is the low sensitivity of detection, when compared to 
materials like SPIONs (Gilad et al., 2007b). If iron availability is not present in 
surrounding areas to the cell in sufficient amounts, magnetic reporter gene 
overexpression may not incorporate sufficient iron volumes to generate MRI 
contrast. Nonetheless, metalloprotein-based reporter genes have been suggested 
to be sufficient to provide a good MRI contrast for stem cell tracking (Deans et al., 
2006; Genove et al., 2005). 
1.1.3 Metalloprotein-based MRI reporter genes 
The next generation of MRI-based approaches for cell tracking rely on new 
technologies for cellular imaging. As previously described, metalloprotein-based 
reporter genes can involve several components of the iron metabolism pathway or 
iron-related proteins in order to induce an up-regulation of intracellular iron. Some 
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of those components targeted so far are proteins such as: the transferrin receptor-1 
(Moore et al., 1998); the tyrosinase enzyme (Alfke et al., 2003); a synthetic 
lysine-rich protein (Gilad et al., 2007a); both subunits of the ferritin complex used 
either together or separately (Cohen et al., 2005; Genove et al., 2005) and even 
synthetically modified ferritin (Iordanova et al., 2013); and, lastly, foreign genes 
such as the bacterial iron transporter protein, MagA (Goldhawk et al., 2009; Zurkiya 
et al., 2008).  
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1.2 IRON METABOLISM  
Iron is a vital and indispensable element to life, as it is necessary to produce 
heme and non-heme iron proteins involved in several cellular processes. The most 
important example is iron present in haemoglobins of erythrocytes, which comprise 
about 60-70% of total body iron and are essential for oxygen transport. Iron is also 
present in cytochromes, which take part in the electron transport during aerobic 
cellular respiration, and is a key constituent in enzyme production and DNA 
synthesis, amongst other functions (Ponka and Lok, 1999). When iron is depleted 
within a cell it may lead to cell arrest and death (Muckenthaler et al., 2008). 
Nevertheless, however important this nutrient is, when present in excess, it 
becomes toxic, leading to the formation of highly reactive oxygen radical species, 
damaging cell membranes, proteins and ultimately affecting the integrity of nucleic 
acids (Hentze and Kuhnt, 1996). 
Iron is often found in two interconvertible oxidation states: ferrous iron 
(Fe2+) and ferric iron (Fe3+). At normal physiological conditions, ferrous iron readily 
converts into ferric iron. This process is known as the Fenton reaction (Equation 1) 
and the resultant oxidation leads to the formation of hydroxyl radicals (HO.) and 
hydroxide ions (OH-). When ferric iron is reduced back into ferrous iron, it forms a 
hydroperoxyl radical (HO2) and another oxygen-radical species (H
+) in the process 
(Ponka et al., 1998; Powell, 1998). 
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Fe2+ + H2O2 → Fe
3+ + HO. + OH- 
Fe3+ + H2O2 → Fe
2+ + HOO. + H+ 
Equation 1 – Fenton reaction (Fenton, 1894). 
This essential element can only be obtained through diet, and therefore, the 
balance to meet the needs between consumption and storage starts by regulation 
of iron absorption at the intestinal level, and later, by the expression of proteins 
involved in iron storage and transport (Bothwell, 1995). Initially, at a broad level and 
in response to specific liver signalling, iron is absorbed through metal transporters 
localized on the intestine duodenal mucosa membrane, like ferroportin and the 
divalent metal transporter-1 (DMT1) (Ganz and Nemeth, 2012; Hentze et al., 2004). 
Iron is then released from intestinal enterocytes into the plasma serum and 
captured by a protein called transferrin. This protein is responsible for the 
bloodstream circulation and transport of iron to all cells in the body. Transferrin can 
be loaded with one or two units of iron and is called mono or diferric transferrin, 
respectively. The latter is also commonly known as holo-transferrin and it is the 
predominant state present in the bloodstream. When this protein does not contain 
any bound iron, it is called apo-transferrin. The bond between iron and transferrin, 
although efficient, is easily reversible to allow the metal to be released upon 
demand (Aisen, 2004). Due to iron’s high reactivity when present in physiological 
oxygen conditions, its metabolism is tightly controlled and well-coordinated by 
post-transcriptional expression of genes that make part of the iron regulatory 
protein/ iron responsive element (IRP/IRE) regulatory system. 
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1.2.1 Regulation of intracellular iron – IRP/IRE regulatory system 
Inside the cell there is transient free iron, known as the labile iron pool (LIP). 
The magnitude of LIP is tightly controlled by the cell and this transient iron is bound 
to low molecular weight molecules, ready to be used in a variety of cellular 
processes (Thomson et al., 1999). The depletion or excess of iron within the LIP is 
easily detected in the cytoplasm by iron regulatory proteins, IRP1 and IRP2. The 
importance of IRPs in development is demonstrated by the occurrence of 
embryonic lethality when IRP1 and IRP2 genes are knocked-out in mice (Smith et al., 
2006). The IRPs bind to iron responsive elements (IRE), which are hairpin structures 
present in untranslated regions (UTR) of mRNAs from genes involved in iron 
metabolism (Wilkinson and Pantopoulos, 2014). Many genes are involved in the 
uptake, utilization, storage and export of iron at the cellular level (Muckenthaler et 
al., 2008). Two of the most important genes are responsible for iron uptake 
(transferrin receptor genes) and storage (ferritin genes) and therefore both contain 
iron responsive elements in their mRNA UTR. Transferrin receptors act at the 
cellular membrane interacting with mono or diferric transferrin from the 
bloodstream. Both ferritin and transferrin receptors can serve either as iron donors 
or acceptors; however, ferritin has the capacity not only to receive and accept large 
quantities of iron, but also to act as an intracellular storage molecule (Aisen et al., 
2001). 
When iron is depleted inside a cell, IRPs bind to an IRE located at the 5’UTR 
of ferritin mRNAs, repressing translation, in order to stop the acquisition and 
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storage of iron present in the LIP. In contrast, it also binds to an IRE found in the 
3’UTR of transferrin receptor-1 transcripts to promote mRNA stability and prevent 
degradation. Consequently, this increases the translation and the number of 
receptors available, allowing more interactions with holo-transferrin molecules, 
thus increasing the levels of intracellular iron. On the other hand, when elevated 
iron levels are detected by IRPs, this regulatory protein unbinds from the 5’UTR IRE 
of ferritins and its expression is readily induced, capturing the majority of iron in the 
form of a soluble non-toxic ferrihydrite mineral (Harrison and Arosio, 1996), before 
the Fenton reaction can take place. Meanwhile, the opposite happens for 
transferrin receptor-1 transcripts, and IRPs unbind from the 3’UTR IRE, allowing its 
cleavage by endonucleases and subsequent degradation (Ford et al., 1984; Ponka et 
al., 1998; Rouault, 2006). With those mechanisms, the translation of ferritins and 
transferrin receptor-1 is efficiently controlled at the post-transcriptional level. 
Figure 1 illustrates this process. 
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Figure 1 – Illustration of IRP/IRE regulatory system acting on a post-transcriptional level of 
two groups of genes involved in iron metabolism, ferritin and transferrin receptor-1 genes. 
When iron is depleted, IRPs bind to IREs present in UTRs and repress the translation, in case 
of ferritins, or promote mRNA stability in case of transferrin receptor-1. On the other hand, 
when the IRPs recognize there is an excess of iron, they unbind from the IRE, promoting the 
translation of ferritins and the endonucleolytic cleavage of transferrin receptor-1 mRNAs. 
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1.3 TRANSFERRIN RECEPTOR-1 
As previously stated, iron is transported by transferrin to virtually all tissues 
within an organism. However, intracellular iron incorporation is proportional to the 
number of receptors available at the cellular membrane; therefore, cells expressing 
more transferrin receptor-1 (TfR-1) usually have higher iron acquisition capacities 
than cells expressing low levels of TfR-1. Examples of cells with high numbers of 
TfR-1 include immature erythroid cells, which contain the highest mass of total 
TfR-1 in an organism, as well as non-proliferating cells, such as hepatocytes and 
endothelial cells of the blood-brain barrier (Gatter et al., 1983; Ponka and Lok, 
1999). Also, rapidly proliferating cells, both normal and malignant, have been 
shown to have a higher number of transferrin receptor-1 (Inoue et al., 1993), which 
may be due to a greater need of iron for synthesis of DNA (Jordan and Reichard, 
1998). Because TfR-1 is known to be expressed in high levels in cancer cells, several 
studies analyse this receptor for targeted drug delivery therapies (Moore et al., 
2001; Qian et al., 2002; Wang et al., 2010). 
It has been shown that external factors may also contribute to an 
up-regulation of TfR-1 expression levels. This is the case when adult MSC were 
labelled in vitro with SPIONs and ultrasmall SPIONs (USPIONs). An up-regulation of 
TfR-1 was observed in this cell line only when transfection agents were not used. 
The authors hypothesized that this enhanced up-regulation of TfR-1 was due to a 
higher iron uptake (Schäfer et al., 2007). 
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1.3.1 Transferrin receptor-1 molecular structure and biochemistry 
The transferrin receptor-1 gene is 33 kb and is located on chromosome 3 in 
humans, and chromosome 16 in mice, and is transcribed into a ~5 kb mRNA. In 
mice, only one variant of this gene exists, while in humans two variants can be 
found, encoding for the same protein, only differing in the 5’UTR (data available 
from National centre for biotechnology information - NCBI). The 3’UTR is one of the 
most important regions in TfR-1 mRNA and it was first discovered by Owen and 
Kühn (1987). This region is remarkably large, composed of about 2500 bp in total, 
and five conserved fragments, corresponding to the IREs involved in 
post-transcriptional control of the receptor (Appendix I, mouse TfR-1 mRNA 
sequence, p.242). 
At the protein level, mammalian TfR-1 is a homodimer with two identical 
transmembrane subunits, each with a molecular weight of approximately 85 kDa, 
and joined by two disulphide bonds (Jing and Trowbridge, 1987). The crystal 
structure was first shown by Lawrence et al. (1999) and revealed three different 
regions: i) a globular extracellular portion, where transferrin binds; ii) a hydrophobic 
intramembranous region to anchor the protein within the cell membrane; and 
finally iii) a cytoplasmic region, essential for normal endocytosis. More importantly, 
within the globular extracellular portion, three different domains were identified: a 
protease-like domain, an apical domain and a helical domain (Lawrence et al., 
1999). It is important to note that in this extracellular domain, there is a 
trypsin-sensitive site, and if proteolytic cleavage occurs, transferrin binding activity 
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is lost (Rutledge et al., 1994). Complete knock-out of TfR-1 leads to death during 
embryonic development, as this gene is essential for normal development of 
erythrocytes as well as the nervous system (Levy et al., 1999). 
1.3.2 Cellular internalization of iron though transferrin/TfR-1 complex 
At physiological pH (7.4), once iron-bound transferrin reaches the cell 
membrane, it interacts with TfR-1. Each subunit of TfR-1 binds to one transferrin 
molecule and the transferrin/TfR-1 complex is internalized by receptor-mediated 
endocytosis. This binding between transferrin and TfR-1 only takes place if 
transferrin is loaded with iron, in the form of mono or diferric transferrin. The 
binding with diferric transferrin is about 30 times stronger than with monoferric 
transferrin. If transferrin is present without iron (apo-transferrin), it is not 
recognised by TfR-1, thus avoiding an inefficient competition between 
mono/diferric transferrin and apo-transferrin (Young et al., 1984). Then, by an 
energy-dependent process, the endocytic vesicle environment turns rapidly acidic, 
where the pH decreases to about 5.6 (Gomme et al., 2005; Hémadi et al., 2004). At 
this low pH concentration and also aided by TfR-1, iron molecules (in the form of 
Fe2+) are released from transferrin and cross the endosomal membrane through the 
divalent metal transporter DMT-1, also known as Nramp2 (Fleming and Andrews, 
1998). The iron-free Transferrin/TfR-1 complex is then recycled to the cell 
membrane, where at physiological pH, TfR-1 unbinds from apo-transferrin. 
Apo-transferrin is then ready for a new cycle of iron transport. It is estimated that 
each transferrin molecule experiences more than 100 cycles during its life-time 
(Aisen, 1998). 
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1.3.3 Transferrin receptor-2 
A second transferrin receptor, designated as TfR-2, was first revealed by 
Kawabata et al. (1999), and it has a much lesser impact on cellular iron acquisition. 
It has a high homology (45% identity) with the classical TfR-1 and internalizes iron in 
a similar manner, but at a 25-fold lower rate when compared to TfR-1 (Kawabata et 
al., 1999). Contrary to TfR-1, it is responsible for non-transferrin-bound iron uptake 
(Graham et al., 2008) and its tissue distribution is very different. TfR-2 is expressed 
in two transcripts: α-TfR-2 is found mainly in the liver and in liver-derived cell lines, 
while β-TfR-2 is found in several cell types but at low expression levels (Aisen et al., 
2001; Kawabata et al., 1999; Trinder and Baker, 2003). It is also important to note is 
that TfR-2 does not contain any IREs and its expression is regulated at the 
post-transcriptional level by the binding to diferric transferrin (Robb and Wessling-
Resnick, 2004).   
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1.4 FERRITIN  
As previously discussed, ferritin is a highly specialised molecule whose 
primary function is to store ferric iron (Fe3+) inside its protein shell in a 
biochemically safe configuration. Its function is so important that the 
three-dimensional conformation appears highly conserved throughout evolution. 
Also, it is expressed ubiquitously in most eubacteria, archea, plants and animals, 
with the exception of yeasts. Ferritins are commonly known as the cell’s iron 
deposit, storing around 20-30% of the total iron present in an organism. They can 
then release iron in a controlled fashion upon cellular demand (Harrison and Arosio, 
1996; Harrison et al., 1987; Theil, 1987). Ferritins are mainly found in the cell’s 
cytoplasm, but they can be found as well inside lysosomes, the nucleus and 
mitochondria (mitochondrial ferritin or MtF). This distribution enables ferritin not 
only to protect nuclear and mitochondrial DNA from toxic effects resulting from iron 
oxidation, but also to be broadly distributed to easily provide iron where and 
whenever needed (Corsi et al., 2002; Koorts and Viljoen, 2007; Levi and Arosio, 
2004). Also, some common functions associated with ferritins include the 
participation in the iron recycling process in macrophages and storage of iron in 
hepatocytes not only during short, but also during long-term periods (Theil, 1990). 
According to the Gene Ontology (GO) database, besides the well-known cellular iron 
homeostasis function, ferritins are also involved in various biological processes, 
such as the immune response, cell proliferation (Wu et al., 1999) and 
transmembrane and post-Golgi vesicle-mediated transport (UniProt KB P02794). 
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1.4.1 Ferritin molecular structure and biochemistry  
Ferritins are protein complexes formed of two different subunits: H or heavy 
subunit and L or light subunit. At the gene level, H and L subunits derive from two 
different genes, ferritin heavy chain-1 (Fth-1) and ferritin light chain-1 (Ftl-1), and 
are located in different chromosomes: Fth-1 gene is found on chromosome 11 and 
19 and Ftl-1 gene is found on chromosome 19 and 7, in humans and mice, 
respectively (data available from NCBI). The complete knock-out of Fth-1 in mouse 
was proven to be embryonically lethal, but if one of the alleles is present the mice 
were healthy and fertile (Ferreira et al., 2000). Both genes have homologous coding 
sequences but greatly differ in their UTRs. The 5’UTR of Fth-1 has been vastly 
studied over the years and several regulatory regions have been described. 
Amongst four described so far, the most important one is the IRE, which is a highly 
conserved 28 base-pair sequence (Appendix I, mouse Fth-1 mRNA sequence, p.242). 
This cis-acting element forms a stem-loop structure which interacts with 
trans-acting IRPs according to iron availability, as previously described (Torti and 
Torti, 2002; Worwood, 1990). Ferritin expression is not only controlled 
post-transcriptionally via IRP/IRE regulatory system, but it is also subject to a strict 
genetic control, depending on the particular tissue and conditions associated with 
oxidative stress (Arosio and Levi, 2002; Boyd et al., 1985). 
At the protein level, each ferritin is a heteropolymer composed of variable 
ratios of heavy and light subunits, of 21 and 19 kDa, respectively. Ferritins usually 
assemble subunits in different ratios giving rise to a large variety of isoferritins. In 
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mammals, ferritins consisting of just one subunit can be assembled, although 
homopolymers are rarely formed (Santambrogio et al., 1993). Multiple copies of 
ferritins are usually present within a cell and 24 subunits are needed to form an 
empty ferritin shell whose outer and inner diameter are about 12 and 8 nm, 
respectively. Ferritin is known as apo-ferritin when iron is not present inside its 
core. Each apo-ferritin molecule can store up to 4500 Fe3+ atoms (Harrison and 
Arosio, 1996). 
1.4.2 Ferritin internalization of iron 
Studies have demonstrated that the heavy-subunit is the main controller of 
ferritin function and has a ferroxidase activity centre, which is essential for iron 
oxidation and incorporation. In contrast, the light-subunit facilitates the 
heavy-subunit activity and is responsible for iron nucleation and mineralization (Levi 
et al., 1988; Treffry et al., 1997). Therefore, the heavy-subunit incorporates iron 
several-fold faster than the light-subunit, even though the light subunit is more 
stable to physical denaturation (Lawson et al., 1989; Santambrogio et al., 1992). To 
sequester iron in a non-toxic way, the ferroxidase centre of the heavy-subunit 
interacts with ferrous iron (Fe2+) to promote its oxidation, also consuming peroxides 
used in the Fenton reaction, and thus avoiding the production of hydroxyl radicals. 
For that reason, ferritin is also known to be a dynamic inhibitor of free radical 
production with an antioxidant action (Arosio et al., 2009; Chasteen and Harrison, 
1999).  
  
INTRODUCTION | 20  
1.5 MAGNETOTACTIC BACTERIA, MAGNETOSOMES AND MAGA 
More commonly known as magnetotactic bacteria, Magnetospirillum sp. is a 
gram-negative bacterium. The two most studied species are M. magneticum and 
M. gryphiswaldense. They are found in freshwater, have motility, mostly due to 
flagella, and in their pure form are known to perform aerobic respiration (Bazylinski 
and Frankel, 2004). This type of bacteria is also thought to migrate and 
self-orientate according to the earth’s magnetic field (Blakemore, 1975). This is only 
possible due to a specialized organelle, known as the magnetosome (Stolz et al., 
1986), also routinely described as a bacterial magnetic particle or intracellular 
superparamagnetic nanocrystal. The organelle derives from invaginations of the 
prokaryotic inner plasma membrane and is able to accumulate biomineralized iron, 
if an iron-rich environment is present (Komeili et al., 2006). During the 
mineralization process, iron incorporation can occur either by the formation of 
crystals of magnetite (Fe3O4), giving rise to iron oxide magnetosomes (Frankel et al., 
1979), or crystals of greigite (Fe3S4), creating iron sulphite magnetosomes (Mann et 
al., 1990). Both of these types are typically between 35 and 120 nm in diameter, 
depending on stage of maturity, and are protected by a thin lipid bilayer (Bazylinski 
et al., 1994) (Figure 2). 
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Figure 2 – Transmission electron microscopy of a Magnetospirillum magneticum with a 
magnetosome chain (A) and of isolated magnetosomes (B) with intact membranes, 
indicated by the arrow. Scale bars are 100 nm. Reproduced with permission from Benoit et 
al. (2009) (A) and from Schüler (2004) (B). 
Different species of magnetotactic bacteria have specific types and 
morphologies of magnetosomes, but share some characteristics such as a high 
chemical purity, narrow sizes and specific arrangements within the cell. Usually, 
magnetosomes form a linear chain and align according to the cytoskeletal filaments. 
This alignment allows the organisms to orientate relative to an external magnetic 
field (Komeili et al., 2006). The rare features of this prokaryotic organelle make it an 
interesting candidate of MRI cell tracking studies. Over the past decade, 
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magnetotactic bacteria or harvested and purified magnetosomes (Lang and Schüler, 
2006) have been used as biogenic magnetic nanoparticles for several applications in 
biotechnology (Yoshino et al., 2010), cancer therapeutics (Mannucci et al., 2014) 
and even robotics research (Martel et al., 2009). 
1.5.1 Magnetosome formation 
A large number of genes have been identified in an organized and conserved 
genomic region named the magnetosome island or MAI, that have been shown to 
be of great importance in magnetosome formation and function. In the 
magnetotactic bacterium AMB-1 strain, the MAI was predicted to comprise 
approximately 2% of the whole genome content (Fukuda et al., 2006; Ullrich et al., 
2005). This cluster of genes effectively coordinates the cytoplasmic membrane 
invagination, vesicle formation, iron absorption, transport and incorporation, and 
finally, magnetite crystallization (Komeili et al., 2006; Murat et al., 2010). Also, an 
iron responsive study revealed hundreds of up-regulated and down-regulated genes 
are involved in magnetosome regulation (Suzuki et al., 2006). Amongst these genes, 
there is a particular interest in MagA, firstly identified by Matsunaga et al. (1992), 
which encodes for an iron transporter localized both in the cytoplasmic and 
magnetosome membranes (Matsunaga et al., 1992; Nakamura et al., 1995b) 
(Figure 3). 
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Figure 3 – Simplified illustration showing a hypothesized mechanism for membrane 
invagination, iron biomineralization of magnetosomes and MagA function as an iron 
transporter protein. Illustration based on Komeili et al. (2006). 
1.5.2 MagA gene 
As previously stated, MagA was identified as an iron transporter of 
magnetotactic bacteria and in magnetotactic bacterium AMB-1 strain, the MagA 
gene is translated into a protein homologous to the potassium efflux 
membrane-binding protein found in Escherichia coli (Nakamura et al., 1995b). The 
MagA coding sequence from Magnetospirillum magnetotacticum MS-1 strain, 
which is of nearly 1.3 kb, can be found in Appendix I (p.242). Gene expression 
analysis led to the finding that MagA transcription is higher when iron 
concentrations are low. Also, MagA accumulates iron inside the magnetosome 
vesicles in an energy-dependent manner, acting like an H+/Fe2+ antiporter and 
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therefore, MagA is believed to be a vital element in magnetosome synthesis 
(Nakamura et al., 1995a; Nakamura et al., 1995b). Conversely, a recent study where 
a targeted deletion of the MagA gene was performed in both M. magneticum and 
M. gryphiswaldense suggests that MagA is not essential for magnetosome 
formation. This study showed that both mutants were able to form magnetosomes 
as efficiently as wild-type bacteria. Further investigation revealed that the MagA 
gene is not localized within the MAI, the genomic region that contains all essential 
genes for magnetosome formation (Uebe et al., 2012). 
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1.6 AIMS 
The field of cell tracking using MRI as the base technology is of great interest 
and has been explored over the past decades. However, a labelling or tracking 
method that proves to be both efficient and stable in a long term-basis and that can 
also be used to detect cells in deep-set organs in vivo is yet to be further explored. 
The main focus of this work was to compare three magnetic reporter genes, 
transferrin receptor-1, ferritin heavy chain-1 and MagA genes, previously reported 
to provide an efficient iron load when overexpressed in target cells, thus giving rise 
to a stronger MRI contrast. In order to do this: 
1. Magnetic reporter genes were stably introduced into established 
cell/ stem cell lines, using a HIV-lentiviral approach, alongside 
fluorescent reporter genes, allowing for bicistronic expression of 
both genes. 
2. Several iron concentrations and derived supplements were evaluated 
to adjust optimum supplementation conditions to transduced cells in 
order to maximize the cell iron load capacity and, thus, MRI contrast 
capability. 
3. Transferrin receptor-1 was individually evaluated as a potential 
magnetic reporter gene in a model cell line, Chinese Hamster 
Ovary K1 (CHO K1) cell line. 
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4. Ferritin heavy chain-1 and transferrin receptor-1 were assessed as 
magnetic reporters both individually and together in mouse 
mesenchymal stem cells (mMSC). 
5. MagA was individually evaluated as a potential magnetic reporter 
both in stem cell lines such as, mouse embryonic stem cells (mESC), 
mMSC and mouse kidney stem cells (mKSC), and in established cell 
lines like CHO K1 and human embryonic kidney (HEK) 293T(N) cells. 
6. Once the different magnetic reporters (or respective controls) were 
introduced in a specific cell line, some common parameters were 
assessed: i) reporter gene integration, over passages and when 
exposed to different iron concentrations; ii) cell viability at different 
time-points; iii) differences in iron homeostasis when confronted 
with the overexpression of iron-related proteins; iv) intracellular iron 
uptake in vitro and finally, v) MRI imaging of cell pellets and of chick 
embryos, which were used as the animal model for this study. 
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CHAPTER 2  
MATERIALS AND METHODS 
OVERVIEW 
This chapter describes molecular biology techniques and cell culture 
procedures that were used to generate and evaluate the reporter cell lines. The 
production and integration of self-inactivating (SIN) replication-defective VSV-G 
pseudotyped HIV-based lentiviral particles, as well as the protocols for the 
assessment of the transgenes at the mRNA and protein expression levels are 
described. Also, the potential of these transgenes to serve as magnetic reporters in 
stem cells was evaluated by determining the iron content and MRI contrast of cells. 
Finally, the viability, proliferation and differentiation capacity of these cells was 
explored. Buffers, solutions, media, restriction enzymes, equipments and other 
underlined material are detailed in Appendix II (p.245). Manufacturer’s protocols 
are only described in case modifications were made. 
2.1 MOLECULAR CLONING  
2.1.1 Reporter genes cDNA  
Three reporter genes were chosen for this research, Mus musculus ferritin 
heavy chain 1 (Fth-1) and transferrin receptor-1 (TfR-1) and 
Magnetospirillum magnetotacticum (MS-1 Strain) MagA. Mouse Fth-1 and TfR-1 
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cDNAs were synthesized from an RNA sample of the D1 mesenchymal stem cell line 
(see section 2.2.1 Cell lines, p.39). Iron responsive elements, present in both cDNAs, 
were identified using the online software SIREs Web Server 2.0 (Campillos et al., 
2010) and excluded from amplification. Magnetotactic bacteria MagA cDNA was 
extracted from a commercial pCR2.1MS-magA plasmid (Addgene, 21751). 
Sequences of cDNAs can be found in Appendix I (p.242). 
2.1.2 Extraction of total RNA 
Cells cultured in a 35 mm dish were used for RNA extraction with TRIzol® 
Reagent. Growth medium was removed from the culture dish and 1 ml of TRIzol® 
Reagent was added and the cells were lysed by pipetting up and down. The 
homogenate was transferred to a 1.5 ml microcentrifuge tube to which 200 µl of 
chloroform was added. This solution was then shaken by hand for about 15 s, 
incubated for 2 min at room temperature (RT) and finally centrifuged at 12,000 xg 
for 15 min at 4oC. This resulted in the formation of three clearly separated phases of 
which the top one contained the RNA. This phase was carefully transferred to a 
clean tube and mixed with 500 μl of 100% 2-propanol, incubated at RT for 10 min 
and then centrifuged in the same conditions as described previously to pellet the 
RNA. The supernatant was carefully removed and the pellet was washed with 1 ml 
of 75% ethanol and centrifuged at 7500 xg for 5 min at 4oC. After discarding the 
supernatant, the RNA pellet was air-dried and dissolved in the appropriate volume 
of molecular biology water.  
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2.1.3 DNase treatment of RNA 
A DNase treatment was performed to remove any traces of DNA 
contamination: 8 µl of total RNA were mixed with 1x RQ1 DNase 10x Reaction 
Buffer and 1 U of RQ1 RNase-Free DNase per µg of RNA and incubated for 30 min at 
37oC. Afterwards, 1 µl of RQ1 DNase Stop Solution was added to the mix and 
incubated at 65oC for 15 min, in order to completely stop the reaction. From this 
point, samples were either handled on ice or stored at -80oC until further use. 
2.1.4 Synthesis of cDNA by reverse transcriptase 
The synthesis of the first-strand cDNA from total RNA was performed with 
SuperScript™III Reverse Transcriptase. Briefly, a maximum of 5 µg of total RNA were 
added to a solution containing 200 ng of random hexamers, 10 mM 
deoxyribonucleotide (dNTP) mix and molecular biology water up to 13 µl, 
denatured at 65oC for 5 min, followed by a quick chill on ice. A mix of 5x First Strand 
Buffer, 0.1 M dithiothreitol (DTT) and 200 U of SuperScript™III-RT were then added. 
The resulting solution was mixed gently and incubated for 5 min at room 
temperature, followed by incubation at 50oC for 60 min. Afterwards, the reaction 
was inactivated by heating up to 70oC for 15 min. The solution was stored at -20oC 
until further use. 
2.1.5 cDNA amplification by polymerase chain reaction 
Fth-1, TfR-1 and MagA cDNA fragments were amplified by polymerase chain 
reaction (PCR) in a 2720 Thermal Cycler, using a set of specific primers (Sigma), 
  
MATERIALS AND METHODS | 30  
Fth-1_F/Fth-1_R for Fth-1, TfR-1_Kozak_F/TfR-1_R for TfR-1 and 
MagA_Kozac_F/MagA_R for MagA cDNA amplification, as well as a proof-reading 
polymerase, to unsure there were no amplification errors (Table 1). The primers and 
the annealing temperatures (Ta) used here and in section 2.1.10 Cloning of lentiviral 
constructs (p.33) are detailed in Table 2. Ta was determined by subtracting 5oC from 
the melting temperature (Tm) of each set of primers. The gene-specific primers 
were designed with restriction enzyme BamHI or EcoRI at the 5’ end. 
Table 1 – Conditions of PCR reaction and cycling for cDNA fragment amplification. 
PCR Set up 1x Reaction Mix 
Cycling 
conditions 
 
cDNA / plasmid DNA 2 µl / 10 ng/µl   
Forward primer (10 µM) 1 µl 95oC, 1 min – 1x  
Reverse primer (10 µM) 1 µl 95oC, 45 s 
30x dNTPs (10 mM) 1 µl Ta, 45 s 
AccuBuffer (10x) + MgSO4 (1.5 mM) 5 µl 72
oC, 2 min 
Accuzyme™ DNA polymerase (2.5 U/µl) 1 µl 72oC, 5 min -1x  
H2O Vol up to 50 µl   
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Table 2 – Description of primers used to amplify cDNA fragments by PCR, with the 
respective annealing temperatures and resulting product size. Note that in the primer 
sequences, the red nucleotides represent either the start codon (ATG) or the stop codon 
(TTA, TCA). The green sequence is a Kozac sequence that was purposely introduced before 
the start site of TfR-1 and MagA cDNA to help initiate the translation process. This was not 
performed for Fth-1 cDNA because a native Kozac sequence is already present. Novel 
restriction enzymes are highlighted in bold. 
 * - A BamHI restriction site was introduced to the primer. 
** - An EcoRI restriction site was introduced to the primer. 
2.1.6 Electrophoresis by FlashGel® System 
The resulting PCR products were confirmed by running a mix of 1 µl of PCR 
product, 1 µl of FlashGel® Loading Dye and 3 µl of water in a 1.2% FlashGel® 
Cassette using the FlashGel® System. In order to estimate the cDNA fragment sizes, 
either FlashGel® DNA Marker 100 bp-4 kb or FlashGel® QuantiLadder were used. 
Each single band was recovered according to the manufacturer’s instructions with 
the use of FlashGel® Recovery Kit. 
 
cDNA Primer 
Sequence 
(5’-3’) 
Ta 
(oC) 
Product 
(bp) 
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 Fth-1 
Fth-1_F* GGGATCCCCGCCGCCACCATGAC 
59 575 
Fth-1_R* GGATCCCTTAGCTCTCATCACCGT 
TfR-1 
TfR-1_Kozak_F GGAGCCACCATGATGGATCAAGCCAG 
55 2319 
TfR-1_R GCATGTTACATTTAAAACTCATTGTC 
MagA 
MagA_Kozac_F* GGGATCCGCCACCATGGACCTGCATCATC 
57 1314 
MagA_R* CGGGATCCTCAGATTCCAGT 
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Fth-1 
Fth-1_EcoRI_F** GGATTAGGAATTCCCGCCG 
57 586 
Fth-1_BamHI_R* GCAACTGGGATCCCTTAGCTC 
TfR-1 
TfR-1_Kozak_BamHI_F* GACGGATCCAGCCACCATGATGGAT 
60 2322 
TfR-1_BamHI_R* GCAATCGGGATCCTTTAAAACTC 
MagA 
MagA_EcoRI_F** GGGGAATTCGCCACCATGG 
59 1319 
MagA_BamHI_R* GCGTACGGGATCCTCAGATTC 
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2.1.7 Cloning transgenes cDNA into pCR®II-TOPO® 
cDNA fragments of each transgene were cloned into pCR®II-TOPO®. As 
suggested in the TOPO TA Cloning Kit, an A-tail was added to the purified PCR 
fragments by the addition of 1x BIOTAQ Buffer, 0.5 µl of dNTPs (10 mM) and 2.5 U 
of BIOTAQ™ DNA Polymerase up to a reaction volume of 10 µl and incubating for 10 
to 15 min at 72oC. Afterwards, ligation reactions were prepared by adding 4 µl of 
PCR fragments, with 1 µl of salt solution and 1 µl of TOPO vector. This solution was 
mixed gently and incubated at room temperature for 5 min. 
2.1.8 Transformation of chemically competent cells by heat-shock 
Approximately 2 µl of ligation reaction were mixed with 
One Shot® Match™-T1R Competent Cells (provided with the TOPO TA Cloning Kit) 
and processed according to manufacturer’s instructions. Afterwards, 50 µl of the 
culture were plated in pre-warmed selective LB-Agar plates (100 µg/ml ampicillin 
selection) supplemented with 40 mg/ml of X-gal and incubated overnight at 37oC. 
The purpose for the supplementation of LB plates with X-gal is to allow the 
blue/ white screening of colonies. If an insert is cloned to pCR®II-TOPO® vector, it 
will disrupt the LacZ gene present within the multiple cloning site (MCS) and 
consequently the β-galactosidase enzyme will not be produced, giving rise to a 
white colony. On the other hand, if the LacZ gene is kept undisrupted because no 
insert was cloned into MCS, the production β-galactosidase enzyme will form a blue 
precipitate when exposed to X-gal substrate, leading to the formation of a blue 
colony (see Appendix III for more details on the vector, p.251). 
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2.1.9 Analysis of transformed colonies 
Several white colonies were individually picked and grown in the presence of 
the appropriate antibiotic. Each colony was diluted in 3 ml of LB medium with 
100 µl/ml of ampicillin and incubated at 37oC overnight, with shaking (200 rpm). 
High quality plasmid DNA mini-preparations were then made using QIAprep® spin 
miniprep kit, following the protocol provided by the manufacturer. The plasmid 
DNA preparations were measured for DNA concentration with a NanoDrop™ 1000 
spectrophotometer, and were then used for colony restriction analysis, sequencing 
of positive clones and cloning into lentiviral vectors. 
 For colony restriction analysis, 250 ng of plasmid DNA were digested with 
5 U of the appropriate restriction enzyme(s) in 1x of the corresponding buffer, up to 
a final reaction volume of 20 µl. The digests were left for at least 2h with the 
incubation temperature respecting the manufacturer’s instructions for each 
enzyme. Afterwards, one or two clones containing plasmids with the expected sizes 
evaluated by gel electrophoresis of the digestion products were selected for 
confirmation by sequencing. All sequencing analysis was performed by DNA 
Sequencing and Services (University of Dundee) and the primers used for 
sequencing are detailed in Table 4 (section 2.1.13 Ligation, p.36). 
2.1.10 Cloning of lentiviral constructs 
Mouse Fth-1 and bacteria MagA PCR fragments were individually cloned into 
the MCS of pHIV-dTomato vector (Addgene, 21374) and TfR-1 PCR fragment into 
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the MSC of pHIV-eGFP vector (Addgene, 21373). To do this, 4.5 µg of vector 
(pHIV-dTomato) was opened through two rounds of digests for at least 2 h, at 37oC: 
first digest was with 5 U of restriction enzyme EcoRI-HF™ and the 1x corresponding 
buffer, up to a volume of 20 µl with molecular biology water, followed by a phenol: 
chloroform purification and ethanol precipitation step (see section 2.1.11 Nucleic 
acid purification and precipitation, p.35), and digested once again with 5U of 
restriction enzyme BamHI, under the same conditions. In the case of pHIV-eGFP, 
4.5 µg of vector were simply digested with BamHI. Digestions were confirmed by 
running 1 µl of digestion product, in a 1.2% FlashGel Cassette. Both vectors were 
then subjected to phosphatase treatment with 10 U of Calf Intestinal Alkaline 
Phosphatase (CIP), for 1h at 37oC, to prevent vector re-circularisation. 
Inserts previously cloned in pCR®II-TOPO® were amplified by PCR using a 
new set of primers, in which, for Fth-1 and MagA, an EcoRI restriction enzyme was 
present in the forward primer and a BamHI restriction enzyme in the reverse 
primer; in the case of TfR-1, both primers presented BamHI restriction sites. All 
primers with introduced restriction sites were followed by a non-specific nucleotide 
tail (Table 2, p.31) to allow an efficient digest of the enzymes in the PCR fragment 
ends. After cDNA amplifications as described before, the entire PCR products were 
cleaned using a PCR Cleaning Kit, following the manufacturer’s instructions. Then, 
Fth-1 and MagA cDNA fragments were subjected to two subsequent restriction 
digestions, while TfR-1 cDNA fragment was subject to a single digestion, as 
performed for the plasmid vector pHIV-dTomato and pHIV-eGFP, respectively. The 
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resulting products (vector and inserts) were then purified by agarose gel 
electrophoresis. 
2.1.11 Nucleic acid purification and precipitation 
This procedure was used to clean nucleic acid solutions (DNA or RNA). 
Molecular grade water was used to bring the solution to a final volume of 100 µl 
and an equal volume of solution consisting of Phenol: Chloroform: Isoamyl alcohol 
(25:24:1) was added. The sample was vortexed and centrifuged at 15,682 xg for 
2 min, at room temperature; the upper aqueous phase (with the nucleic acids) was 
collected and transferred into a clean tube. 
Nucleic acids were precipitated by adding 2.5x volumes of pure ethanol and 
1:10 volume of 3 M sodium acetate pH 5.2 to the previous solution. After a quick 
vortex, the solution was left at -80oC for at least 30 min and then centrifuged at 
15,682 xg, for 25 min at 4oC. The supernatant was discarded and the pellet washed 
with 100 µl 70% ethanol and centrifuged once again at 15,682 xg, for 10 min at 
room temperature. After removing the supernatant, the pellet was air-dried and 
resuspended in the appropriate amount of molecular grade water, usually 10 to 
20 µl. 
2.1.12 Electrophoresis of agarose gels 
This technique was mainly used to visualise and verify the integrity of nucleic 
acids, to estimate the size of fragments when comparing to a known 
molecular-weight marker, to confirm the complete digestion of a restriction enzyme 
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with its substrate or to recover a specific DNA band. Agarose powder was added to 
1x TAE buffer, to make a final gel concentration of 1% (w/v), boiled in a microwave 
oven and left to cool for a while; then, 10,000x dilution of SYBR®Safe DNA Gel Stain/ 
Ethidium Bromide was added for visualization of nucleic acids under ultraviolet (UV) 
light. The solution was poured into a gel tray, where it was left to solidify. 
Afterwards, digested PCR fragments were mixed with 5x HyperLadder™ loading 
buffer, to 1x final concentration, to increase the density to the sample and for visual 
control of the electrophoresis. An electric potential of 100 V was applied to the gel 
immersed in 1x TAE buffer. Samples were observed under UV light and sizes of 
fragments were estimated by comparison with a molecular-weight maker, 
HyperLadder™I (200 bp-10 kb) or HyperLadder™IV (100 bp-1000 bp), depending on 
the expected size of the sample. Specific size bands, corresponding to 
pHIV-dTomato, pHIV-eGFP linear vectors, Fth-1, TfR-1 and MagA cDNAs, were 
carefully extracted from the agarose gel and purified using QIAquick gel extraction 
kit. 
2.1.13 Ligation 
The ligation reactions between plasmid vectors and each cDNA were 
performed at molar ratios of 1:3 and 1:7 (vector DNA: insert DNA), up to a 
maximum of 200 ng of DNA in a 10 µl solution, prepared according to Table 3. The 
ligations were left for 16 h, at 4oC. Two controls were performed: 1:0 corresponds 
to the digested vector with phosphatase treatment and 1:0 P to the digested vector 
with no phosphatase treatment. 
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Table 3 – Conditions used for ligation reactions. 
Ligation Set up 
Molar 
Ratios 
Controls 
1:3 1:7 1:0 1:0 P  
Plasmid Vector DNA 1 1 1 1 
Insert DNA 3 7 0 0 
10x Ligation Buffer 1 1 1 1 
T4 DNA Ligase (1 U/µl) 1 1 1 1 
H2O 4 0 7 7 
Total Volume 10µl 
Half of each ligation reaction was transformed into One Shot® Stbl3™ 
Chemically Competent E. coli cells, according to the manufacturer’s protocol. 
Transformed colonies were selected by growth in the presence of 100 µg/ml 
ampicillin, screened for positive clones and processed for sequencing as described 
above (section 2.1.9 Analysis of transformed colonies, p.33). Positive lentiviral 
constructs were also sent for sequencing of the whole vector (Table 4) to confirm 
the presence of all key features detailed in Appendix III, pHIV-dTomato and 
pHIV-eGFP plasmid maps. 
  
MATERIALS AND METHODS | 38  
Table 4 – Primers used for sequence analysis of the constructs generated. F – Forward 
orientation; R – Reverse orientation. 
2.1.14 Sequence analysis 
The sequencing output was analysed using Chromas Lite Software, 
Version 2.01 and homology searches of DNA databases were performed through 
NCBI, using the basic local alignment search tool (BLAST). 
Vector Sequenced Primer - Orientation Sequence (5’-3’) 
pCR2.1MS-magA 
(Addgene, 21751) 
T7 
M13 
F 
R 
TAATACGACTCACTATAGGG 
CAGGAAACAGCTATGAC 
pCR®II-TOPO_Fth-1 
pCR®II-TOPO_TfR-1 
pCR®II-TOPO_MagA 
pHIV-dTomato_Fth-1/ 
pHIV-eGFP_TfR-1/ 
pHIV-dTomato_MagA 
Seq_insert F CTCAAGCCTCAGACAGTG 
Seq_insert R GGCTTCGGCCAGTAACG 
Seq1 F CTGGAAGCTTCTTG 
Seq2 F CCAGGCCCTGAAGC 
Seq3 F CGTAAAAAGGCCGCG 
Seq4 F CTACGATACGGG 
Seq5 F GGGGTTCCGCGCA 
Seq6 F GATGCGGTTTTGGCAG 
Seq7 F GAGGAAGAGCAAAAC 
Seq8 F GAGACAGATCCATTCG 
Seq9 F CGCTGCTTTCGATAAG 
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2.2 CELL CULTURE 
2.2.1 Cell lines 
In total, six adherent cell lines were used in the course of this study, 
specifically: 
 Human embryonic kidney (HEK) 293 T(N) cells, purchased from 
System Biosciences (LV900A-1); 
 Mouse Brachyury (Bra)-GFP knock-in embryonic stem cells, here 
simply described as mESC, were kindly provided by Dr Georges 
Lacaud, from Paterson Institute for Cancer Research (Manchester). 
Detailed information about this cell line can be found in Fehling et al. 
(2003); 
 Mouse mesenchymal stem cells (mMSC) (D1 ORL UVA), purchased 
from ATCC (CRL-12424™); 
 Mouse kidney-derived stem cells H6 (mKSC), established by the 
Stem Cell Research group (University of Liverpool). More information 
about this cell line can be found in Mora et al. (2012); 
 Chinese hamster ovary (CHO) cell line K1, purchased from ATCC 
(CCL-61TM). 
2.2.2 Routine cell culture 
Cell culture procedures were performed in sterile conditions in a 
Biomat class II safety cabinet and solutions were pre-warmed to 37oC before use. 
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All surfaces, materials and mediums in direct or indirect contact with the working 
area were either sterile or disinfected with 70% ethanol. 
Cells were cultured in specific medium for each cell type, always grown at 
37oC in a humified incubator with 5% CO2 and passaged every 2-3 days when they 
reached a density of around 70-80%. HEK 293T(N), mMSC and mKSC were grown in 
cell culture medium A, mESC in cell culture medium B and CHO K1 in cell culture 
medium C. For subculturing, the culturing medium was discarded and the cells were 
detached from the dish by treatment with 1% trypsin/EDTA for 2 min. Trypsin 
treatment was stopped by adding 2x times the trypsin volume with culture medium 
containing 10% foetal calf serum (FCS). After a 3 min and 233xg centrifugation, the 
supernatant was discarded and the cells resuspended in the appropriate amount of 
fresh growth medium. This solution was used to make 1:3 or 1:5 dilutions, in case 
the cell line was to be maintained in culture, or the cells were counted using a 
haemocytometer or a TC20™ Automated Cell Counter and a specific number of cells 
were seeded in new plates/ dishes. For mESC and CHO K1 cells, the plates/ dishes 
were treated with 0.1% (w/v) gelatine solution at room temperature for at least 
15 min, prior to seeding. 
2.2.3 Cryopreservation and recovery of cells 
For cryopreservation of cells, trypsin treatment was performed as described 
previously. After discarding the supernatant of pelleted cells, cells were 
resuspended in freezing medium, at approximately 106 cell density per ml of 
medium. The cell suspension was then transferred into cryovials (1ml each), 
  
MATERIALS AND METHODS | 41  
inserted into a freezing container filled with 2-propanol and incubated at -80oC for 
2 days, after which they were transferred to a liquid nitrogen tank. 
In order to thaw cryopreserved cells, the vial was quickly thawed in a 37oC 
water bath and its contents immediately transferred to 5 ml of the appropriate 
medium. The suspension was centrifuged at 500xg for 3 min and the supernatant 
was discarded. The cells were resuspended in the proper amount of culture 
medium and maintained as described above. 
2.3 GENERATION OF REPORTER CELL LINES 
The lentiviral expression vectors pHIV-dTomato and pHIV-eGFP are a third 
generation vectors, suitable for 2nd and 3rd generation packaging systems. Here, a 
second generation packaging system was used, which involves the use of three 
plasmids for the production of viral particles (expression or transfer plasmid, an 
envelope plasmid and a packaging plasmid). The system is divided in several DNA 
units to ensure the user’s safety and avoid unwanted self-assembly of viral particles. 
These HIV-based plasmids are also self-inactivating, i.e., once they infect (or 
transduce) a cell they become inactive and cannot replicate. In particular, 
pHIV-dTomato and pHIV-eGFP were chosen due to certain desirable characteristics, 
such as a constitutive elongation factor 1-alpha (EF1-α) promoter, a MCS to 
introduce genes of interest upstream an internal ribosome entry site (IRES) and 
fluorescent reporters dTomato and eGFP, respectively. The IRES present between 
the target gene and the fluorescent reporter allows bicistronic expression of both 
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genes. More information about the plasmids can be found in Appendix III (p.251). 
Here, the packaging plasmid psPAX2 (Addgene, 12260) and the envelope 
plasmid pMD2.G (Addgene, 12259) were transiently cotransfected with the 
expression vector of interest to the producer cell line HEK 293T(N) to produce 
lentiviral particles. These particles, in turn, were used to transduce several cell lines 
in this research (Figure 4). The following procedures of transfection, concentration 
and titration of lentiviral particles were based on a protocol described by Kutner et 
al. (2009). All solutions, materials and surfaces that were in direct contact with the 
lentiviral particles were disinfected with 1% Virkon. 
 
Figure 4 – Illustration of transfection of the producer cell line HEK 293T(N) with transfer, 
packaging and envelope plasmids, which comprise a 2nd generation HIV-based lentiviral 
system. After collecting the lentiviral particles from the media, cells of interest can be 
transduced in a target cell line. 
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2.3.1 Production optimization of lentiviral particles 
The relative amounts of the transfer, packaging and envelope plasmids 
involved in the production of lentiviral particles have to be optimized on a 
case-by-case basis before transfection with the final constructs can be performed. 
For this, 3.8x105 HEK 293T(N) cells were seeded per well in a 6-well-plate, in order 
to obtain around 40-50% density at the start of the experiment. After allowing the 
cells to attach for 3-4 h, the growth medium was replaced with 2 ml of fresh cell 
culture medium in each well. The transfection was tested with the lentiviral 
expression vectors pHIV-dTomato or pHIV-eGFP as transfer plasmids and analysing 
five different mass ratios, together with a negative control (1:0:0). Transfer, 
packaging and envelope plasmids were mixed up to a total amount of 2 µg, as 
presented in Table 5. 
Table 5 – Relative amounts of each individual plasmid and mass ratios tested for 
transfection optimization. Note that in the negative control (1:0:0) the packaging and 
envelope plasmids are not included for the transfection of HEK 293T(N) cells. 
Expression 
constructs 
Mass 
ratios 
Relative amounts (µg) 
Water Transfer 
vector 
Packaging 
(psPAX2) 
Envelope 
(pMD2.G) 
pHIV-dTomato/ 
pHIV-eGFP 
1:0:0 2 0 0 
Up to a final 
volume of 
54 µl 
1:1:1 0.667 0.667 0.667 
3:2:1 1 0.667 0.333 
4:2:1 1.143 0.571 0.286 
7:2:1 1.4 0.4 0.2 
10:10:1 0.952 0.952 0.095 
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The transient transfection into HEK 293T(N) cells was performed by calcium 
phosphate precipitation, where 6 µl of 2.5 M of calcium chloride were added to the 
solution containing the plasmids, resulting in a total volume of 60 µl. An equal 
amount of 2x HEPES (4-(2-hydroxyethyl)—1-piperazineethanesulfonic acid) was 
carefully added to this solution, one drop at the time. This final solution was left to 
rest for approximately 20 min and then added to a single well in the 6-well-plate, 
again in a dropwise mode. After approximately 30 min, calcium phosphate 
precipitates were visualized under the light microscope. The cells were incubated 
for 16 h, at which point the medium was replaced with fresh growth medium. The 
cells were left to grow under the same conditions for another 48 h. During this time, 
replication defective lentiviral particles are secreted into the culture medium. 
Therefore, this medium was harvested into a 15 ml tube and centrifuged at 500xg 
for 10 min to pellet dead cells and large debris. The supernatant was then filtered 
into a clean tube using a 0.45 µm PES filter. The supernatant containing lentiviral 
particles was divided into 500 µl aliquots frozen in crushed dry ice and stored 
at -80oC until further use. 
To evaluate production efficiencies, cells of interest were seeded in a 
24-well-plate at 10-20% density at the beginning of the experiment. Cells were 
given 300 µl of fresh cell culture medium supplemented with 8 µg/ml of polybrene. 
200 µl of lentiviral supernatant for each production condition were added to the 
cells and these were incubated for 16 h. The medium was replaced with fresh 
culture medium and incubated for another 48 h, in the same conditions. 
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Afterwards, the cells were washed twice with 1x Dulbecco’s Phosphate Buffered 
Saline (PBS), fixed with 4% formaldehyde for 10 min and washed again with PBS. 
Analysis was performed by flow cytometry (see section 2.3.6 Fluorescence 
Activated Cell Sorting, p.48). 
2.3.2 Transfection of the producer cell line 
For the production of high titters of pseudoviral particles, HEK 293T(N) cells 
were seeded in a 6-well-plate. Each of the expression constructs 
(pHIV-dTomato_Fth-1/ pHIV-eGFP_TfR-1/ pHIV-dTomato_MagA) and the parental 
vectors (pHIV-dTomato/pHIV-eGFP) to serve as controls, were mixed with the 
envelope and packaging plasmids up to a total amount of 2 µg, with a mass ratio of 
4:2:1. The transient transfection was carried out as described before. The resulting 
supernatant containing lentiviral particles was either concentrated by 
ultracentrifugation (see below) or aliquoted and frozen. 
2.3.3 Concentration of lentiviral particles 
To concentrate lentiviral particles, supernatant containing the viral particles 
was pooled in 50 ml tubes. Equal volumes were distributed between the Ultra-Clear 
SW28 ultracentrifuge tubes and 1/10 of the final volume of 20% (w/v) sucrose 
solution were then slowly added to the bottom of the tube, up to a maximum of 
38.5 ml. The tubes were carefully placed and balanced in a pre-cooled Beckman 
SW28 Ultracentrifuge Rotor. The ultracentrifugation was carried out at 82,700xg at 
4oC, during 2 h. Afterwards, the tubes were carefully removed and the supernatant 
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discarded. The tubes were left upside down in a paper towel for 10 min and then 
air-dried for a few minutes until a transparent pellet was observable. To slowly 
dissolve the pellet, 100 µl of PBS were added to centre bottom of the tube. The 
tubes were incubated on ice and vortexed gently every 20 min up to a period of 2 h. 
After this period, tubes were centrifuged for 1 min at 500 xg and pellets were 
resuspended by pipetting up and down. The concentrated lentiviral particles were 
divided into 50 µl aliquots, frozen in crushed dry ice and stored at -80oC until further 
use. 
2.3.4 Determination of viral titres and efficiency of transduction 
In order to determine the viral titre, HEK 293T(N) cells together with the 
target cells to be transduced were seeded in 6-well-plates at a density of 5x104 cells 
per well. Cells were given approximately 3-4h to attach. The growth medium was 
then replaced with 2 ml of fresh growth medium supplemented with 8 µg/ml of 
polybrene. For the titration of supernatant containing lentiviral particles several 
volumes (from 0.05 to 200 µl) of viral supernatant were added to each 6-well-plate 
and incubated at 37oC in a humified incubator with 5% CO2 for 16 h. The medium 
was then replaced with fresh culture medium and incubated for another 48 h, 
under the same conditions. After this period, the cells were harvested and 
centrifuged for 3 min at 500xg; the supernatant was discarded and cells were 
washed with 1 ml of PBS and centrifuged as before. After removing the 
supernatant, the cells were resuspended in 1 ml of PBS and kept in ice until further 
use. 
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Titration of transducing lentiviral particles was performed by evaluating the 
percentage of transduced cells using flow cytometry, translating this into single 
transducing units (TU), calculated according to Equation 2: 
𝑇𝑈/𝑚𝑙 =
𝐹𝑁
𝑉
∗ 𝐷 
Equation 2 – Calculation of individual viral titre, which is the number of transducing units 
(TU), i.e., single lentiviral particles, that exist per volume unit of harvested viral 
supernatant. F corresponds to the ratio of fluorescent cells, N is the total number of cells at 
the time of transduction (5x104), V the volume (ml) of diluted vector added to each well 
and D the fold-dilution of vector used for transduction (Kutner et al., 2009). 
With the viral titre for concentrated and unconcentrated lentiviral particles 
having been established, cells were transduced at a precise multiplicity of infection, 
or MOI. For example, to transduce cells at a MOI=1, the number of TU needed to 
infect a known number of cells was calculated, so that there was 1 lentiviral particle 
per cell. In the case of MOI=5, there would be 5 lentiviral particles per cell. 
2.3.5 Transduction of stem cells 
To stably integrate reporter genes into the genome of different stem cell 
lines, typically 1x103 cells were seeded in a 48-well-plate and once attached, 
medium was replaced with specific growth medium mixed either with 
unconcentrated or concentrated lentiviral particles. The medium was also 
supplemented with 8 µg/ml of polybrene to allow a more efficient virus-cell 
interaction. The cells were incubated in these conditions for 16 h; afterwards, the 
medium was replaced with fresh medium and cultured as usual. Please note that in 
order to have biological replicates, transduction of cells were performed on an 
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individual basis in at least in three independent experiments (n=3). Also, after the 
transduction process, cells were not subcultured for a minimum period of 7 days, at 
which point it was designated as P1 post-transduction. 
2.3.6 Fluorescence Activated Cell Sorting 
Fluorescence activated cell sorting (FACS) was initially used for the 
functional titration of lentiviral preparations. This was possible due to the presence 
of a fluorescent reporter in the lentiviral constructs. 
When possible, transduced cells were expanded up to 2-4x106 cells and 
sorted at the earliest passage possible. Cells were harvested and resuspended in 
medium, transferred into round-bottom glass tubes and kept in ice until sorted. 
FACS was performed using a BD FACSAria (BD Biosciences) instrument. Sorted cells 
were collected in culture medium and seeded with supplementation of 
1% Penicillin/Streptomycin to avoid possible infections. 
Cells were routinely analysed for percentage of fluorescent cells using a 
BD FACScalibur (BD Biosciences) instrument, using a 488 nm laser and the 
appropriate fluorescence detectors depending on the transgene used (FL1 for eGFP 
or FL2 for dTomato). When appropriate, compensation thresholds were optimized 
to analyse double transduced cells (containing both GFP and dTomato transgenes). 
Non-transduced cells were used as a baseline control, a threshold set to less than 
1% fluorescence. FACS output was analysed using CyflogicTM Software (CyFlo Ltd, 
Finland). 
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2.4 EVALUATION OF INTRACELLULAR IRON 
2.4.1 Cell viability when exposed to ferric citrate 
A colorimetric assay was performed to evaluate the cell viability of cells 
when exposed to increasing concentrations of ferric citrate, to assess suitable levels 
of iron supplementation. In order to do so, 5x103 cells of each cell line studied were 
seeded in a 96-well-plate and allowed to grow overnight under normal cell culture 
conditions. The medium was then removed and replaced with culture medium 
supplemented with 2-fold increasing concentrations of ferric citrate (9.8, 19.5, 39.1, 
78.1, 156, 312.5, 625, 1250, 2500 and 5000 µM). A positive and a negative control 
were present, cells with no supplementation and cells exposed to 0.1% Triton X-100 
represented the highest and lowest possible number of viable cells. A blank 
(medium only) was also measured for normalization of the data. All conditions were 
done in triplicates to precisely determine the standard deviation for each condition. 
The cells were exposed to these conditions for 24 h. Cell counts were measured 
using a Cell Counting Kit-8, based on the compound WST-8 [2-(2-methoxy-4-
nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium] which forms a 
colorimetric dye once its reduced by dehydrogenases present in living cells, and 
thus, the amount of colour formed is proportional to the live cells in study. The cell 
medium was therefore removed and a cell counting solution plus culture medium 
(1:10, respectively) were added to the cells and incubated for a range of 1-5 h; the 
absorbance was measured in an Anthos labtec instruments 
spectrophotometer LP400 at wavelengths of 450 nm for detection and 620 nm as a 
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reference. The output was then analysed in terms of percentage of cell number in 
relation to the concentration of toxic agent. 
2.4.2 Intracellular iron quantification 
Iron supplementation 
Controls and transduced cells were seeded at a specific density and 
incubated either with iron supplemented media or simply in standard medium. Iron 
supplementation conditions included 0.2 or 2mM of ferric citrate, 50µM of 
L-ascorbic acid and 1.28 mM of human holo-transferrin. From here on, these will be 
designated simply as iron supplements. Note that in the standard medium the iron 
supplementation present is 300nM of ferric nitrate (DMEM) plus an unknown 
concentration of iron-related supplements (including transferrin) present in the 
Foetal Calf Serum. 
Ferrozine Assay 
Controls and transduced cells were seeded in 6-well-plates at a specific 
density, depending on the cell type and incubated with iron supplements or simply 
in standard medium for 4 days. The medium was refreshed 24h before 
measurement. Cells were then washed twice with PBS, trypsinized with 500 µl, 
harvested into a microcentrifuge tube and diluted in 1 ml of complete media. At this 
point, cells were centrifuged in a table-top centrifuge for 3 min, at 700 xg. The 
supernatant was discarded and cell pellet resuspended in 1 ml of media. The cell 
density was measured and then 1.4-2.5x106 cells were placed in a new tube. The 
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number of cells used for iron quantification was dependent on the cell line used, 
but it was kept constant for all experimental conditions. Cells were once again 
centrifuged in the same conditions and were resuspended in 50 µl of 1.2M HCl, 
followed by the addition of 50 µl 4.5% Potassium permanganate. At the same point, 
dilutions of a known iron standard (1, 0.5, 0.25, 0.125, 0.06 and 0.03 µg) were 
prepared with the same reagents, in order to build a standard curve. A blank tube, 
only with a mix of the two reagents was also prepared. All the above conditions 
were heated at 60oC, for 2 h, under a fume hood. After allowing the tubes to cool 
down, they were centrifuged at 6400 xg, for 1 min. 20 µl of Ferrozine reagent were 
mixed with the solution and let to develop for at least 30 min. To remove any cell 
debris, one last centrifugation was performed at 5100 xg for 3 min and 100 µl of 
supernatant were placed in a 96-well-plate in order to read the absorbance at 
570 nm in an Anthos labtec instruments spectrophotometer LP400. For each 
biological condition, three technical replicates were performed. The data was 
treated by removing the blank value from all conditions and the iron content per 
cell was calculated based on the standard curve and the total number of cells. 
Prussian blue and DAB Staining 
Control and transduced cells were seeded in a 24-well-plate, incubated with 
standard medium (no iron) and standard medium supplemented with either 
0.2 mM or 2 mM of ferric citrate and were left to proliferate until confluent. 
Afterwards, cells were washed with PBS and fixed with 4% formaldehyde for 
10 min. For Prussian blue staining, an iron stain kit was used and a 1:1 mixture of 
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4% potassium ferrocyanide solution with 4% hydrochloric acid was added to the 
cells for 30 min at RT. Cells were then washed several times with PBS and incubated 
for 15 min with 3,3′-Diaminobenzidine (DAB) enhancement solution. The reaction 
was stopped by washing the cells several times with distilled water. 
2.5 EXPRESSION OF TRANSGENES AT MRNA AND PROTEIN LEVEL 
2.5.1 Reverse transcription quantitative Real-Time PCR 
Experimental set-up 
This method was used to evaluate relative mRNA expression between cells. 
At least three biological replicates were performed for each cell line, i.e., 
individually transduced cells at different time points. Cells were either processed at 
day 0 (before transduction) or control cells were included, to confirm the total 
absence of the transduced genes. 
Primer design 
The expression of genes of interest as well as endogenous reference genes, 
specific to each species, was measured. Primer pairs were specifically designed for 
Real-Time quantitative PCR amplification, using NCBI Primer Blast and the following 
optimal parameters: Tm of 60oC (expect for primers F_IRES and T_IRES which was 
65oC), size product between 60-150 bp, length of 18-25 bp, GC content between 
40-60% and unique annealing to the targeted gene (Udvardi et al., 2008). In case of 
Fth-1 and TfR-1, to specifically distinguish between viral and the total amount of 
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gene expressed, different sets of primer pairs were designed. To quantify only the 
transgenes present in a certain sample, forward primer flanked the 5’ region of the 
gene of interest and the reverse primer flanked the 3’ region of the IRES. On the 
other hand, to quantify the total expression of viral + endogenous genes, the 
primers designed flanked an identical region. Specific primers to identify the sole 
expression of an endogenous gene were not possible to be built in the situations 
viral and native cDNAs were identical. All reverse transcription quantitative 
Real-time PCR (RT-qPCR) primers used in this study are detailed in Table 6. 
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Table 6 – Sequence of primers used for amplification of cDNA by Real-Time PCR and resultant amplification product. H-Homo sapiens, M-Mus musculus, 
C-Cricetulus griseus; GAPDH primers were designed to amplify a cDNA region common to both mouse and human variants; Pabpn1 and Vezt were taken 
from Bahr et al. (2009). 
 Primer Denomination Reference Species Forward Primer (5’-3’) Reverse Primer (5’-3’) Product (bp) 
Reference 
genes 
TBP TATA box Binding Protein NM_003194.4 H GACGAGTTCCAGCGCAAGGGTT GCACCCTGAGGGGAGGCCAA 110 
Tbp TATA box Binding Protein NM_013684.3 M AATAGTGATGCTGGGCACTGCGG GTGCGTCAGGCGTTCGGTGG 113 
GAPDH/
Gapdh 
Glyceraldehyde 3-phosphate 
dehydrogenase 
NM_002046.4/ 
NM_008084.2 
H/M CGGAAGGCCATGCCAGTGAGC TGCCAAGGCTGTGGGCAAGG 63 
Pgk1 Phosphoglycerate kinase 1 NM_008828.2 M CTGACTTTGGACAAGCTGGACG GCAGCCTTGATCCTTTGGTTG 110 
Pabpn1 Poly(A) binding protein, nuclear 1 NM_019402 C GTGGCCATCCTAAAGGGTTT CGGGAGCTGTTGTAATTGGT 205 
Vezt 
Vezatin, adherens junctions 
transmembrane protein 
NM_172538 C GTGTGAAAGTGGGGCTGAAT GTTCCTGCATGGTGGTGAAT 200 
Transgenes 
dTomato dTomato red fluorescent protein - - TGAAGATGCGCGGCACCAACT TGGTGGATCTCGCCCTTCAGCA 124 
eGFP 
Enhanced Green fluorescent 
Protein 
- - GAAGTTCATCTGCACCACCG GCTTCATGTGGTCGGGGTAG 107 
F_IRES 
Construct specific ferritin heavy 
chain-1_IRES 
- - TACGCAAGATGGGTGCCCCTGA ATTCCAAGCGGCTTCGGCCA 140 
T_IRES 
Construct specific transferrin 
receptor-1_IRES 
- - GGGAGTCGCAAATGCCCTCT ATTCCAAGCGGCTTCGGCCA 113 
MagA MagA AB001699.1 - GGCGAGTTGGAAACGCCGGT AGATCGGCGGGCAGCAACAC 125 
Endogenous 
genes 
Total_F Ferritin heavy chain-1 
NM_010239.2/ 
XM_003513182.1 
M/C TGAGGAGAGGGAGCATGCCGA CCAGTCATCACGGTCTGGTTT 100 
Total_T Transferrin Receptor-1 NM_011638.4 M TGAGTGGCTACCTGGGCTAT CTCCTCCGTTTCAGCCAGTT 74 
CHO_T Transferrin Receptor-1 NM_001246819 C CAGGCAATTCAGAAATCATCCAAGA CAGCTGCTTGATGGTGTCAGTG 128 
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Sample preparation and quantitative PCR 
Cell lyses and RNA extraction, DNase treatment and cDNA synthesis by 
reverse transcriptase were performed at each point as per manufacturer’s 
instructions of Fast SYBR® Green Cells-to-CT™ Kit. For the RT-qPCR reaction set up, 
4 µl of cDNA were mixed with 10 µl of Fast SYBR® Green Master Mix (one of the 
kit’s components), forward and reserve primers specific to the gene of interest to a 
final concentration of 200 nM, and finally, molecular biology water up to a reaction 
volume of 20 µl. For each cDNA analysed, two technical replicates were prepared. In 
each run, 500 pg of each construct (pHIV-dTomato_Fth-1, pHIV-dTomato_MagA, 
pHIV-eGFP_TfR-1) were included as a positive control for transgene amplification. 
As negative controls, non-template controls (NTC) were performed for every gene 
evaluated and no reverse transcriptase (NRT) controls were also included to verify 
the complete elimination of genomic DNA. RT-qPCR was performed using a 
Real-Time PCR machine Stratagene MxP005 for the study in Chapter 6 (p.178) and a 
Biorad CFX Connect Real-Time PCR Detection System, for all other studies. The 
cycling conditions were the following: enzyme activation at 95oC, for 20 s, followed 
by a 2-step PCR cycle of 95oC for 3 s and 60oC for 30 s (annealing temperature, Ta). 
Ta was 60oC for all primers, with the exception of F_IRES and T_IRES, which was of 
65oC for better specificity. At the end of the PCR reaction, a dissociation curve was 
constructed (0.5oC increase every 5 s, detecting the product’s melting temperature 
from 65oC to 95oC). Relative expression levels were evaluated using Bio-Rad CFX 
System Test Software and verified using Excel (Microsoft) through the Pfaffl method 
(Pfaffl et al., 2002) to represent the fold change in mRNA levels. 
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2.5.2 Immunofluorescence 
Cells were seeded in 8-well glass chamber slides at different densities, 
depending on the cell type. Cells were left to attach and grow, at least overnight, 
before fixation with 4% formaldehyde, which was performed for 15 min at RT. Cells 
were then washed three times with PBS, permeabilised with 0.1% Triton-X 100, and 
blocked with 10% serum (either goat, chicken or donkey), depending on the host 
animal in which the secondary antibody (Ab) was raised. The blocking step was 
performed for 1h at RT. After another three washes with PBS, the primary Abs were 
applied in a solution containing 1% of specific serum and 0.1% Triton-X 100, and left 
at 4oC, overnight, in a humidified chamber. The following day, the cells were 
washed three times in PBS and the secondary Ab was applied and incubated for 2h 
at RT, protected from light. After washing again three times in PBS the cell’s nuclei 
was stained for 10 min with DAPI (300 nM in PBS). Negative controls were included 
to test the secondary Ab specificity to the primary Ab. Therefore, during the primary 
Ab incubation, negative controls were kept in the same solution as previously 
described without the primary Ab and from that step onwards they were treated 
exactly as all the other samples. Primary and secondary Abs used, as well as specific 
dilutions, can be found in Table 7. Slides were mounted using Dako Fluorescence 
Mounting Media and micrographs acquired under epifluorescence illumination 
using a Leica DM2500 microscope coupled to a Leica DFC420C camera. 
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Table 7 – Description of primary and secondary Abs used in immunofluorescence (IF) and 
western blot (WB). 
Type Description Application Dilution Reactivity 
Company,  
Cat. no. 
Primary 
Rabbit Polyclonal  
Anti-ferritin heavy 
chain-1 
IF 
WB 
1:500 
1:250 
Mouse, 
human 
Abcam, 
ab65080 
Rabbit Polyclonal  
Anti-transferrin 
receptor-1  
IF 
WB 
1:1000 
1:3000 
Mouse, 
human 
Abcam, 
ab84036 
Rabbit Polyclonal 
Anti-actin 
WB 1:1500 Mouse, 
others 
Abcam, 
ab1801 
Secondary 
Alexa Fluor® 594  
Goat Anti-Rabbit 
IgG (H+L) Antibody 
IF 1:1000 Rabbit Life 
Technologies, 
A-11012 
Alexa Fluor® 488 
Chicken Anti-Rabbit  
IgG (H+L) 
IF 1:1000 Rabbit Life 
Technologies, 
A-21441 
IRDye 680RD  
Donkey Anti-Rabbit  
IgG (H + L) 
WB 1:15000 Rabbit Licor,  
926-68073 
2.5.3 Western Blotting 
Protein extraction and quantification 
Cells were harvested and counted and 106 cells were transferred into a 
microcentrifuge tube and centrifuged for 3 min, at 700 xg to concentrate the cells 
into a pellet. The cells were then washed with PBS and centrifuged again. Once the 
supernatant was discarded, 200 µl of lysis buffer were mixed with the cells. The 
tubes were placed on ice with a rotation shaker for 30 min. Afterwards, the solution 
was centrifuged for 10 min at 13400 xg to remove cell debris. The supernatant was 
harvested, aliquoted and stored at -80oC until further use. Protein concentration 
was quantified following instructions of Pierce™ BCA Protein Assay Kit. Briefly, 10 µl 
of sample were mixed with 200 µl of working reagent, incubated for 30 min at 37oC 
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and cooled down to room temperature. Three technical replicates were performed 
per sample and for each experiment, a blank and samples with known 
concentrations of albumin were also measured to produce a standard curve. The 
absorbance measured in Anthos labtec instruments spectrophotometer LP400 at a 
wavelength of 570 nm was then used to calculate the protein concentration by 
using the standard curve as a reference. 
Sample preparation 
Samples were thawed on ice and 10 µg of protein were mixed with 
1x NuPAGE LDS Sample buffer, 1x NuPAGE Reducing Agent and distilled water up to 
a final volume of 25 µl. This solution was incubated at 70oC for 10 min in a heating 
block. Afterwards, a brief centrifugation was performed to collect any 
condensation. 
Protein Electrophoresis 
XCell SureLock Electrophoresis apparatus was mounted with the inside 
chamber filled with 200 ml of 1x MOPS running buffer together with 500 µl of 
NuPAGE Antioxidant and the outside chamber filled with 600 ml of 1x running 
buffer. For each sample, 5 µg of protein were loaded per well in a NuPAGE® Novex® 
4-12% Bis-Tris Protein Gel. All samples were done in duplicate, where one of the 
gels was used for blotting and the other one for quantification of the total protein 
(see below). 3 µl of Odyssey Protein Molecular Weight Marker were included as a 
reference for protein size. Protein electrophoresis was performed at 200 V 
constant, for 50 min. 
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Wet Transfer 
Immobilon®-FL Transfer Membranes were activated for 30 s in 
100% methanol, briefly rinsed in distilled water and then placed in a container with 
transfer buffer until used. Sponge pads and Whatman paper were also soaked in 
transfer buffer before the “sandwich” was prepared as following (cathode to the 
anode direction): 2 pads, 2 sheets of paper, gel, the membrane, 2 sheet of paper 
and 2 pads. This was placed in the transferring apparatus (XCell II Blot Module) and 
the inside chamber was covered with transfer buffer plus 1% NuPAGE Antioxidant 
and the outside chamber with distilled water. The transfer was run at 30 V constant 
for 1 h. 
Blocking and antibody incubation 
After transfer, the membrane was blocked for 1h with Odyssey® Blocking 
Buffer, with gentle shaking. The membrane was then incubated with the primary 
antibodies anti-ferritin heavy chain-1, anti-transferrin receptor-1 and anti-actin (see 
Table 7 for dilutions, p.57) in the same blocking buffer with 0.2% Tween 20, 
overnight, at 4oC, in a shaker. Afterwards, the membrane was first rinsed and then 
washed for three times in a solution of PBS and 0.1% Tween 20. The secondary 
antibody used was IRDye 680RD Donkey anti-Rabbit IgG (H+L) (Table 7, p.57) and it 
was diluted in the same blocking buffer, with 0.2% Tween 20 and 0.01% SDS. The 
membrane was incubated with this solution for 1 h, at RT, with gently shanking and 
protected from light. After 1 h, the solution was discarded and the membrane 
washed three times as before. Finally, the membrane was rinsed in PBS to remove 
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any traces of SDS. 
Total protein quantification 
After electrophoresis, one of the gels was incubated in an Instant Blue 
solution for 1h at room temperature. Afterwards, the gel was rinsed several times 
with distilled water and left washing overnight. 
Quantification and normalization 
All membranes and stained gels were imaged with a LICOR Odyssey® Sa 
Infrared imaging System, at the 700 nm channel, 200 µm resolution and intensity of 
5.0. Images were processed and analysed using Image Studio™ Lite, Version 3.1 
Software. 
Whenever possible, total protein gels were used not only to verify the exact 
amount of protein loaded in each well, but also to serve as a reference when 
determining the expression of target proteins. Actin protein expression was the 
housekeeping gene chosen and was used to verify data normalization. In the rare 
cases total protein gels were not performed in conjunction with the target gel, actin 
alone was used to normalize target protein expression. Note that actin was not 
primarily used for data normalization because its expression was not stable 
between all cell lines studied, especially in the case of CHO K1 cells. 
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2.6 TRANSMISSION ELECTRON MICROSCOPY (TEM) ANALYSIS 
Cells were seeded at 10% density in 3.5 cm dishes. After cell attachment, 
medium was replaced with normal medium to non-transduced cells; for transduced 
cell lines, culture medium was supplemented with 0.2 mM of ferric citrate. Cells 
were grown under these conditions for 4 days. The cells were then fixed with 
4% formaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer for 1h under 
the fume hood. Cells were subsequently washed with PBS and osmicated by adding 
4-5 drops of 1% Osmium tetroxide (made in water) for 1h. After three washes with 
1x PBS, 30 min each, cells were dehydrated in increasing ethanol concentrations, as 
follows: i) 30% EtOH for 30 min; ii) 4-5drops of 0.5% Uranyl acetate in 30% EtOH; iii) 
and then followed by 30, 60, 70, 80 and 100% EtOH for 5 min each. Afterwards, cells 
were processed for epoxy resin embedding. For this, infiltration resin was 
pre-warmed for about 5 min at 60oC and mixed 1:1 with 100% EtOH. The bottom of 
the dish was covered with this preparation and left to solidify for 30 min, followed 
by 100% resin again for 30 min. The samples were placed inside capsules, filled with 
100% resin and placed upside down in the dish. This was left at 60oC for least 48h. 
Finally, 70 nm sections were obtained with an ultramicrotome and collected over 
copper grids containing a formvar support film. Sections were imaged in FEI 120kV 
Tecnai G2 Spirit BioTWIN instrument. 
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2.7 CELL VIABILITY CAPACITY 
Cell proliferation was determined in terms of percentage of cell number, in 
relation to control cells. This assay was performed to evaluate how cell proliferation 
responded to transduction with different viral constructs, at specific time-points 
post-transduction. Cells were seeded at a density of 1x104 cells per well of a 
48-well-plate and left to proliferate for a period of 7 days. In most cases, cells were 
incubated under normal cell culture conditions with the exception of mMSC that 
were cultured under specific supplements 24h from transduction (Chapter 5, 
p.129). At day 7, the cell number was measured with Cell Counting Kit-8 Solution, as 
described in section 2.4.1 Cell viability when exposed to ferric citrate (p. 49). 
2.8 MULTILINEAGE DIFFERENTIATION 
In order to verify mMSC differentiation potential after reporter gene 
integration, cells were induced to differentiate in vitro into the three standard 
lineages: osteogenic, adipogenic and chondrogenic. mMSC differentiation assays 
were performed between P12-P15 and at least 2 passages from transduction. The 
protocols used for differentiation are described below and were adapted from (Zhu 
et al., 2010) and (Glennon-Alty et al., 2013). 
For osteogenic and adipogenic differentiation, mMSC were seeded at a 
density of 1x104 and 2x104 cells, respectively, per well in a 24-well-plate and left to 
attach overnight in α-MEM media with 10% FBS. The following morning, the 
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medium was replaced with osteogenic or adipogenic induction medium. Negative 
controls were performed, where induction media was omitted. Induction and 
control media were substituted every 2-3 days for a period of 14 (osteogenic) and 
21 (adipogenic) days, in which the cells were not passaged. At the end of the 
2 weeks, cells were washed with PBS and fixed with 4% formaldehyde for 10 min. In 
case of osteoblast differentiation, calcium deposits were stained with 2% Alizarin 
Red S solution for 2 min. In the case of adipocyte differentiation, after fixation, cells 
were equilibrated with 60% of isopropanol for 5 min at RT. Afterwards, a freshly 
prepared and filtered solution of 0.5% Oil-red-O (made in isopropanol) diluted in 
water at 3:2 ratio, was used to stain fat deposits for 10 min. Both conditions were 
then washed several times with water and visualized with a light microscope. 
For chondrogenic differentiation, 2x105 cells, initially cultured as adherent 
cells were transferred into 15 ml centrifuge tubes and pelleted by a 3 min 
centrifugation, at 162 xg. Cells were left to incubate for a day in the centrifuge 
tubes with standard mMSC medium. The mMSC pellets were then transferred to 
96-well-plate for suspension cells and washed with PBS, before adding the specific 
chondrogenic induction media. This was replaced every 2-3 days up to a total of 
21 days. Negative controls were performed, in which mMSC pellets were 
maintained in standard mMSC media. After the supplementation period, pellets 
were washed with PBS, fixed with 4% formaldehyde for 20 min, washed again and 
incubated with 15% sucrose (made in PBS) for 20 min at room temperature. Pellets 
were then mounted using Bright Cryo-m-Bed embedding medium and frozen in dry 
  
MATERIALS AND METHODS | 64  
ice for cryosectioning. Sections 7 µm in thickness were rinsed in 1% acetic acid for 
10 s and stained with Safranin-O for 5 min, washed several times in distilled water 
and visualized under a light microscope. 
2.9 ANIMAL WORK 
Cells to be injected were incubated with ferric citrate, in case of HEK 293TN 
cells, or ferric citrate and other iron-related supplements, for all other cell types, for 
3 days in normal conditions. Afterwards, cells were trypsinized as usual and 
resuspended in Dulbecco’s Modified Eagle’s Medium (DMEM) with 30% 1:1 ratio of 
deoxyribonuclease I : fast green. Cells were kept on ice until injection. 
White Leghorn chicken eggs (Gallus gallus) were employed as an animal 
model. Fertilized eggs were kept at 12°C until use for a period up to 2 weeks. Once 
incubation started, eggs were maintained in an incubator at 38°C with 40% 
humidity. All animal work followed standard ethical guidelines according to UK 
regulations (Consolidated version of ASPA 1986) and embryos were not allowed to 
develop beyond embryonic day 5 (E5). At E3, eggs were windowed and 
approximately 2x105 transduced cells in 2 µl of the above solution were first 
introduced into a microcapillary pipette and injected in the brain ventricle of the 
chick embryo using an aspirator tube assembly for calibrated microcapillary 
pipettes. Embryos were allowed to develop for a further 2 days, at which point they 
were harvested and imaged using a fluorescence dissection 
Leica M165FC stereomicroscope. Bright field and fluorescence images were 
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acquired as projections of the whole embryo, equally on the right and left sides. 
Both bright field and fluorescent pictures were then overlaid using ImageJ software, 
and the location of cell clusters were able to be precisely identified and used as 
guidance for MR imaging of chick embryos. After fluorescent imaging, embryos 
were fixed overnight with 4% formaldehyde and washed several times with PBS. 
Embryos were kept at 4°C, in PBS, until further use. 
2.10 MAGNETIC RESONANCE IMAGING 
2.10.1 Sample preparation 
In vitro cultured transduced cells were grown either in iron-supplemented or 
non-supplemented (negative controls) medium. A total of 107 cells from each 
condition were harvested, fixed with 4% formaldehyde and transferred to 0.2 ml 
polypropylene tubes and centrifuged at 13400 xg for 30 min. Afterwards, 
supernatant was substituted with 1% low-melting temperature agarose. Fixed chick 
embryos were embedded in 1% low-melting temperature agarose and mounted in 
0.5 ml microcentrifuge tubes. 
2.10.2 Imaging 
Cell pellets and chick embryos were imaged using a Bruker 7 T Avance III MRI 
instrument with a 38 mm transmit/receive quadrature volume coil, as described in 
Taylor et al. (2014). Both sample types were positioned for axial imaging using a 
sample holder. T2-weighted MRI images were initially acquired for cell pellets. After 
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outlining a specific region within the cell pellet, T1/T2 maps were produced in order 
to obtain the longitudinal relaxivity data between the different samples. This was 
acquired using a modified Rapid Acquisition with Refocused Echoes (RARE) 
sequence, with the following repetition times (TR): of 5000, 3000, 1500, 800, 400 
and 200 ms, and echo times (TE): 11, 22, 55, 77 and 99 ms. Imaging of animal 
embryos was performed to acquire anatomical images only (T2-weighted) and no 
relaxivity studies were performed on these samples. All images were equally 
processed using ImageJ software. 
2.11 ERROR BARS AND STATISTICAL ANALYSIS 
Standard deviation (SD) error bars were used when a descriptive analysis 
was performed and standard error of the mean (SEM) when inferential statistics 
were used, with a minimum number (n) of 3 independently conducted experiments 
(n≥3). SD and SEM were calculated using OriginPro 9.0.0 (OriginLab Corporation). 
Student t-test was calculated using Microsoft Excel and employed to 
evaluate statistical significances between two groups of samples. The statistical 
probability is demonstrated in terms of p-value (p), which was considered 
“significant” when p<0.05 (*); “very significant” when 0.01>p>0.001 (**) and “very 
highly significant” when p<0.001 (***). 
  
STABLE INTEGRATION OF REPORTER GENES INTO ESTABLISHED CELL LINES| 67  
CHAPTER 3 
STABLE INTEGRATION OF REPORTER GENES INTO ESTABLISHED CELL LINES 
3.1 INTRODUCTION 
3.1.1 Transfection methods 
Over the years, several methods to integrate genes of interest into specific 
cell lines have been used. One of the most routinely used methods is 
electroporation, which can be described as a physical method for transgene 
delivery, in which an electric field is externally applied creating transient pores in 
the cellular membrane allowing the entrance of foreign elements as, for example, 
plasmid DNA. Even though this method is a mechanical transfection and can be 
used in a wide range of cell lines, if the current is not optimal it can result in cell 
death (Neumann et al., 1982). A more recent approach for physical transfection is 
using magnetic beads. The negatively charged transgene DNA is mixed with 
positively charged magnetic particles and delivered to the cells by magnetic force 
(Isalan et al., 2005). Another very common method is chemical transfection and this 
can be achieved using reagents based on cationic lipids (or liposomes, mostly 
known as lipofection) (Felgner et al., 1987) or calcium phosphate (Graham and van 
der Eb, 1973), amongst others. The transgenes are believed to be incorporated by 
the cells through endocytosis or phagocytosis, although the underlying mechanism 
of how nucleic acids cross the cell membrane or reach the nucleus is still unknown 
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(Kim and Eberwine, 2010). In all these transfection methods described above, the 
transgene is effectively incorporated inside the host cell, but is it not directly 
integrated in the nuclear genome, and therefore, in most cases it leads to a 
transient expression. This might be either due to degradation of the gene delivered 
and/or its dilution as mitosis takes place. Even if there is a selection marker, like a 
drug resistance gene, only rarely the transgene integrates with the host genome 
and becomes a stable transfection (Dimitrov, 2012). An approach to overcome 
these shortcomings is the stable chromosomal integration of the genes of interest 
using virus-mediated transfection, mostly known as transduction. 
Firstly used as an expression mechanism in 1979 (Hamer and Leder, 1979), 
transduction is a biological method to incorporate genetic material into a host cell 
using a viral vector. There are several choices of viral vectors possible to use such as 
adenoviruses or adeno-associated viral vectors (AAVs), retroviral vectors (RVs) or 
lentivirus-based vectors (LVs), amongst others (Kay et al., 2001). Adenoviruses are 
of episomal origin and usually lack of replication ability and thus the signal derived 
from these vectors is only transient (Adamson et al., 2011), while RVs are unable to 
efficiently infect non-dividing cells (Yamashita and Emerman, 2006). Therefore, LVs, 
such as the human immunodeficiency virus type 1 (HIV-1), are many times 
preferred in detriment of others due to its effective mechanism to introduce foreign 
DNA into the host genome of dividing as well as non-dividing cells (Naldini et al., 
1996; Roe et al., 1993). Also, they can accommodate transgenes up to 10 Kb, while 
in AAVs the packaging limit is about 5 Kb (Trono, 2000). 
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3.1.2 Lentiviral-mediated transduction 
Transgene incorporation takes place in the nucleus, where just the target 
material between specific sites of the viral vector, named long terminal repeats 
(LTRs), is integrated into the host cell’s genome. In order for this mechanism to be 
safe for the user, the HIV-1 genome was “disassembled” and genes involved with 
unwanted characteristics, like virulence and replication, were removed, leading to 
an elimination of about 60% of the genome. Only genes absolutely necessary for 
virus assembly, reverse transcription and target gene integration (gag, pol and rev 
genes) were used, and these were distributed in several plasmids to allow a safe 
handling of the viral components (Dull et al., 1998). These viral components 
together with the vector holding the transgene can then be transfected into a 
“producer” cell line that will express all proteins necessary for the assembly of the 
lentiviral particles. Once assembled, these viral particles are secreted in the culture 
medium that can then be directly used to infect other cells. This method typically 
yields high titers, of about 107 transducing units (TU) per ml, and this can be further 
increased by concentrating the particles, using techniques such as 
ultracentrifugation (Kutner et al., 2009). 
Other characteristics that make lentiviral vectors an ideal method of 
incorporating foreign DNA into a cell, besides safety and high titer production, are 
the minimal interaction with the normal physiology of the cell, stability and 
reproducibility and the ability to transduce a wide range of cell types, including 
non-dividing and difficult to transfect cells (Mátrai et al., 2010; Trono, 2000). Also, 
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genetic engineering has made it possible to design lentiviral vectors that contain a 
drug resistant gene or an imaging traceable gene, such as a fluorescent gene 
reporter, in order to allow a rapid and easy identification of successfully transduced 
cells. 
LVs have been widely used not only in molecular biology as a means to 
up- or down-regulate a certain gene in a study, but also as delivery agents for gene 
therapies in the clinical field. At the moment, in the United Kingdom alone, five 
clinical trials using lentiviral gene therapy are being led specially to correct 
monogenic diseases, such as X-Linked Severe Combined Immune Deficiency 
(Trial UK-0198 registered under Gene therapy clinical trials worldwide). In spite of 
the efficiency and applicability of this method, one concern remains with the use of 
any viral vector in medical therapies, namely,  the risk of insertional mutagenesis 
(IM) resulting from the random nature of LV integration. For instance, random gene 
integration may possibly activate silenced oncogenes or disrupt tumour suppressor 
genes (Woods et al., 2002). IM has been associated with some unwanted effects 
reported in gene therapy trials (Hacein-Bey-Abina et al., 2003) and has led to a 
reassessment of the risks associated with gene therapies involving viruses. Some 
work has been done on integration preferences of HIV and its engineered lentiviral 
vector counterpart but the results are controversial. For instance, it has been shown 
by different groups that HIV-1 is likely to integrate at clusters of highly active genes, 
particularly those which were activated due to HIV-1 infection (Schröder et al., 
2002; Wu et al., 2003). On the other hand, more recent studies using HIV-lentiviral 
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based vectors have found that the lentiviruses were more prone to integrate within 
introns, rather than active transcription sites or CpG islands (Ustek et al., 2012; Yang 
et al., 2008). Nevertheless, there are also studies focused on controlling this 
phenomenon and directing the integration site of lentiviruses (Bushman, 2002). 
3.1.3 Choice of lentiviral vectors 
There is an enormous choice of lentiviral transfer vectors in the market, and 
one must decide on which one to choose depending on the specific application 
desired. Here, we used pHIV-dTomato and pHIV-eGFP due to some particular 
features of the vectors, such as (i) the presence of a MCS to introduce our gene of 
interest upstream of an IRES and fluorescent reporter, allowing an equivalent 
expression of both genes; (ii) the relatively small size of about 7.7 kb; and (iii) the 
EF1-α promoter. The EF1-α promoter was selected because in MSCs, it has been 
reported to maintain a stable transgene expression over 20 population doublings 
without interfering with differentiation potential (Lee et al., 2004). Also, it has been 
shown to be the most stable promoter during mESC-derived embryoid body 
differentiation (Norrman et al., 2010). On the other hand, at high MOIs (≥100), it 
has been described to transiently arrest the cell cycle at S phase and also to 
decrease transgene expression during mESC differentiation in vitro (Hong et al., 
2007; Lee et al., 2004). 
In this chapter, a HIV-based lentiviral approach is described to stably 
introduce magnetic and fluorescent reporter genes into established cell and 
stem cell lines, creating a means of tracking cells using fluorescence methods 
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in vitro and MRI technology in animal embryos. The effect of the use of different 
concentrations of iron (in the form of ferric citrate) as a culture medium 
supplement on the viability of several cell lines is also investigated in order to define 
safe (non-toxic) conditions to achieve high intracellular iron concentrations. 
However, iron by itself cannot enter the cell and in high concentrations can become 
toxic due to its oxidative potential. For this reason, other components, such as 
transferrin and ascorbic acid, were also evaluated as a means to assist iron in 
entering the cell, and their effects are described in this chapter.  
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3.2 RESULTS 
3.2.1 Generation of lentiviral constructs 
To obtain Fth-1, TfR-1 and MagA transgenes, the cDNAs were PCR amplified 
with specific primers. In the case of Fth-1 and TfR-1, primers were purposely 
designed to exclude both untranslated regions (see sequences in Appendix I, p.242), 
as these regions are known to have an influence at the post-transcriptional level, 
inhibiting the translation of the mRNA. A synthetic Kozac sequence (GCCACC) was 
included when designing specific primers for TfR-1/MagA cDNA amplification, as it is 
known to promote the initiation of the translation process (Kozak, 1981). This was 
not necessary for the Fth-1 gene as it has a native Kozac sequence. Amplification 
strategies are shown in Table 8 (A, C and E), together with PCR fragments of cDNAs 
that were run on an electrophoresis gel. 
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Table 8 – Cloning strategies, including the amplification method, electrophoresis of amplified fragments and colony restriction digests performed to create 
and evaluate individual constructs containing Fth-1 (A and B), TfR-1 (C and D) and MagA (E and F) cDNAs. Half arrows represent forward (F) or reverse (R) 
primers. Components of the lentiviral vectors: red – dTomato gene; grey – IRES; dark green - EF1-α promoter; light green – GFP gene. 
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After PCR amplification with a proof-reading enzyme, both transgenes were 
introduced into a feasible working cloning vector, pCR®II-TOPO®. The cloning 
method chosen, in this case, was TA cloning, in which inserts are cloned in a 
non-directional way. Colony restriction digests were performed to select constructs 
containing an insert with the expected Fth-1/Tfr-1/MagA cDNA size. The restriction 
enzymes used are detailed within the cloned vectors’ illustration and respective 
fragment products with the estimated band sizes are shown on the right hand side 
of Table 8 (A, C and E). Enzyme digestions showed that TfR-1 cDNA was cloned in 
the reverse orientation into pCR®II-TOPO®. This was possible to determine due to 
the presence of two Xba I sites, outside and inside TfR-1 cDNA insert. For 
pCR®II-TOPO®-Fth-1 and pCR®II-TOPO®-MagA the insert cloning orientation was 
determined by sequencing analysis using a T7 promoter, where it was possible to 
verify that Fth-1 insert was cloned in the forward direction and MagA insert in the 
reserve direction. The positive constructs were also sequenced to verify the 
sequence integrity of the inserts. Sequencing analysis revealed two point mutations 
in the MagA gene, which were also present in the parental vector from which it had 
been cloned (provided by Addgene). These mutations were identified as being silent 
mutations, not altering amino acid sequence. However, Addgene reported two 
amino acid substitutions (S94L and P390S) in MagA gene which do alter amino acid 
coding and are not conservative substitutions. The impact that these substitutions 
have on the normal function of MagA gene is unknown, but it is thought to be the 
same cDNA as used in previous studies (see Chapter 6, p.173). MagA cDNA 
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sequence and point mutations details are provided in Appendix I, p.242). 
Due to the high recombination frequency between the long terminal repeats 
(LTRs) present in the lentiviral vectors (pHIV-dTomato/pHIV-eGFP), inserts were 
initially introduced into pCR®II-TOPO. This facilitated the synthesis of inserts, i.e., by 
simply expanding the plasmid in a bacterial culture, followed by a plasmid DNA 
preparation. To generate lentiviral constructs, all cDNAs were once again PCR 
amplified with a new set of primers to include specific restriction enzymes in both 5’ 
and 3’ ends, which allowed a directional cloning of Fth-1/MagA into the 
pHIV-dTomato lentiviral vector. The cloning of TfR-1 into pHIV-eGFP was 
non-directional due to the lack of available restriction enzymes (only BamHI was 
present in the parental vector). Amplification strategies and PCR fragments of 
cDNAs were run on an electrophoresis gel and are shown in Table 8 (B, D and F). As 
previously, cells were transformed, expanded and colonies with the expected insert 
size were selected after an initial restriction digest step and the resulting products 
are shown in the electrophoresis gel on the right hand side of Table 8 (B, D and F). 
Whole sequencing analysis of final lentiviral plasmid constructs revealed that 
sequences of interest were successfully cloned into the lentiviral plasmids, without 
new mutations being introduced. Lentiviral constructs were then ready to be used 
in the production of lentiviral particles. The parental vectors are from now on 
described simply as dT or GFP and the constructs as dT_F (for Fth-1), GFP_T (for 
TfR-1) and dT_M (for MagA) (Figure 5). 
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Figure 5 – Plasmid maps of parental vectors dT (A) and GFP (B) and lentiviral constructs 
dT_F (C), GFP_T (D) and dT_M (E). Some key features are represented, such as the 
fluorophore of each plasmid (dTomato or eGFP transgene) connected to the gene of 
interest (Fth-1/TfR-1/MagA) through an IRES to allow bicistronic expression of both genes. 
Also represented is the promoter elongation factor 1-alfa (EF1-α) to initiate the constitutive 
expression and the HIV-long terminal repeats (LTR), which flank the region to be 
incorporated into the host’s cell genome. 
As the following chapters describe several cell types transduced with either 
single (dT, GFP, dT_F, GFP_T, dT_M) or multiple viral preparations (dT_F + GFP_T) 
there was a necessity to clone the chosen genes in lentiviral vectors with different 
fluorophores. Hence, when working with multiple viral preparations, transduction 
was easily followed-up by the expression of two different fluorescent proteins. 
3.2.2 Production of lentiviral particles 
In a lentiviral packaging system involving multiple plasmids, the optimization 
of relative amounts of each plasmid involved allows for an efficient production of 
high titers of lentiviral particles. For this reason, several mass ratios of the transfer 
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(dT/GFP), packaging (psPAX2) and envelope (pMD2.G) plasmids were tested by 
cotransfection of the producer cell line HEK 293T(N). Afterwards, the resultant 
particles were transduced into the same cell line with an equal volume of viral 
supernatant, in order to evaluate the production efficiency for each condition. The 
results were analysed using flow cytometry (Figure 6) to detect the percentage of 
fluorescent cells in the population. 
 
Figure 6 – Flow cytometry analysis of red (dT) and green (GFP) fluorescent populations of 
HEK 293T(N) cells after being transduced with the same volume of viral supernatant, 
produced with different plasmid ratios. Error bars represent SEM (n=3) (M&M, p.43). 
Figure 6 shows that the mass ratios 1:1:1, 3:2:1, 4:2:1 and 7:2:1 gave rise to 
similar production efficiencies, with 40 to 50% of cells being transduced with both 
viral particles types. A ratio of 10:10:1 was less efficient, and as expected, when 
packaging and envelope vectors were not present (1:0:0), the transfer vector alone 
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was unable to form efficient lentiviral particles, confirming the safety of this 
lentiviral production system. A plasmid ratio of 4:2:1 was thus chosen as it offered a 
good yield with both vectors and this ratio was used for producing lentiviral 
particles with the parental vectors and the constructs containing the magnetic 
reporter genes. 
3.2.3 Determination of viral titer of lentiviral particles 
In order to transduce cells of interest with a specific multiplicity of infection 
(MOI) the viral titer for each batch of lentiviral particles was determined. To do this, 
5x104 HEK 293T(N) cells were transduced with different amounts of unconcentrated 
(concentrated in the case of MagA) lentiviral particles and the number of 
fluorescent cells was determined by flow cytometry. Figure 7 shows the results 
obtained for different transducing particles in HEK 293T(N) cells. 
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Figure 7 – Flow cytometry analysis of red (dT, dT_F and dT_M) and green (GFP, GFP_T) 
fluorescent cells in relation to the volume of lentiviral particles used for transduction of 
HEK 293T(N) cells. A 40% fluorescent threshold was set and the chosen value for titration is 
annotated with a *. Error bars represent SEM (number of biological replicates are indicated 
in the legend) (M&M, p.46). 
The results obtained with flow cytometry show an expected rise in the 
percentage of fluorescent cells with the increasing volume of lentiviral particles. To 
calculate accurate titrations, a value that fitted the linear relationship between the 
fluorescent population and the volume of viral supernatant added was chosen. 
Therefore, only volumes that gave rise to less than 40% fluorescent cells were taken 
into consideration (Kutner et al., 2009). According to Equation 2 (p.47), the number 
of transducing units per ml of solution was determined and results are shown in 
Figure 8. 
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Figure 8 – Viral titer of different lentiviral preparations determined in HEK 293T(N) cells. 
Error bars represent SEM (number of biological replicates are indicated in the X-axis) 
(M&M, p.47). 
3.2.4 Transduction efficiency between cell lines 
To evaluate transgene integration efficiency of lentiviral particles in the 
different cell lines used in this study, 5x104 cells were transduced with the same 
amount of viral particles and the results were analysed with flow cytometry 
(Figure 9). 
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Figure 9 – Flow cytometry analysis of populations of fluorescent cells after transduction 
with different viral preparations, such as dT (A), GFP (B), dT_F (C), GFP_T (D) and dT_M (E) 
in several types of cells, demonstrating the variation of transduction efficiency between cell 
lines. As previously, the chosen value to calculate the viral titer was below the 40% 
fluorescent threshold and is annotated with a *. Error bars represent SEM where possible 
(numbers of biological replicates are indicated on the graphs) (M&M, p46). 
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Figure 9 shows that there is a prominent difference in transduction 
efficiency if the same virus amount is used on different cells. This is especially true 
for mESC, which proves to be the least transducible cell line, independent of 
lentiviral construct used. For the other cell lines, HEK 293T(N), mMSC, mKSC and 
CHO K1 cells, the difference in transduction efficiency is not so prominent. It should 
be noted that not all cell lines were used to evaluate the integration efficiency of 
the different constructs as this was performed as necessary according to the work 
described in the following chapters. When identifying the theoretical number of 
transgenes that have integrated, it is important that differences between specific 
cell lines are accounted for. For this reason, the most correct way to proceed is to 
not only rely on the titration performed on the producer cell line, HEK 293T(N), but 
also to take into account the efficiency of transgene integration dependent of each 
cell line. 
After integration efficiency was determined individually in each cell line, the 
number of transducing units per ml of supernatant was once again calculated and is 
shown in Figure 10. 
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Figure 10 – Viral titer of different lentiviral preparations specifically determined for each 
cell line (A). Error bars represent SEM where possible. Numbers of biological replicates are 
indicated in the table in B (M&M, p47). 
The multiplicity of infection (MOI) used for each condition was tested on a 
case-by-case basis and depended on the lentiviral integration ability without 
compromising cell health and proliferative capacity of a specific cell type. In order 
to do this, a range of different MOIs were tested in target cell lines and cell counting 
assay was performed (see 2.7 Cell viability capacity, p.62). The highest MOIs that 
were able to maintain proliferation of cells in comparable levels to controls were 
chosen to use subsequent experiments (data not shown). 
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3.2.5 Optimization of Intracellular Iron Loading 
To optimize the suitable iron supplementation that allows a significant 
increase in intracellular iron content, five wild-type (WT) cell lines used in the 
course of this study were exposed to increasing amounts of ferric citrate 
concentrations, from 10 µM up to 5 mM. A cell counting assay was performed to 
detect the percentage of viable cells in each condition tested (Figure 11). 
 
Figure 11 – Cell viability evaluation of several cell lines, when exposed to increasing 
amounts of ferric citrate for a period of 24h (A). Absorbance is shown in relation to control 
cells (cultured without supplementation). The best logistic fit for each cell line is 
represented in the cell’s correspondent colour. The 0.2 and 2 mM marks display the chosen 
concentrations of ferric citrate used in further experiments, supported by the table in B. 
EC50 and EC80 represent the ferric citrate concentration (mM) that causes 50 and 80% cell 
reduction relative to control. Error bars represent SEM (n=3) (M&M, p49). 
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As shown by Figure 11, when supplemented with low iron concentrations 
(0.01-0.2 mM), all cell lines maintain a 100% or higher living capacity in relation to a 
non-supplemented control. Relying on these results and on the iron 
supplementation values commonly described in the literature, an optimum 
concentration of 0.2 mM of ferric citrate was used to supplement cells of interest. 
Furthermore, in order to fully determine the reporter gene potential of 
accumulating intracellular iron, a ten-fold higher concentration of 2 mM was also 
used in the following work. However, as shown in Figure 11, 2 mM of ferric citrate 
decreases cell viability in two cell lines, in HEK 293T(N) to about 80% and in mKSC to 
approximately 50% cell viability. Other cell lines studied are only slightly below 
100% viability when ferric citrate is incubated at 2 mM. Nevertheless, it is 
speculated that once cells are overexpressed with iron-clustering genes, such as 
ferritin heavy chain-1, they may be more resistant to the effects promoted by high 
concentrations of ferric citrate. In relation to the iron concentration which is 
normally present in the cell culture medium (approximately 300 nM of ferric 
nitrate) the supplementations with 0.2 or 2 mM of ferric citrate provide, 
respectively, a 700 or 7000-fold increase of iron. 
Besides ferric citrate, other supplements such as L-ascorbic acid (Lane et al., 
2013) or holo-transferrin (Deans et al., 2006) have also been described in the 
literature to play a role in the cellular iron loading process. To test if either of these 
supplements would contribute to increase intracellular iron, four cell lines were 
exposed to different supplementations. The concentrations used were: 0.2 mM of 
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ferric citrate, as determined previously, 50 µM of L-ascorbic acid, as it was 
described to be an approximation to physiological conditions (Lane et al., 2013) and 
1.28 mM of human holo-transferrin, equivalent to 100 µg/ml. For this last 
supplement, even though some reports suggest its use in concentrations of 1 mg/ml 
and higher (Deans et al., 2006; Iordanova et al., 2010), optimization experiments 
showed that concentrations higher than 1.28 mM did not have a significant impact 
in terms of cellular iron loading (data not shown). As demonstrated in Figure 12, the 
condition that proved to have the best iron loading capacity was the 
co-supplementation of ferric citrate, L-ascorbic acid and holo-transferrin. This was 
particularly true for mMSC and mKSC, where significant increases in intracellular 
iron concentrations were observed with the combination of all three supplements. 
For this reason, these components were included in all iron loading experiments 
described in the next chapters. HEK 293T(N) are the only exception, where no 
benefit was seen with the use of L-ascorbic acid and holo-transferrin and thus ferric 
citrate was the only supplement used for iron loading. 
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Figure 12 – Measurement of intracellular iron content of mMSC, mKSC, HEK 293T(N) and 
CHO K1 with different supplements: FC-0.2 mM of ferric citrate, AC-50 µM L-ascorbic acid, 
HT-1.28 mM human holo-transferrin. Error bars represent SEM (n=3). 
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3.3 DISCUSSION 
The iron content inside any organism needs to be tightly controlled in order 
for it to function properly, and to achieve this, the expression of key proteins 
involved in iron metabolism is tightly regulated. For instance, Fth-1 and TfR-1 
possess iron responsive elements (IRE) in their 5’ and 3’ UTR, respectively 
(Appendix I). These elements have the ability to inactivate Fth-1 mRNA and stabilize 
TfR-1 translation if iron is not present in the cell and do the reverse when iron is in 
excess (Figure 1). While generating the lentiviral constructs, untranslated regions 
from Fth-1 and TfR-1 cDNAs were intentionally excluded from amplification, to 
allow a constitutive expression of viral Fth-1 and TfR-1 genes, bypassing the cell’s 
gene regulation mechanisms. The rationale behind this procedure was to increase 
the cellular uptake of iron and its accumulation inside ferritin cages, safely 
increasing the cell’s iron content and thus providing a good contrast in MRI. In the 
case of MagA, since it has a bacterial origin, this cDNA does not possess 
untranslated regions and only an artificial Kozac sequence was included in cDNA 
amplification. 
Following cloning of lentiviral constructs with the specific target genes, 
individual amounts of each plasmid required for the viral assembly were optimized 
and the plasmid ratio of 4:2:1 (transfer: packaging: envelope vectors) was selected 
as the best choice for producing the lentiviral particles. Once all the lentiviral 
batches were produced and before transducing the cells of interest, the 
concentration of virions in the supernatant was calculated to make the transduction 
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process standardized and reproducible over time. As expected, distinct viral 
preparations had different efficiencies when transducing the same cell line 
HEK 293T(N) (Figure 7). These results can be translated in terms of viral titer for 
each preparation, and they are demonstrated in Figure 8. Differences in the 
resultant viral titers can be explained, in part, due to the construct size, as it is 
known that the bigger the lentiviral construct, the less efficient it is (Urbinati et al., 
2009). This can be observed in the case of GFP_T (10 kb), with approximately 
1x105 TU/ml and its parental vector, GFP (7.7 kb), with 3.75x105 TU/ml. Such is not 
observed between dT_F (3.6x105) and its original construct dT (3.37x105). This 
effect is even more prominent in the case of the dT_M construct, with an initial 
unconcentrated version of 1.14x104 TU/ml (data not shown). Only after 
concentration was it possible to achieve a value similar to the other viral 
productions, with 6.18x105 TU/ml. This poor production efficiency seen in dT_M 
cannot alone be explained by insert size and is much more significant than that 
observed with GFP_T. It can be hypothesized, however, that this outcome is related 
to a potential toxic effect of MagA expression in HEK 293T(N) cells, although this has 
not been explored in detail in the course of this work. 
It is not only important that transduction with different viral preparations 
are reproducible (achieved by calculating the viral titer), but one also needs the 
transduction to be similarly efficient between cell lines. This means that MOI must 
be calculated taking into account the transgene integration efficiency, thus 
contributing for a more similar transgene expression between cell lines, in order to 
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allow results to be compared. For this reason, we calculated the efficiency of 
transduction by titration of each viral preparation in the specific cell line to be 
transduced. Even though the use of this method is more accurate, it is not perfect 
and we still can perceive some variation when the viral genes are quantified at the 
mRNA level (later chapters). Also, other factors may contribute to certain variability. 
For example, target genes may be inserted in places where gene expression is not 
active, leading to variable expressions in different cells. On the other hand, this may 
also pose as an advantage in stem cell biology because in a therapeutic setting, 
stem cells might differentiate and epigenetic changes could silence the transgenes 
depending on their site of integration. 
In this chapter, three potential magnetic reporter genes were successfully 
introduced into a variety of stem cell lines. Target genes were cloned alongside a 
fluorescent gene (dT or GFP) to allow bicistronic expression, thus allowing an easy 
identification of transduced cells by flow cytometry. The influence of iron 
concentration on cell number for a variety of different cell lines was also 
determined. It was found that low concentrations of iron are actually beneficial for 
cell proliferation and this observation reinforces the notion that iron is a crucial 
element for cell health and perhaps should be used in routine cell culture conditions 
(Figure 11, p.87). Also, and as expected, each cell line has its own individual 
resistance to higher concentrations of ferric citrate and that the use of 
supplements, such as holo-transferrin and/or L-ascorbic acid, also aid in iron 
incorporation in most cells studied. 
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CHAPTER 4 
TRANSFERRIN RECEPTOR-1 AS A REPORTER GENE FOR MRI TRACKING OF 
CELLS 
4.1 INTRODUCTION 
TfR-1 is a membrane glycoprotein which has an indispensable role in 
maintaining iron homeostasis, serving as a mediator in the iron uptake by most cells 
through the internalization of iron-bound transferrin (Aisen, 2004). 
4.1.1 Studies targeting transferrin receptor-1 
Most studies relating to TfR-1 involve the up-regulation and/or 
overexpression of this gene, mainly for targeted therapeutic applications, such as 
using this receptor and its conjugate (transferrin) as a drug delivery system (Moore 
et al., 2001; Qian et al., 2002; Wang et al., 2010). This is based on the fact that 
tumour/ cancer cell lines often have very high numbers of TfR-1 on their 
membrane, when compared to most healthy tissues within an organism (Inoue et 
al., 1993). TfR-1 can therefore be targeted by two different approaches: i) to deliver 
a therapeutic agent to a malignant cell, promoting cytotoxic effects; or ii) inhibiting 
TfR-1 at the cellular surface with specific molecules, therefore directly promoting 
cell death (Daniels et al., 2012). Therefore, this system proves to be advantageous 
in terms of drug tissue distribution, preferentially targeting high expressing TfR-1 
cells and avoiding non-specific toxicity. Also, extended half-life of the drug when 
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combined with transferrin would bypass its spreading into the blood stream. Finally, 
a somewhat “controlled” intracellular drug release would then be possible (Daniels 
et al., 2012; Qian et al., 2002). However, this use of TfR-1 is mainly focused on 
cancer therapeutics and to a lesser extent on cell tracking applications. 
4.1.2 Transferrin receptor-1 as an MRI reporter gene 
One of the earliest cell tracking studies based on TfR-1 levels was performed 
by Moore et al. (1998), where gliosarcoma cells were stably transfected with an 
engineered human transferrin receptor-1 (ETR). This engineered gene lacked the 
3’ untranslated region containing the iron responsive elements responsible for 
post-transcriptional regulation of TFR-1 in iron uptake regulation. These cells were 
exposed to a conjugation of dextran-coated monocrystalline iron oxide 
nanoparticles (MION) with transferrin (Tf-MION). In the first instance, the group 
showed that when Tf-MION was presented as an iron source, it was internalized by 
TFR-1 mediated endocytosis and did not interfere with ETR expression levels. Later 
on, ETR was overexpressed again in a gliosarcoma cell line using a lentiviral 
approach and cells were non-invasively monitored with MRI in a mouse model, 
where the cells gave a distinct contrast as a result of the higher iron uptake. This 
was then the first research group to primarily explore TFR-1 as an MRI reporter 
gene (Ichikawa et al., 2002; Moore et al., 1998; Moore et al., 2001; Weissleder et 
al., 2000). 
Since then, another two groups have investigated the role of TfR-1 as a cell 
tracking probe for visualization with MRI. However, one of these studies was mostly 
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focused on targeted delivery of cancer therapies using a breast cancer cell line 
(Wang et al., 2010). The other report is the only one which has evaluated TfR-1 as a 
potential MRI reporter gene in the field of cell tracking. This was performed by 
Deans et al. (2006), where human TFR-1 in conjunction with human ferritin heavy 
chain-1 (FTH-1) were stably transfected by electroporation into an immortalized 
mouse cerebellar progenitor cell line (also known as C17 cell line). Both transgenes 
were deprived of 3 and 5’ UTR in TFR-1 and FTH-1, respectively, to allow 
constitutive expression. When analysing transgene integration, human TFR-1 and 
FTH-1 were investigated at mRNA and protein level. It was found that in transgenic 
cells, FTH-1 was increased 2.5-fold more than in controls when both cell types were 
iron supplemented. However, since this study overexpressed TFR-1 and FTH-1 genes 
from human origin into a mouse cell line, the authors failed to investigate if the 
endogenous levels of these genes (mouse TfR-1 and Fth-1) were affected. 
Therefore, they did not show if the transgenic cells were compensating the 
overexpression by down-regulating their own TfR-1 and Fth-1 levels, in order to 
maintain iron homeostasis. Nevertheless, in this study it was found that cells 
expressing both transgenes stored more intracellular iron than controls, without 
affecting cell viability. This intracellular iron accumulation resulted in an increase in 
T2 and T2* contrast both in vitro and in vivo when transgenic cells were transplanted 
into mouse (Figure 13) (Deans et al., 2006). 
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Figure 13 – Control (C17s) and TFR-1/FTH-1 transfected cells (C17-12s) were supplemented 
with iron (1 mM of ferric citrate and 1 mg/ml holo-transferrin) for 48h before 
transplantation into an adult mouse brain. a – schematic representation of a coronal 
section of a mouse brain, indicating the injection site (is), control regions in the cortex (ctx) 
and striatum (str). b and c – Magnetic resonance (7 T) T2*-weighted images of ex vivo 
mouse brain sections, 20 days after injection. A clear contrast is observed between injected 
cells and the surrounding brain tissue; analysing regions of interest within the injection site, 
a significant signal loss is detected for C17-12s (n=3), when compared to C17s (n=2). 
Reproduced with permission from Deans et al. (2006). 
In this chapter, mouse transferrin receptor-1 gene is evaluated for its 
potential as a reporter gene for MRI tracking of cells. To do this, first, a stable and 
long-term overexpression was evaluated in a model cell line, CHO K1. Transduced 
cells were then compared to controls in terms of cell viability and also iron 
homeostasis, by investigating endogenous and total levels of TfR-1. Finally, iron 
retention capacity of TfR-1 transduced cells and the feasibility of imaging these cells 
using MRI are also evaluated.  
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4.2 RESULTS 
Transferrin receptor-1 was initially assessed as a potential magnetic reporter 
in several cell lines such as HEK 293(N), CHO K1, mouse fibroblast cells 
STO (ATCC® CRL-1503™) and MEF-1 (ATCC® CRL-2214™), and stem cell lines such as 
mESC and mMSC. The most promising results were obtained using HEK 293T(N) 
(data not shown), CHO K1 and mMSC. Therefore, the present chapter describes 
CHO K1 as a model cell line to explore the full potential of TfR-1 as an MRI reporter 
and in the following chapter TfR-1 is assessed in mMSC (Chapter 5). 
CHO K1 cells were transduced with lentiviral particles encoding either for 
GFP, to serve as control, or GFP_T, to evaluate the potential of transferrin 
receptor-1 as a magnetic reporter. These cells were transduced with a MOI=100 and 
were not subjected to FACS sorting. Three independent transductions were carried 
out for each condition and represent, therefore, three biological replicates (n=3). 
4.2.1 Evaluation of reporter gene integration 
Transgene expression, in the form of green fluorescence due to the presence 
of a GFP reporter, was monitored over several passages using fluorescence 
microscopy (Figure 14) and flow cytometry (Figure 15). 
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Figure 14 – Representative pictures of CHO K1 cells, at P3 (A) and P8 (B) post-transduction, and control cells (untransduced) at an equivalent passage. GFP 
corresponds to GFP transduced cells and GFP_T to TfR-1 transduced cells. All green fluorescent pictures were taken with the same exposure conditions. 
Scale bars correspond to 100 µm. 
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Figure 15 – Flow cytometry histograms of (A) CHO K1 cells, at P3 and P8 after transduction. Histograms show the number of events (cells) counted (y-axis) 
versus the fluorescence intensity (x-axis). Green fluorescence (GF) gate represents GFP-positive cell population plotted in B. The Xmean (C) represents the 
mean fluorescence obtained from the gated region (GFP cells). Error bars represent SEM (n=3); a.u. - arbitrary units; (M&M, p.48). 
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Figure 14 and Figure 15 demonstrate that GFP and GFP_T transductions 
were very efficient in both conditions as cells are nearly 100% GFP-positive and 
maintain green fluorescence over the period of time studied. A small difference in 
the brightness of green fluorescence is also perceptible between GFP-control cells 
and GFP_T cells (Figure 14). This is further evaluated with flow cytometry 
(Figure 15, C), where the mean fluorescence intensity not only has a clear shift 
between GFP and GFP_T at P3, meaning that GFP_T are less bright than GFP 
control, but also between P3 and P8, where there is a decrease in green 
fluorescence intensity for both conditions, even though they are still almost 100% 
GFP-positive. 
To additionally complement integration stability evaluation and its effects on 
the native TfR-1, the transgenes GFP/ viral transferrin receptor-1 (Viral_T) as well as 
endogenous TfR-1 (here named as CHO_T) were also assessed at P1 and P3 with 
RT-qPCR (Figure 16). Because the integrated transgene was derived from a mouse 
cell line, whose sequence is not completely homologous to Chinese hamster, viral 
(Viral_T) and endogenous (CHO_T) TfR-1 mRNA transcripts could be detected 
individually by RT-qPCR. The total amount of TfR-1 (Total_T) expressed in the cell at 
a certain condition was later determined by protein quantification. For RT-qPCR 
evaluation Pabpn1 and Vezt genes were used as a reference for CHO K1 cells to 
normalize Ct values obtained for target genes. 
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Figure 16 – RT-qPCR relative quantification of GFP, Viral_T and CHO_T targets in control, 
GFP and GFP_T transduced CHO K1 cells at P1 and P3 post-transduction. GFP and Viral_T 
expression values are normalised to P1 (A) and endogenous CHO_T to control cells (B). A 
very significant statistical decrease of endogenous TfR-1 is observed only in TfR-1 
overexpressed cells (GFP_T), both at P1 and P3. Error bars represent SEM (n=3) (M&M, 
p.52). 
The data presented in Figure 16, A confirms the observation with flow 
cytometry (Figure 15, C), in which GFP expression decreases in both cell lines over 
time. The same, however, is not confirmed for Viral_T expression, which appears 
relatively stable from P1 to P3. This suggests that the bicistronic expression in this 
case might not be equivalent for both transgenes. Also, the data in Figure 16, B 
shows that the endogenous TfR-1 (CHO_T) expression is stable in control and GFP 
cells over the period of time studied, while there is a very significant decrease in 
GFP_T cells, due to the overexpression of TfR-1 transgene. This decrease is 
maintained from P1 to P3. 
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4.2.2 Cell viability 
In order to understand to what extent GFP and/or TfR-1 transgene 
integration was affecting cell health and proliferative capacity, a viability assay was 
performed on GFP and GFP_T transduced cells. This was done at two time-points, 
P1 and P4, having control cells as a reference for comparison. Results are presented 
in Figure 17. 
 
Figure 17 – Viability of GFP and GFP_T transduced CHO K1 cells at P1 and P4 
post-transduction. Data points are normalised to Control (untransduced) cells. Error bars 
represent SEM (n=3) (M&M, p.62). 
Figure 17 shows that cells transduced with either GFP or GFP_T have a 
viability/ proliferation capacity in similar levels to control cells, both at P1 (7 days 
post-transduction) and at P4. This suggests that transgene overexpression is not 
causing any cellular survival. 
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4.2.3 Iron homeostasis 
To estimate how the cell’s iron homeostasis was being affected due to the 
integration of TfR-1 transgene, GFP and viral TfR-1 (Viral_T) expression were 
explored. Moreover, the endogenous TfR-1 (CHO_T) mRNA transcripts were also 
quantified by RT-qPCR and the total TfR-1 (Total_T) expression, comprising both 
endogenous and viral TfR-1, was quantified at the protein level by WB. To do this, 
control, GFP and GFP_T cells were exposed to an iron concentration of 0.2 mM, 
previously determined (Figure 11 – Chapter 3) (+ 1.28 mM holo-transferrin; 
+ 50 µM L-ascorbic acid – not mentioned from here on), alongside a 
non-supplemented control (0 mM) for a period of 4 days (Iron supplementation, 
p.50). Target genes were evaluated at the mRNA level by RT-qPCR (Figure 18 and 
Figure 19 A, C) and at the protein level by WB (Figure 19 B, D and 
Supplementary figure 1). For RT-qPCR amplification, the reference genes used were 
the same as previously described. For WB detection, actin and total protein gels 
were used as references for data normalization. 
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Figure 18 – RT-qPCR relative quantification of transgenes GFP (A) and Viral_T (B) when GFP 
and GFP_T transduced cells were exposed to 0 and 0.2 mM of iron. Error bars represent 
SEM (n=3) (M&M, p.52). 
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Figure 19 – Relative quantification of endogenous TfR-1 (CHO_T) expression obtained via 
RT-qPCR (A and C) and of total (endogenous + viral) TfR-1 (Total_T) protein levels obtained 
via WB (B and D), when control, GFP and GFP_T transduced cells were exposed to different 
iron concentrations of 0 and 0.2 mM (M&M, p.50). Graphs A and B evaluate target 
expression levels when each cell line is exposed to different iron concentrations and graphs 
C and D the difference between cell lines when exposed to the same iron concentration. 
Error bars represent SEM (n=3) (M&M, p.52 for RT-qPCR and p.57 for WB). 
In Figure 18, GFP (graph A) and Viral_T (graph B) target expression was 
plotted against a non-supplemented control for each condition (GFP and GFP_T) in 
order to evaluate transgene expression when iron was present at a concentration of 
0.2 mM. The results show that GFP and TfR-1 transgene expression is stable with 
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0.2 mM of iron, with no significant differences between the two conditions. A 
further evaluation in TfR-1 levels was performed, in which mRNA transcripts were 
quantified at the endogenous level (i.e., TfR-1 derived from CHO K1 origin only) 
(Figure 19, A and C) and the total expression of TfR-1 (endogenous and viral origin) 
was quantified at the protein level (Figure 19, B and D). The results displayed in 
Figure 19, graph A, show that when comparing individual conditions with different 
iron concentrations, the natural tendency would be that when iron is present in 
high concentrations, the TfR-1 mRNA transcripts are cleaved by endonucleases 
(Figure 1– Chapter 1) and thus the mRNA levels are decreased when compared to a 
non-supplemented control. This is seen for control and GFP cells with a high 
statistical significance. The same is observed at the protein level (Figure 19, graph B) 
for the same conditions, with the total TfR-1 protein levels being decreased to 
about half. However, for GFP_T transduced cells there is no significant decrease in 
endogenous and total TfR-1 levels when iron is present and this may be explained 
by the results demonstrated in Figure 19, graph C. Here, at each supplementation 
condition (without or with iron), GFP and GFP_T transduced cells are compared to 
control cells. Interestingly, without iron supplementation, GFP_T cells are the only 
ones with a very significant decrease of endogenous mRNA TfR-1 levels. At 0.2 mM 
of iron, the levels in GFP_T cells are very similar to control cells which explain why 
there is no decrease in graph A, because endogenous mRNA levels are already low 
to begin with. At the protein level, in Figure 19, graph D, the scenario is totally 
opposite, in which the quantification of total TfR-1 shows a 60 to 70-fold 
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overexpression of this gene in GFP_T cells when compared to controls, both without 
and with 0.2 mM iron supplementation, respectively. These results clearly show 
that insertion of GFP_T virus is influencing the overall expression levels of TfR-1. 
To further confirm TfR-1 overexpression levels of GFP_T in relation to 
controls (control, GFP) and to specifically localize the TfR-1 protein within the cell, 
immunofluorescence was performed. Control, GFP and GFP_T cells with no iron 
supplementation were immunostained with rabbit anti-TfR-1 primary Ab and then 
visualized with a red fluorophore linked to an anti-rabbit secondary Ab. DNA was 
stained with DAPI in order to visualize the nuclear region. The results obtained for 
GFP_T cells are displayed in Figure 20. Immunofluorescence pictures of other 
conditions (Control, GFP), as well a negative control to confirm the specificity of the 
secondary to the primary Ab, are shown in Supplementary figure 2. 
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Figure 20 – Representative immunofluorescence pictures of GFP_T transduced CHO K1 
cells, showing nuclear staining with DAPI (A), green fluorescence (GF) obtained by GFP 
reporter (B) and the detection of TfR-1 proteins, visualized by red fluorescence (RF) (C). The 
overlay between these conditions shows that GFP reporter is mainly expressed in the 
nucleus (D), TfR-1 is present outside the nuclear region, more likely localized at the cellular 
membrane (E) and that there is a mixed population in (F), where only the high expressing 
GFP cells also have an overexpression of TfR-1. A higher magnification of the insets is 
presented on the right hand side pictures. Scale bars: 25 µm; (M&M, p.56). 
In Figure 20, the precise localization of TfR-1 is not very clear, but it is 
predicted to be identified at the cellular membrane (E), while the GFP expression is 
only seen in the nuclei (D). The overexpression of TfR-1 is identified in F, where 
there is a mixed population of GFP/viral TfR-1 cells. The cells highly expressing GFP 
also show a high detection of TfR-1, while cells expressing a low GFP present a 
lower level of detection of TfR-1. All the same, when compared with control and 
GFP cells in Supplementary figure 2, there is a clear TfR-1 overexpression in GFP_T 
cells. 
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Another important complex responsible for keeping iron homeostasis is 
ferritin, also tightly controlled by the cell through the IRP/IRE regulatory system 
(Figure 1 – Chapter 1). To evaluate the cell’s control over ferritins when transgenes 
were introduced, ferritin heavy chain-1 expression levels (here named as Total_F) 
were analysed in the same conditions as previously described at the mRNA (by 
RT-qPCR, Figure 21, A and C) and at the protein level (by WB, Figure 21, C, D and 
Supplementary figure 1). Reference genes and proteins used for data normalization 
of RT-qPCR and WB, respectively, are the same as described above. 
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Figure 21 – Relative quantification of Fth-1 (Total_F) expression obtained via RT-qPCR (A 
and C) and the respective protein levels obtained via WB (B and D), when Control, GFP and 
GFP_T transduced cells were exposed to different iron concentrations of 0 and 0.2 mM. 
Graphs A and B evaluate Total_F expression levels when each cell line is exposed to 
different iron concentrations and graphs C and D the difference between cell lines when 
exposed to the same iron concentration. Error bars represent SEM (n=3) (M&M, p.52 for 
RT-qPCR and p.57 for WB). 
The results displayed in Figure 21 show that at the mRNA level there is not 
much variation of Fth-1 and the levels are maintained relatively constant either 
when iron is supplemented for each cell line (comparing to a non-supplemented 
control) (graph A) or when GFP and GFP_T are compared to control cells, at each 
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supplementation condition (graph C). In contrast, at the protein level, Fth-1 protein 
expression is elevated for each cell line when iron is added (graph B). Note that in 
graph B, while control and GFP cells have an up-regulation of 45 and 25-fold 
respectively in relation to non-supplemented cells, GFP_T cells have only a 3.5-fold 
increase. Similarly to the down-regulation of TfR-1 mRNA levels, this smaller 
increase may be explained by the results presented in graph D, where Fth-1 protein 
levels are much higher in GFP_T cells when compared to controls (Control, GFP), at 
both supplementation conditions. This contrast between mRNA and protein 
expressions may be explained by the post-transcriptional regulation of Fth-1 (i.e., 
when iron is present in excess, translation of Fth-1 is promoted). 
The results presented above show the effect of integrated GFP and/or TfR-1 
transgenes on cellular iron homeostasis, through the analyses of endogenous and 
viral TfR-1, as well as the endogenous Fth-1. The results obtained suggest that GFP 
cells are very similar to control cells, while GFP_T cells express high levels of TfR-1, 
also leading to an endogenous overexpression of Fth-1. Next, the intracellular iron 
present in each condition was evaluated. 
4.2.4 Intracellular Iron Uptake in vitro 
The capacity of GFP_T to retain more iron than controls (Control, GFP) was 
explored by measuring the intracellular iron content of Control, GFP and GFP_T 
transduced CHO K1 cells non-supplemented or supplemented with 0.2 and 2 mM of 
iron. Results are displayed in Figure 22, where the intracellular amount of iron is 
shown as a function of iron supplementation. 
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Figure 22 – Intracellular iron content of CHO K1 cells determined with the Ferrozine assay 
(A). Control, GFP and GFP_T transduced cells were supplemented with different iron 
concentrations of 0, 0.2 and 2 mM for 4 days prior to measurement (Iron supplementation, 
p.50). Fold-differences between GFP_T cells and Control or GFP are presented for each 
supplementation condition in B. Error bars represent SEM (n=3) (M&M, p.50). 
Figure 22 (A) shows an increased capacity of GFP_T cells to retain 
intracellular iron when compared to controls. This capacity is statistically significant 
for 0 and 0.2 mM of iron supplementation conditions. With 2 mM of iron an 
increase is also observed, although it is not statistically significant. The 
fold-differences presented in table B (Figure 22) show that GFP_T cells have a 
higher difference to controls when iron is not supplemented, i.e., relying only in the 
iron/ transferrin available in cell culture medium (Iron supplementation, p.50), with 
around 4-fold increase. These results suggest that TfR-1 might be a promising 
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reporter gene for MRI, as it increases intracellular iron accumulation when 
compared to controls. 
4.2.5 MRI 
To study the potential of TfR-1 transgene as an MRI reporter, cell pellets of 
control, GFP and GFP_T were scanned using T2-weighed sequences. To do this, 
107 cells were centrifuged at high speed to form a compact cell pellet and imaged 
via MR, where T1/T2 maps were produced for relaxivity studies. Results are 
displayed in Figure 23. 
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Figure 23 – MR imaging of cell pellets of CHO K1 cells. A is a T2-weighted representative MR 
image obtained with the MRI of control with no iron supplementation (0 mM), GFP and 
GFP_T both supplemented with 0.2 and 2 mM of iron (Iron supplementation, p.50). 
Relaxation times T1 and T2 were quantified on a specific region of the cell pellet and are 
represented in B and C, respectively. Error bars represent SEM (n=3) (M&M, p.65). 
Figure 23 shows that at 0.2 mM condition, GFP_T cells when compared to 
GFP control were able to produce a statistically very significant (p=0,002) T2 
shortening effect, presented in graph C. Nevertheless, this difference may not be 
sufficient to detect an MRI contrast once cells are introduced in vivo. Again, at 
2 mM condition, even though it is not statistically significant, a small T2 shortening 
effect is still observed. Also, in graph C, 0 mM control condition appears not to be 
correct, since the signal loss is even more intense than for the other conditions 
supplemented with iron. None of these differences are perceptible in MR image A, 
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where the signal intensity obtained is very much alike in all conditions. 
Then, GFP and GFP_T cells were injected into the brain of chick embryos 
in ovo, the model organism used in this work. 2x105 cells were microinjected into 
the midbrain of the chick embryo at embryonic day 3 (E3). Both cell types were 
either incubated in normal cell culture conditions (0 mM) or supplemented with 0.2 
or 2 mM of iron for 3 days prior to injection. At E5, embryos were imaged with two 
complementary platforms: by fluorescence microscopy to detect green 
fluorescence derived from the GFP gene, and by MRI, by observing hypointense 
regions derived from iron retained in transduced cells, which was influenced by 
extracellular iron supplementation and/or due to TfR-1 overexpression (Figure 24). 
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Fluorescence Imaging MRI 
Iron 
conc. 
Transduction 
condition 
Biological rep. 
(technical rep.) 
Iron 
conc. 
Transduction 
condition 
Biological rep. 
(technical rep.) 
0 mM 
GFP n=1 (1) 
0 mM 
GFP n=1 (1) 
GFP_T n=2 (5) GFP_T n=1 (2) 
0.2 mM 
GFP n=1 (3) 
0.2 mM 
GFP n=1 (1) 
GFP_T n=1 (2) GFP_T n=1 (1) 
2 mM 
GFP n=2 (2) 
2 mM 
GFP n=2 (2) 
GFP_T n=2 (3) GFP_T n=2 (3) 
Figure 24 – Fluorescence and MR imaging of GFP (A, C and E) and GFP_T (B, D and F) 
transduced CHO K1 cells, 2 days after injection in the midbrain of a chick embryo (E5). Cells 
were injected after culture with or without iron supplementation (0, 0.2 and 2 mM of iron 
for 3 days) (Iron supplementation, p.50). In the fluorescence imaging panel, bright field (BF) 
and green fluorescence (GF) are projection images from the whole embryo; overlays are 
presented for both left and right views and were used as a reference guidance for MR 
imaging; scale bars correspond to 1 mm. In the MRI panel, anatomical images are displayed 
as transverse sections along the rostrocaudal axis of the embryo (left to right); 10 sections 
are displayed for each embryo. All images are representative from the results obtained and 
were equally processed with ImageJ software. Arrows indicate T2 shortening effect; b –
 bubble of air. Position of the embryo: F – front; B – back; R – right; L – left; number of 
biological and technical replicates is indicated in the table above (M&M, p.65). 
In some areas in Figure 24, tiny bubbles of air (designated as “b”) got 
trapped in the agarose during sample preparation, resulting in areas with no signal 
in close proximity to the embryo, and are indicated in the images. To identify if 
transduced cells integrated into chick embryo’s brain, first, bright field and 
fluorescence imaging were performed on whole embryos. Due to the presence of 
fluorescent reporters, transduced cell clusters were easily identified and located 
within the brain. This served as a guideline to identify hypointense cell clusters with 
MR imaging. Without this support, identifying cell clusters based only on anatomical 
images would have proven to be much more difficult. 
In Figure 24, when iron supplementation was not provided (panels A and B), 
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it was only possible to detect hypointense regions in GFP_T cells, corresponding to 
the location of fluorescent cells in embryos. On the other hand, no hypointense 
region was found when embryos were injected with GFP control, even though green 
fluorescent cell clusters are observed. A similar situation is detected for 0.2 mM 
condition (panels C and D), in which only two clusters of cells are identified in GFP 
control, even though there are many others imaged with fluorescence microscopy. 
On the other hand, all GFP_T cell clusters first identified with green fluorescence, 
were able to be correlated and identified using MR imaging. Surprisingly, when iron 
was supplemented at 2 mM (panels E and F), the most concentrated condition of 
the three, hypointense regions were found for both GFP and GFP_T cells, but the 
contrast was not noticeably stronger when compared to GFP_T with low iron 
concentrations (B and D). Also, no obvious difference is found between GFP and 
GFP_T hypointense regions. Overall, these results suggest that when using such a 
high iron supplementation, as 2 mM, there might be an overload of iron present in 
the cell, disguising the influence of TfR-1 overexpression. Therefore, in order to use 
TfR-1 as a valuable reporter gene, in vitro iron supplementation prior to injection 
may not even be necessary to visualize GFP_T cells under MRI.  
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4.3 DISCUSSION 
Over the past two decades, TfR-1 has been investigated as an MRI reporter, 
mostly for targeted cancer therapies, using nanoparticles to encapsulate 
chemotherapeutical agents and TfR-1 as a drug delivery system (Moore et al., 1998; 
Qian et al., 2002). Only once the use of TfR-1 as an MRI reporter was focused on 
stem cell tracking and it was performed in conjunction with Fth-1 overexpression, in 
a mouse neural stem cell line (Deans et al., 2006). In this chapter, the sole 
overexpression of mouse TfR-1 was used to increase intracellular iron content in 
CHO K1, a model cell line chosen to evaluate TfR-1 as a potential reporter gene for 
MRI tracking of cells. 
In Chapter 3, TfR-1 cDNA was cloned into a pHIV-eGFP lentiviral vector. 
Because this cDNA was originally obtained from mouse cells, viral and endogenous 
TfR-1 transcripts were possible to be individually detected in the current study. 
Also, a primer pair to detect simultaneously viral and endogenous TfR-1 mRNA 
transcripts was attempted; however, even though the predicted homology between 
the two cDNAs is 88%, it was not possible to find a common region. Nevertheless, at 
the protein level, the antibody chosen to target TfR-1 was able to detect 
simultaneously the endogenous and viral TfR-1 proteins, allowing for a 
quantification of the total TfR-1 (or Total_T). 
GFP/ Viral_T transgene integration was evaluated in CHO K1 cells initially 
over several passages (P3 to P8) (Figure 14, Figure 15 and Figure 16) and then when 
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supplemented with two concentrations of iron (0 and 0.2 mM) (Figure 18). It was 
found that transduction was very effective with nearly 100% of cells GFP-positive 
and stable irrespective of iron supplementation. However, in Figure 16, a small 
decrease in GFP expression was found when analysing GFP and GFP_T cells over the 
course of the study (P1 to P3), which was not seen for Viral_T expression in GFP_T 
cells. This might be explained by the fact that, within the transfer lentiviral vector, 
GFP transgene is located downstream of the internal ribosome entry site (IRES), 
which also flanks upstream the reporter gene of interest, in this case TfR-1. 
Therefore, the promoter EF1-α is about 3 kb upstream from GFP transgene, possibly 
not permitting efficient transcription in this region. Also in Figure 16, a significant 
decrease in the endogenous expression of TfR-1 (CHO_T) is observed in GFP_T cells, 
both at P1 and P3, when compared to control and GFP cells. The same is seen 
likewise in Figure 19 (graph A and C), where the endogenous TfR-1 mRNA levels are 
decreased in GFP_T cells, when compared to controls, both with and without iron 
supplementation. This decrease might be due to the presence of iron responsive 
elements (IREs) present in 3’UTR of the endogenous TfR-1, allowing the cell to have 
a post-transcriptional control over the mRNA cleavage, and therefore decreasing 
TfR-1 mRNA transcripts available. Nevertheless, as viral TfR-1 transgene was 
deprived of IREs from the untranslated region, as described in Chapter 3, this 
allowed for a constitutive expression without the cell’s control (Figure 19, D and 
Figure 20). Supplementary figure 2 also demonstrates that the integration of mouse 
TfR-1 transgene (GFP_T) leads to an overexpression of this gene, while controls 
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(Control and GFP) remain with basal levels. 
As opposed to TfR-1, where there is an endonucleolytic cleavage for mRNA 
stability control, and thus mRNA transcripts may be decreased or increased 
depending on iron availability, the way the IRP/IRE system regulates ferritins is to 
either allow or block the translation process. Therefore, whether iron is present or 
not, the total amount of Fth-1 mRNA transcripts may be relatively constant, as seen 
in Figure 21 (graphs A and C). However, at the protein level is where the cell’s 
control over ferritins is quite distinctive. When total protein Fth-1 levels are 
compared between the different conditions, at a defined iron concentration 
(Figure 21, graph D), an up-regulation of 15 and 3.5-fold is observed for GFP_T cells, 
when supplemented with 0 and 0.2 mM of iron, respectively. A similar 
up-regulation was described by Deans et al. (2006), where protein levels of human 
FTH-1 were increased 2.5-fold in TFR-1/FTH-1 transfected cells when supplemented 
with iron, compared to control cells. However, their supplementation conditions 
were far greater, with 1 mg/ml of holo-transferrin and 1 mM of ferric citrate, ten 
and five times more than used here. They also mention that when cells were not 
supplemented, FTH-1 protein levels were decreased in TFR-1/FTH-1 transfected 
cells. On the contrary, our results indicate that at low iron concentrations, such as 
0 mM (relying only in the iron/transferrin present in cell medium and FCS) (please 
see Iron supplementation on p.50), Fth-1 protein levels are increased. This 
difference might be due to the fact that in this study, only TfR-1 was overexpressed, 
while in Deans et al. (2006), both TFR-1 and FTH-1 were overexpressed in 
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conjunction. It is very likely that due to the presence of high levels of TfR-1, GFP_T 
cells have an increased Fth-1 protein expression both with and without iron 
supplementation, which may indirectly result in an increase in ferritin light chain 
expression, leading to an increase in the number of ferritin heteropolymers 
available within the cell. Immunofluorescence was also employed in detecting Fth-1 
proteins, but no differences were found between GFP_T and control conditions 
(data not shown). Overall, these results suggest that, in GFP_T transduced cells, the 
iron available may be entering the cells through the accessible overexpressed TfR-1 
and then clustering in ferritin cages, as a consequence of the normal iron 
homeostasis regulation process. 
Next, intracellular iron was measured and it was found that GFP_T cells have 
a higher capacity to retain iron than controls (Control and GFP cells), with statistical 
significance for two concentrations tested (0 and 0.2 mM) (Figure 22). Also, when 
cell pellets were evaluated with MR imaging at 0.2 mM of iron a significant T2 
shortening effect was observed for GFP_T cells (Figure 23). The results suggest that 
because both TfR-1 and Fth-1 levels were up-regulated in GFP_T cells when 
compared to controls, intracellular iron content was also reasonably increased. This 
reinforces the hypothesis that ferritins might be clustering iron inside the cell and in 
a non-toxic way (Figure 17). 
To complement this study, GFP and GFP_T cells injected in chick embryos 
were imaged with fluorescence microscopy and MRI. Interestingly, only when cells 
were either not supplemented or supplemented with 0.2 mM of iron prior to 
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injection that a distinguishable contrast was observed for GFP_T cells, but not for 
GFP control (Figure 24, A-B and C-D). This is comparable with the previous results of 
iron retention capacity, obtained with the intracellular iron measurement and MRI 
imaging of cell pellets. Such a difference was not so evident when cells were 
supplemented with 2 mM (Figure 24, E and F), suggesting that at this concentration 
there might be an excess of iron present and TfR-1 overexpression in GFP_T cells is 
no longer noticeable. Also, the use of TfR-1 as a reporter gene for cell tracking might 
not even need iron supplementation prior to cell injection. This would prove to be a 
very useful feature in a reporter gene, as long-term studies would be possible 
without adding any iron-related supplementation. 
In summary, TfR-1 gene was overexpressed in a model cell line, CHO K1, and 
analysed for its potential as an MRI reporter. The targeted overexpression was first 
found to up-regulate the overall TfR-1 levels in cells, without interfering with their 
viability and allowing iron to enter the cell in a constitutive manner. The results 
indicate that iron homeostasis was affected by TfR-1 overexpression and was able 
to adjust by inducing an increase in the ferritins available. This resulted in higher 
intracellular iron retention of TfR-1 transduced cells relative to controls, in 
particular with low levels of iron (0 and 0.2 mM), thus facilitating detection with 
MRI. Therefore, TfR-1 gene overexpression in mammalian cells can be a useful tool 
to track cells with MRI technology.  
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4.4 SUPPLEMENTARY DATA 
 
Supplementary figure 1 – Representative western blots and correspondent total protein 
gels from control, GFP and transferrin receptor-1 (GFP_T) transduced CHO K1 cells, 
supplemented for 4 days with 0 or 0.2 mM of iron. Orange rectangle highlights total TfR-1 
(endogenous + viral, here described as Total_T) protein expression, with a predicted 
molecular weight (MW) of 100 kDa; white rectangle corresponds to actin expression with 
42 kDa and blue rectangle to Fth-1 (or Total_F) with 21 kDa. Protein quantification was 
normalized using total protein gels and confirmed using actin as a reference protein (M&M, 
p.57).
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Supplementary figure 2 – Representative immunofluorescence pictures of Control, GFP and GFP_T transduced CHO K1 cells, showing nuclear staining with 
DAPI, green fluorescence (GF) originating from the GFP reporter and the detection of TfR-1 proteins, visualized with a red fluorescent antibody (RF). A clear 
protein overexpression of TfR-1 is found in GFP_T. All pictures sets were taken with the same exposure conditions. RF pictures with a longer exposure time 
are shown in the insets. A negative control targeting only the secondary Ab is included to confirm the specificity to the primary Ab. Scale bars: 25 µm; (M&M, p.56). 
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CHAPTER 5 
FERRITIN HEAVY CHAIN-1 AND TRANSFERRIN RECEPTOR-1 AS REPORTER 
GENES FOR MRI TRACKING OF CELLS 
5.1 INTRODUCTION 
TfR-1 is transmembrane glycoprotein responsible for internalizing 
iron-bound transferrin which is then released and stored in a non-toxic form inside 
metalloprotein complexes, called ferritins. This is only possible due to the 
ferroxidase activity present in the heavy subunit of ferritin (Fth-1), which not only 
incorporates but also transforms cytoplasmic ferrous iron into a safe ferric iron 
configuration. Both TfR-1 and Fth-1 are known to have a significant role in iron 
metabolism and thus, have been targeted as a means to increase intracellular iron 
concentration of specific cell types. This would prove useful in particular for MRI 
tracking studies, using iron as a natural contrast agent. 
5.1.1 Studies targeting ferritin heavy chain-1 
The first evidence of using ferritin heavy chain-1 gene as an overexpression 
system was reported by Picard et al. (1996), in which a mouse erythroleukemia cell 
line was stably transfected with Fth-1. The transgene included two point mutations 
in the IRE site, and showed a decrease of 20 to 30% of heme in haemoglobin 
production in cells overexpressing Fth-1, indicating iron starvation as a consequence 
of iron accumulation within ferritins. They also demonstrated that the labile iron 
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pool (LIP) was significantly reduced in these cells and they were more resistant to 
H2O2 oxidative damage (Picard et al., 1998; Picard et al., 1996). 
Next, a study published by Cozzi et al. (2000), confirmed the massive 
reduction in the LIP in cells overexpressing human wild-type FTH-1, even though the 
iron uptake by transferrin receptor-1 was increased. It was demonstrated that 
FTH-1 overexpression increased the resistance to formation of reactive oxygen 
species. Furthermore, they generated a human FTH-1 mutant with an inactivated 
ferroxidase centre, which when overexpressed in cells did not obtain the same 
results as wild-type FTH-1, thus providing evidence for the importance of 
ferroxidase activity in iron incorporation. This paper describes an important 
observation on culturing cells with FTH-1 overexpression, namely that cell 
proliferation appears to be slower than in normal cells. They also state that this 
could be simply overcome by long-term iron supplementation (Cozzi et al., 2000). 
5.1.2 Ferritin heavy chain-1 gene as an MRI reporter gene 
Although Fth-1 overexpression was shown to allow an increase of 
intracellular iron above background levels (Cozzi et al., 2000; Picard et al., 1996), it 
was only in 2005 that two different research groups investigated if ferritin complex 
could be a potential reporter for MR imaging (Cohen et al., 2005; Genove et al., 
2005). Genove et al. (2005) engineered both human heavy and light ferritin 
subunits, removing IRE regulatory regions to allow free overexpression of both 
proteins without interference of the IRP/IRE regulatory system. This way, they 
obtained the necessary contrast needed for MRI without introducing any exogenous 
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contrast agents. Then, ferritin-overexpressing cells were inoculated into a mouse 
brain and monitored in vivo for 5 weeks. The results obtained with MRI were also 
validated with histological staining (Genove et al., 2005). The other study was from 
Cohen et al. (2005), who overexpressed solely the mouse Fth-1 in rat glioma cells, 
again with the IREs removed, and under the control of a tetracycline promoter. 
After inoculation of ferritin-expressing cells in the hind limb of mice, tumours 
formed and were left to grow up to 6 mm. Just like in the previous study, Fth-1 
alone allowed sufficient contrast for MRI detection and their findings could be 
correlated with histology (Cohen et al., 2005). 
Over the following years, a few more studies described the use of Fth-1, 
often associated with fluorescent proteins, as a novel reporter gene for use in MRI. 
Many cell types were used: several types of cancer cells (Aung et al., 2009; Feng et 
al., 2012; Iordanova et al., 2010; Kim and Eberwine, 2010; Ono et al., 2009), a 
mouse embryonic stem cell (ESC) line (Liu et al., 2009), cardiac cell lines (Campan et 
al., 2011; Naumova et al., 2010) and neural stem/ progenitor cells (Vande Velde et 
al., 2012). To introduce human/mouse Ferritin heavy chain-1 gene into the cell, 
different methods were used such as virus transduction (Genove et al., 2005, Vande 
Veldde et al., 2011), transfection (Aung et al., 2009) or electroporation (Deans et al., 
2006). Parameters like proliferation, viability, cytotoxicity and differentiation 
potentials were assessed by most studies and overall, no differences in relation to 
control cells were observed. In fact, in one case, it was reported that Fth-1 
overexpression induced a decrease in iron toxicity when compared to control cells, 
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suggesting an antioxidant protective role against iron toxicity (Genove et al., 2005). 
Also, the intracellular iron retention of transgenic cells in relation to controls was 
very often studied before transplantation into an animal model. In most cases, iron 
was supplemented in vitro in the form of ferric citrate or nitrate, with 
concentrations ranging from 0.2 to 1 mM, with additional 1-2 mg/mL of human 
holo-transferrin, for periods between 1-4 days (Deans et al., 2006; Genove et al., 
2005; Iordanova et al., 2010; Kim and Eberwine, 2010; Naumova et al., 2010). 
More recently, researchers have developed engineered ferritins in order to 
increase the contrast obtained with MRI, for example, a chimeric ferritin, 
comprising of a unique polypeptide with heavy and light chain subunits (L*H) fused 
together. This chimeric fused ferritin was found to have a significantly higher iron 
incorporating capacity than wild-type and even Fth-1 overexpressing cells and 
consequently, a higher relaxation rate when imaged with T2-weighted MRI 
(Iordanova et al., 2010). The same authors went a step further and reported an 
even greater iron accumulating ferritin, by modifying a specific site in the 
mitochondrial ferritin (MtF) allowing it to localize into the cytoplasm instead of the 
mitochondria (Iordanova et al., 2013). MtF is known to have a ferroxidase centre 
and an iron binding capacity similar to the native heavy-chain of ferritin. This was 
found by Corsi et al. (2002), when the transfection of HeLa cells with MtF lead to a 
higher iron uptake, specifically located in the mitochondria, as it was reported that 
transferrin receptors-1 were up-regulated, allowing the iron to enter the cell and, at 
the same point, the cytoplasmic ferritins were reduced (Corsi et al., 2002). 
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Even though Fth-1 seems to be a very promising MRI reporter gene for 
long-term in vivo investigations, more studies are needed in order to explore the 
full potential of this gene and in particular, to validate its efficacy with cell lines that 
are relevant for regenerative therapies. Here, mouse Fth-1 and TfR-1 are explored 
as potential reporters for MRI tracking studies, both individually and in conjunction, 
in a mouse mesenchymal stem cell line.  
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5.2 RESULTS 
As described in Chapter 3, Fth-1 was cloned in a dTomato lentiviral plasmid 
(dT_F), allowing for red fluorescence when transduced into cells. On the other hand, 
TfR-1 was cloned together with a GFP reporter (GFP_T), thus producing green 
fluorescence upon transduction. In the current chapter, mMSC were transduced 
with individual lentiviral particles, encoding for either dT or GFP, to serve as 
controls, and dT_F or GFP_T, to evaluate the potential of Fth-1 and TfR-1, 
respectively, as magnetic reporters. Also, a mMSC line in which dT_F and GFP_T 
lentiviral particles were transduced in conjunction was created and is designated as 
dT_F+GFP_T. These cells were transduced with MOI=50, including dT_F+GFP_T with 
MOIs=50+50, and were subjected to FACS sorting at P6 after transduction to obtain 
highly expressing dT or GFP-positive populations. Three independent transductions 
and FACS sorting were carried out for each condition and represent, therefore, 
three biological replicates (n=3). 
5.2.1 Reporter gene integration in normal cell culture conditions 
Transgene expression, in the form of red or green fluorescence, due to the 
presence of dTomato or GFP reporter, respectively, was initially monitored using 
fluorescence microscopy. Figure 25 displays phase contrast and fluorescence 
microscopy images taken 7 days after transduction (here designated as P1 
post-transduction), in which cells were grown in standard (without iron 
supplementation) cell culture medium. 
  
FTH-1 AND TFR-1 AS REPORTER GENES FOR MRI TRACKING OF CELLS| 135  
  
FTH-1 AND TFR-1 AS REPORTER GENES FOR MRI TRACKING OF CELLS| 136  
 
Figure 25 – Representative pictures of mMSC at P1 post-transduction. Control cells (untransduced) are displayed at an equivalent passage. dT corresponds 
to dTomato transduced cells; dT_F to Fth-1 transduced cells; GFP to GFP transduced cells; GFP_T to TfR-1 transduced cells and dT_Fth-1+GFP_T to cells 
transduced in conjunction with Fth-1 and TfR-1. All sets of pictures were taken with the same exposure conditions. A higher magnification of the insets is 
presented on the right hand side panel. RF - Red fluorescence; GF - Green fluorescence; RF/GF - Merge. Scale bars correspond to 100 µm.  
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Figure 25 shows that mMSC were efficiently transduced with specific 
lentiviral particles, however not all transduced cells behaved similarly to Control 
cells. This was the case, for example, for dT_F transduced cells, which had a very 
different morphology when compared to control and dT cells, displaying a very 
large cytoplasm as opposed to an elongated shape typical of mMSC. This may be 
due to the overexpression of Fth-1, since dT cells were morphologically similar to 
untransduced cells (Control). However, in terms of transduction efficiency, even 
though both conditions were subjected to the same MOI, a difference in red 
fluorescence is quite outstanding, with dT_F cells being much brighter than dT 
control cells. The same atypical morphology was present in dT_F+GFP_T cells, even 
though in a smaller number. Also in this condition, the transduction of two lentiviral 
particles in conjunction appears to be comparable, in terms of red and green 
fluorescence, to the parental transductions (dT_F and GFP_T). As for GFP and 
GFP_T, morphologically these cells were very similar to control cells even though 
GFP_T cells were present in a much lower number and only on the side of the well, 
thus the phase-contrast picture being a bit distinct from the others. At this specific 
time-point (P1), it was clear that cells exposed to different transduction conditions 
had different proliferation rates. This partially had to do with the transduction 
process, which by itself may disturb the normal cell cycle, but the integrated 
transgene could also be responsible. A viability assay was performed at this point 
(7 days after transduction) and is presented in Figure 26. 
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Figure 26 – Viability assay on transduced mMSC at P1 post-transduction with normal cell 
culture conditions. Data points and statistics are presented in relation to Control 
(untransduced) cells. Error bars represent SEM (n=3) (M&M, p.62). 
The viability assay demonstrated in Figure 26 assessed proliferative capacity 
of mMSC cell line transduced with different viral preparations and compared to 
untransduced cells. This assay corroborated the results shown in Figure 25, in which 
all transduced cells had a decrease in the proliferation rate, however some cell 
lines, such as dT_F and dT_F+GFP_T, are more affected than others. Therefore, 
Fth-1 overexpression in mMSC may be contributing to a deregulation in iron 
homeostasis and indirectly promoting proliferative arrest. All cell lines were 
monitored with fluorescence microscopy over several passages and a decrease in 
transgene expression in the form of red or green fluorescence was never observed 
for transduced cells (data not shown). However, while dT/GFP controls proliferated 
normally when compared to untransduced mMSC, cells overexpressing with Fth-1 
transgene never recovered from a slower proliferation capacity. Thus, in this 
condition, the population was enriched for low-expressing dT_F or untransduced 
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cells given their higher proliferation rate effectively diluting the fraction of the 
population consisting of high-expressing dT_F. As for cells transduced with TfR-1, 
such as GFP_T, viability rate was also significantly decreased, relative to 
untransduced cells, as all the other cell lines. However, GFP_T viability rate is 
comparable to its GFP control, only with a slight decrease, possibly due to a larger 
insert within the lentiviral construct, as discussed previously in Chapter 3. 
In order to try and overcome this problem, mMSC were again transduced 
and cultured in either normal conditions or with iron supplementation from 24h 
post-transduction. As described in Chapter 3, iron supplementation included 
0.2 mM ferric citrate, 1.28 mM holo-transferrin and 50 µM L-ascorbic acid. To 
compare both culture conditions, integrated transgenes (dTomato, Viral_F, GFP and 
Viral_T) were evaluated over two passages (from P1 to P3) with RT-qPCR and results 
are displayed in Figure 27. For RT-qPCR, Tbp and Pgk1 genes were used as a 
reference for mMSC to normalize Ct values obtained for target genes. 
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Figure 27 – RT-qPCR 
relative quantification of 
dTomato, Viral_F, GFP 
and Viral_T targets in 
transduced mMSC at P1 
and P3 post-transduction 
(without FACS sorting). 
Expression values of 
target genes are plotted 
against P1 without (A) 
and with (B) iron 
supplements from 24h 
post-transduction. Error 
bars represent SEM (n=3) 
(M&M, p.52). 
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Results displayed in Figure 27 show that without iron supplementation (A) 
mMSC integrated with dTomato and Fth-1 (dT_F and dT_F+GFP_T) were not able to 
keep high expression levels neither from dTomato or Viral_F transgenes, with a 
statistically significant reduction. Additionally, a reduction in GFP and Viral_T 
expression levels from P1 to P3 was also observed for dT_F+GFP_T cells. This may 
be as well due to Fth-1 overexpression in these cells, since GFP_T maintain 
expression levels constant of both transgenes from P1 to P3, with even a 2.5-fold 
increase in Viral_T expression at P3, however with no statistically significance. As 
previously mentioned, Fth-1 overexpression may be promoting an iron homeostasis 
deregulation, leading to a population decrease of cells transduced with Fth-1. This 
appears to be partially overcome by adding iron supplements to the cells from 24h 
after transduction (B). In this case, dT_F transduced cells maintained relatively 
constant dTomato and Viral_F expression levels from P1 to P3. As for dT_F+GFP_T 
cells, even though not statistically significant, a small decrease both in dTomato and 
Viral_F target genes remained present. Similarly, GFP and Viral_T expression levels 
were still significantly reduced. 
From this point onwards, all data presented was obtained using iron 
supplemented cells as described above, from 24h post-transduction. 
5.2.2 Reporter gene integration with iron supplementation 
mMSC transduced with specific lentiviral particles and iron supplemented 
from 24h post-transduction were given a few passages to recover and expand and 
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were then FACS sorted at P6 post-transduction. Figure 28 shows phase contrast and 
fluorescence microscopy images from the different transduced cell lines after FACS 
sorting for high expressing dT or GFP-positive population. Flow cytometry was then 
performed to confirm FACS sorting and results are illustrated in Figure 29. 
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Figure 28 – Representative pictures of mMSC at P7 post-transduction and FACS sorted, as well as control cells (untransduced) at an equivalent passage. All 
sets of pictures were taken with the same exposure conditions. RF-Red fluorescence; GF-Green fluorescence; RF/GF - Merge. Scale bars correspond to 100 µm.  
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Figure 29 – Flow cytometry histograms (A and D) of mMSC cells, at P8 post-transduction and after FACS sorting. Histograms show the number of events 
(cells) counted (y-axis) versus the fluorescence intensity (x-axis). Red/ green fluorescence (RF/GF) gate represents dTomato/GFP-positive cell population 
plotted in B and E. The Xmean (C and F) represents the mean fluorescence obtained from the gated region (dTomato/ GFP cells). Error bars represent SEM 
(n=3). a.u-arbitrary units; M&M, p.48. 
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Figure 28 demonstrates that with iron supplementation, all transduced cells 
appear morphologically very similar to untransduced mMSC. Also, with FACS 
sorting, dT and GFP-positive cells are much more uniform in fluorescence 
expression, with all nearly 100% positive (Figure 29, B and E). Only a difference in 
brightness of green fluorescence is observed between GFP-control cells and the 
other GFP-transduced cells (GFP_T and dT_F+GFP_T) (Figure 28). This was also 
quantitatively measured by flow cytometry (Figure 29, F), where the mean 
fluorescence intensity for GFP cells is more than double compared to the other 
transduction conditions. 
5.2.3 Cell viability 
In order to evaluate to what extent transgene integration was affecting 
long-term cell health and proliferative capacity, the same viability assay shown 
previously in Figure 26, was again performed to cells iron supplemented from 24h 
post-transduction and evaluated not only at P1 (7 days after transduction), but also 
at P8, after FACS sorting. The results are displayed in Figure 30. 
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Figure 30 – Viability of transduced mMSC at P1 and P8 post-transduction when 
supplemented with iron. Cells at P8 were already FACS sorted. Data points and statistics are 
presented in relation to Control (untransduced) cells, cultured in the same conditions. Error 
bars represent SEM (n=3) (M&M, p.62). 
Just like it was observed without iron supplementation (Figure 26), there is a 
statistically significant reduction in cell viability at P1. However, for dT_F transduced 
cells with iron supplementation the viability reduction was not so prominent than 
without iron addition, with an increase from 4 to 22% at P1. By P8, a highly pure 
dT-positive population, such as that shown in Figure 29, recovered up to 87% of 
viability, even though it was still a significantly reduced when compared to Control 
cells. As for dT_F+GFP_T cells, iron supplementation did not play a significant role in 
the increase of viability at P1, having about only 4% of proliferative and healthy 
cells. Nevertheless, over several passages these cells were able to recover to levels 
comparable to controls. On the contrary and as mentioned before, dT_F transduced 
cells without iron supplementation (Figure 25 and Figure 26) were never able to 
recover their viability state and over passages the dT_F-positive population was 
diluted by low expressing dT_F cells or untransduced cells. For this reason, the 
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viability of these cells was not evaluated at P8, as it would not represent a pure 
population of dT_F transduced cells. As for GFP_T cells, while without iron 
supplementation (Figure 26) the viability rate was around 50% at P1, when adding 
iron following transduction, the viability suffered a slight decrease, with values of 
about 40%. Perhaps iron supplementation is influencing these cells, promoting a 
small decrease in their viability. Still, at P8, GFP_T cells present an ever higher 
proliferative/health rate than controls, although not statistically significant. Overall, 
while cells appear to go through a sensitive period a few days after transduction, if 
iron is added to the culture media, overexpression of Fth-1 does not seem to 
interfere so much with normal cell functions and cells can recover up to normal 
levels in a few passages. To fully verify if transduced cells behaved similarly to the 
untransduced parental cell line, differentiation potential was assessed at P8 
post-transduction, again after FACS sorting. This was done by directing mMSC 
differentiation into osteogenic, adipogenic and chondrogenic lineages. Results are 
displayed in Supplementary figure 3 and no apparent differences were found 
between conditions. 
5.2.4 Overexpression of reporter genes at mRNA and protein level 
To estimate the overexpression of genes involved in the iron pathway, such 
as TfR-1 and Fth-1, endogenous and viral transcripts of these genes were evaluated. 
Since Fth-1 transduced cells (dT_F and dT_F+GFP_T) did not proliferate in the 
absence of iron, a comparison between cells cultured with and without iron 
supplementation was not possible, as in the previous chapter. Instead, the total 
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mRNA expression levels of TfR-1 and Fth-1, designated as Total_T and Total_F, were 
measured in control and transduced iron supplemented cells, from P1 to P3 
post-transduction by RT-qPCR (Figure 31). For RT-qPCR amplification, the reference 
genes used were the same as previously described. 
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Figure 31 – RT-qPCR relative 
quantification of endogenous 
and viral TfR-1 transcripts 
(Total_T, A and B) and of 
endogenous and viral Fth-1 
transcripts (Total_F, C and D) in 
Control and transduced mMSC at 
P1 and P3 post-transduction. 
Expression values of target genes 
are normalized in relation to P1 
(A and C) and to Control cells (B 
and D). Error bars represent SEM 
(n=3) (M&M, p.52). 
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In Figure 31, total mRNA expression levels of TfR-1 and Fth-1 were 
quantitatively measured, comparing for each condition from P1 to P3 
post-transduction (A and C) and also, at each passage, transduced cells were 
compared to control cells (B and D). In graph A, the results obtained show that the 
Total_T expression for controls, i.e., Control, dT and GFP, is relatively constant from 
P1 to P3. The same is observed for Total_F mRNA expression levels in graph B, 
however with a slight increase in GFP cells. On the other hand, with the 
overexpression of Fth-1 in dT_F and dT_F+GFP_T cells, there is a statistically 
significant reduction of Total_T expression, even though there is no change in 
Total_F expression from P1 to P3. As for when expression levels at each passage are 
compared to Control cells, in graph C and D, the results show that again levels 
between controls (Control, dT and GFP) are maintained relatively constant, but the 
overexpression of iron related genes alters the expression of Total_T and Total_F. 
More specifically, for dT_F cells at P1 there is an up-regulation both of Total_T and 
Total_F when compared to Control cells; at P3, even though levels of both target 
genes have decreased, there is still a significant up-regulation of Total_T expression 
in dT_F cells. These results suggest that an overexpression of Fth-1 may be also 
promoting an up-regulation of TfR-1. In the case of GFP_T cells, a substantial 
increase is shown for total mRNA TfR-1 levels, both at P1 and at P3 with 65 and 
257-fold increase, respectively, when compared to Control cells. However, at both 
passages Total_F levels are not significantly different than control cells. This 
indicates that even though many more TfR-1 transcripts are being formed, Fth-1 
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mRNA transcripts are maintained at constant levels. At last, the transduction of 
TfR-1 and Fth-1 in conjunction (dT_F+GFP_T) resulted in an up-regulation of both 
Total_T and Total_F targets, with a very significant increase of Total_F, at P1 
(p=0.00037). 
These changes observed at the mRNA level were then assessed at the 
protein level by WB (Figure 32 and Supplementary figure 4) and 
immunofluorescence (Figure 33). Cells used for this evaluation were collected at P8 
post-transduction and after FACS sorting. For WB detection, actin and total protein 
gels were used for data normalization. 
 
Figure 32 – WB relative quantification of Total_T (A) and Total_F (B) targets in Control and 
transduced mMSC at P8 post-transduction and after FACS sorting. Error bars represent SEM 
(n=3) (M&M, p. 57). 
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Figure 33 – Representative immunofluorescence pictures of Control, GFP and GFP_T in panel A and dT, dT_F and negative control in panel B, at P8 
post-transduction and after FACS sorting. Nuclear region is shown by DAPI staining. In panel A, green fluorescence (GF) is originated from the GFP reporter 
and the detection of TfR-1 proteins is visualized with a red fluorescent antibody. On the contrary, in panel B, red fluorescence (RF) is obtained due to the 
presence of dTomato reporter and the detection of TfR-1 proteins is visualized with a green fluorescent antibody. dT_F+GFP_T condition was not possible to 
be evaluated by IF due to the presence of both GFP and dTomato reporters. All pictures sets were taken with the same exposure conditions. Negative 
controls targeting only the secondary Abs used are included to prove specificity to the primary Ab. Scale bars: 25 µm; M&M, p.56. 
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Protein quantification data obtained by WB (Figure 32) shows that, similarly 
to the mRNA quantification data, Control, dT and GFP cells have constant protein 
levels of both Total_T and Total_F targets, while dT_F has a 3.5-fold up-regulation of 
Total_T, possibly promoted by Fth-1 overexpression. Also, Total_T is up-regulated in 
GFP_T and dT_F+GFP_T cells with 15 and 13-fold increases, respectively. However, 
for Total_F protein quantification, differences between transduced magnetic 
reporters and control cells are not so distinctive, with only dT_F+GFP_T cells having 
a slight 1.7-fold increase in relation to Control cells, although this was not 
statistically significant. Data obtained with immunofluorescence (Figure 33) 
confirms that a clear TfR-1 overexpression is present in GFP_T cells, when compared 
with controls (Control and GFP). Also, expression levels of TfR-1 appear to be 
slightly higher in dT_F cells, when compared to its dT control, as observed for WB. 
Immunofluorescence staining for Fth-1 was also performed in transduced cells in 
the same conditions, but no difference was found (data not shown). 
Overall, these techniques show a clear overexpression of TfR-1 in GFP_T and 
dT_F+GFP_T cells, both at the mRNA and protein level. However this is not the case 
with Fth-1 overexpression in dT_F and dT_F+GFP_T cells. Next, the capacity of TfR-1 
and/or Fth-1 transduced cells to retain more iron than controls (Control, dT and 
GFP) is explored measuring the intracellular iron concentration. 
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5.2.5 Intracellular Iron Uptake in vitro 
The capacity of dT_F, GFP_T or dT_F+GFP_T transduced cells to accumulate 
more iron than controls (Control, dT and GFP) was evaluated by measuring the 
intracellular iron content of these cells with Ferrozine assay. To do this, control and 
transduced cells (grown with 0.2 mM of iron from 24h post-transduction) were 
compared to cells that received an extra supplementation of 2 mM of iron for four 
days. Also, untransduced mMSC cultured without iron supplementation were 
included for comparison. Results are displayed in Figure 34, where the intracellular 
amount of iron is shown as a function of iron supplementation. 
 
Figure 34 – Intracellular iron content of mMSC cells determined with the Ferrozine assay. 
Control and transduced cells were supplemented with different iron concentrations of 
0.2 mM from 24 post-transduction or 2 mM for 4 days prior to measurement (Iron 
supplementation, p.50). A non-supplemented (0 mM) Control was also included. Error bars 
represent SEM (n=3) (M&M, p.50). 
Figure 34 shows that mMSC have a great capacity for iron incorporation, 
reaching up to approximately 0.2 and 0.8 pg/cell, when untransduced cells are 
incubated with 0.2 and 2 mM of iron, respectively. With 0.2 mM, no differences in 
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iron accumulation capacity are detected between the different cells. However, with 
2 mM iron supplementation, dT_F+GFP_T cells demonstrate an increased capacity 
of intracellular iron retention relative to other transduced cells, with a statistically 
significant difference relative to control cells. Therefore, TfR-1 and Fth-1 used in 
conjunction might be a promising reporter system for MRI tracking of mMSCs. 
5.2.6 MRI 
To study the potential of TfR-1 and/or Fth-1 transgenes as possible MRI 
reporters, cell pellets from control and transduced cells were scanned using 
T2-weighted sequences. To do this, 107 cells were centrifuged at high speed to form 
a compact cell pellet and imaged via MR, where T1/T2 maps were produced for 
relaxivity studies. Results are displayed in Figure 35. 
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Figure 35 – MR imaging of cell pellets of mMSC cells. A is a T2-weighted representative MR 
image obtained with the MRI of Control with no iron supplementation (0 mM); Control and 
dT_F+GFP_T, dT and dT_F, GFP and GFP_T both supplemented with 0.2 mM from 24h 
post-transduction or with 2 mM of iron for 4 days (Iron supplementation, p.50). Relaxation 
times T1 and T2 were quantified on a specific region of the cell pellet and are represented 
in B and C, respectively. Error bars represent SEM (n=3) (M&M, p. 65). 
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Due to such high levels of iron present in cells incubated with 2 mM of iron, 
as seen in Figure 34, when scanning with MRI (Figure 35, A), the relaxation (signal 
loss) was so quick for these cells that it was only possible to determine T1 and T2 
relaxation times for cells with no iron supplementation (Control – 0 mM) or cells 
supplemented with 0.2 mM of iron (Figure 35, B and C). Relaxivity studies show that 
the averages of samples containing dT_F, GFP_T or dT_F+GFP_T are slightly lower 
than their respective controls. This is more perceptible in MRI image A, in which at 
0.2 mM iron concentration, controls (Control, dT and GFP) appear to be the lightest 
pellets, followed by dT_F and GFP_T, which look much alike, and the darkest pellet, 
or the one with strongest loss of signal appears to be dT_F+GFP_T cells. However, 
none of the conditions at 0.2 mM iron supplementation were able to produce 
statistically significant shortening effects, either with T1 or T2 scans. 
Then, 2x105 transduced cells were microinjected into the midbrain of the 
chick embryo at embryonic day 3 (E3). All transduction conditions were 
supplemented with 2 mM of iron for 3 days prior to injection. A non-supplemented 
control - dT (0 mM) was also included. At E5, embryos were imaged with two 
complementary platforms: by fluorescence microscopy to detect red/green 
fluorescence derived from the dTomato/GFP gene and by MR transversal imaging, 
by observing hypointense regions derived from iron retained in transduced cells, 
which was influenced by extracellular iron supplementation and/or due to TfR-1 
and/ or Fth-1 overexpression (Figure 36). 
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Figure 36 – Fluorescence and MR imaging of dT and dT_F (A and B), GFP and GFP_T (C and 
D) and dT_F+GFP_T and dT (0 mM) (E and F) transduced mMSC cells, 2 days after injection 
in the midbrain of a chick embryo (E5). Cells received 2 mM of iron supplementation for 
3 days prior to injection, with the exception of dT (0 mM) (F), which did not receive any 
supplementation (Iron supplementation, p.50). In the fluorescence imaging panel, bright 
field (BF) and red/green fluorescence (RF/GF) are projection images from the whole 
embryo; overlays are presented for both left and right views and were used as a reference 
guidance for MR imaging; scale bars correspond to 1 mm. In the MRI panel, anatomical 
images are displayed as transverse sections along the rostrocaudal axis of the embryo (left 
to right); 10 sections are displayed for each embryo. All images are representative from the 
results obtained and were equally processed with ImageJ software. Arrows indicate 
T2 shortening effect; b – bubble of air; * – blood. Position of the embryo: F – front; B –
 back; R – right; L – left; number of biological and technical replicates is indicated in the 
table above (M&M, p.65). 
In some areas in Figure 36, tiny bubbles of air are designated as “b” and also 
darker areas which correspond to blood found in the brain are indicated with an 
asterisk (*). These blood spots are perfectly visible with bright field imaging and 
were likely due to a brain haemorrhage caused while injecting at E3 or perhaps 
while dissecting the chick embryo at E5. Due to the presence of haemoglobin which 
contains large amounts of iron (Ponka and Lok, 1999), the blood present in the 
brains containing haemorrhages promotes a loss of signal (darker contrast) relative 
to background when imaged. To identify if transduced cells integrated into chick 
embryo’s brain, first, bright field and fluorescence imaging were performed on 
Fluorescence Microscopy MRI 
Iron 
conc. 
Transduction 
condition 
Biological rep. 
(technical rep.) 
Iron 
conc. 
Transduction 
condition 
Biological rep. 
(technical rep.) 
2 mM 
dT n=3 (6) 
2 mM 
dT n=2 (2) 
dT_F n=3 (5) dT_F n=2 (2) 
GFP n=2 (4) GFP n=1 (2) 
GFP_T n=2 (5) GFP_T n=1 (2) 
dT_F+GFP_T n=3 (5) dT_F+GFP_T n=2 (2) 
0 mM dT n=1 (3) 0 mM dT n=1 (2) 
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whole embryos. Due to the presence of fluorescent reporters, transduced cell 
clusters were easily identified and located within the brain. This served as a 
guideline to identify hypointense cell clusters with MR imaging. Without this 
support, identifying cell clusters based only on anatomical images would have 
proven to be much more difficult. 
At the first instance, results in Figure 36 show that mMSC microinjected into 
an E3 embryo chick formed compact globular cell clusters localized at few locations 
within the brain. This was particular useful in this case, as complementing two 
different imaging platforms, fluorescence with MR imaging, became very accurate. 
Also, at 2 mM iron supplementation, the iron retained by transduced cells allowed 
an easy identification of hypointense regions, all correlated with red and/or green 
fluorescence obtained with fluorescence microscopy. However, at this iron 
concentration no evident differences were found between the different 
transduction conditions (A-E). The cell clusters identified with fluorescence 
microscopy in the control with no iron supplementation (dT, 0 mM) were also 
correlated with MR imaging, but the hypointense regions found were much lighter 
than those with 2 mM of iron supplementation conditions. These results suggest 
that with MRI, 2 mM of iron supplementation to cells creates an almost complete 
loss of signal, i.e., turns the region nearly black, and therefore at this detection limit 
no differences between different reporter genes can be found.  
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5.3 DISCUSSION 
Over the past few years, several studies have evaluated the potential of 
TfR-1 and/or Fth-1 as MRI reporter genes designed specifically for cell tracking 
purposes. As described in the previous chapter, TfR-1 capacity of internalizing 
transferrin-bound iron makes it a suitable system for increasing intracellular iron 
content (Deans et al., 2006). On the other hand, the heavy subunit of ferritin (Fth-1) 
alone or together with the light subunit (Ftl-1) has been overexpressed in a number 
of cell lines and used as a means to store higher levels of intracellular iron, relative 
to controls (Cohen et al., 2005; Genove et al., 2005; Iordanova et al., 2010). The aim 
of overexpressing either gene in a certain cell line is to produce a contrast effect 
sufficiently high to be visualized and followed up with MRI. In this chapter, TfR-1 
and Fth-1 were investigated either individually or in combination to create a 
suitable reporter system for MRI tracking of mouse mesenchymal stem cells. 
In Chapter 3, both TfR-1 and Fth-1 cDNAs were cloned directly from mMSC 
and overexpressed in the same cell line using a lentiviral approach. Both magnetic 
reporters (Tfr-1 and Fth-1) were deprived of the iron responsive elements located in 
their UTRs, allowing for a constitutive expression of these genes, without the cell’s 
interference. Moreover, because these cDNAs were overexpressed in the same cell 
from which they originated, the sole expression of endogenous TfR-1/Fth-1 was not 
possible to be detected as both viral and endogenous transcripts were identical. 
However, a specific primer pair was designed for RT-qPCR, in which the forward 
primer matched the target magnetic reporter (TfR-1/Fth-1) and the reverse primer 
  
FTH-1 AND TFR-1 AS REPORTER GENES FOR MRI TRACKING OF CELLS| 164  
corresponded to a segment within the IRES (internal ribosome entry site). This 
allowed the design of a primer pair to specifically detect only the viral transcripts of 
either TfR-1 or Fth-1, being therefore designated as Viral_T and Viral_F, 
respectively. The total levels of TfR-1 or Fth-1, determined by RT-qPCR and WB, 
corresponded to both endogenous and viral transcripts and were designated as 
Total_T for TfR-1 and Total_F for Fth-1. 
Also in Chapter 3, while TfR-1 was cloned into pHIV-eGFP lentiviral vector, 
expressing GFP gene as a green fluorescent reporter (GFP_T), Fth-1 was cloned into 
pHIV-dTomato, which expressed dTomato gene as a red fluorescent reporter (dT_F). 
This allowed for a longitudinal monitoring of cells with fluorescence microscopy and 
quick identification of which magnetic reporter was present, particularly useful 
when both genes were overexpressed in conjunction (dT_F+GFP_T). MSC were 
transduced with MOI=50 for each viral preparation, which theoretically means that 
about 50 copies of each transgene were integrated per cell. Previous studies, when 
overexpressing Fth-1 gene, have used similar MOIs from 30 to 100 in order to 
obtain significant contrast by MRI (Genove et al., 2005; Iordanova et al., 2010). 
Reporter gene integration in the mMSC line was evaluated initially over a 
period of 7 days with fluorescence microscopy, while transduced cells were cultured 
under normal conditions, i.e., the same cell culture conditions applied to 
untransduced mMSC. A different morphology in dT_F transduced cells was 
immediately perceptible after a few days in culture (Figure 25). Also, the 
proliferative/health rate of transduced cells suffered a big impact, in particular for 
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cells transduced with Fth-1 (dT_F and dT_F+GFP_T), with only 5% of viable cells 
present (Figure 26). These data suggests that Fth-1 constitutive overexpression in 
mMSC might be unbalancing the tightly controlled iron metabolism and promoting 
a toxic effect on these cells. In order to overcome this issue, iron supplements were 
added to the culture media 24h post-transduction. Cells either iron supplemented 
or cultured under normal conditions were compared by evaluating transgene 
integration after 7 days (P1) and at P3 (Figure 27). This evaluation, performed by 
RT-qPCR, showed that the lack of iron supplementation promoted a decrease of the 
transgenes in dT_F and dT_F+GFP_T populations. This decrease in mRNA levels 
might be due to the higher proliferation rate of untransduced or low-expressing 
dT_F cells present in the population at that time-point. On the contrary, when cells 
were iron supplemented, dTomato and Fth-1 transgenes were kept at constant 
levels from P1 to P3, at least for dT_F cells. As for the other conditions that 
integrated GFP and/or TfR-1 transgenes, mRNA levels did not seem to be disturbed 
with the absence or addition of iron supplementation. In order to continue to study 
the evaluation of TfR-1 and/or Fth-1 as potential MRI reporter genes, only cells with 
iron supplementation from 24h post-transduction were used for subsequent 
analysis. This suggests a lack of flexibility when using Fth-1 as a reporter gene, as 
cells have to be on permanent iron supplementation, although it is not clear if other 
stem/progenitor cells would present the same limitation. 
mMSC transduced and iron supplemented were evaluated after FACS sorting 
(Figure 28 and Figure 29), showing nearly 100% of positive dT and GFP populations 
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for all transduced conditions. Also, cell viability was investigated at P1 and P8 
post-transduction. With iron supplementation, the decrease in viability was not as 
noticeable at P1 as seen previously, and with the increase in passage number most 
transduced conditions were able to recover to equivalent values of untransduced 
cells. Of note, a pure population of dT_F cells at P8 still had a small decrease in cell 
viability while, on the other hand, GFP_T cells had an increase, relative to Control 
cells. This increase in cell viability is quite interesting since TfR-1 overexpression is 
usually observed in malignant tumour cells, which also have an increase in cell 
proliferation (Ponka and Lok, 1999; Sutherland et al., 1981). The viability 
fluctuations observed for dT_F and GFP_T cells suggest that constitutively 
expressing only one particular gene involved in the maintenance of iron 
homeostasis might create an unbalanced uptake and/or storage of iron. On the 
other hand, the combination of TfR-1 and Fth-1 overexpression in the same cell line, 
such as performed for dT_F+GFP_T cells, produces viability data at P8 that is very 
similar to controls (dT and GFP), possibly restoring a balanced iron homeostasis for 
this condition. 
Next, reporter genes were evaluated at the mRNA and protein level 
(Figure 31 and Figure 32) and results show that when iron related genes, such as 
TfR-1 and Fth-1, are overexpressed in mMSC, the total levels of these transcripts 
vary significantly. For instance, in dT_F cells, a small up-regulation at the mRNA and 
protein levels are observed for Total_T when compared to Control cells, indicating 
that Fth-1 integration is promoting Total_T up-regulation, possibly due to the 
  
FTH-1 AND TFR-1 AS REPORTER GENES FOR MRI TRACKING OF CELLS| 167  
necessity of more intracellular iron. This was confirmed by immunofluorescence, 
where cells were immunostained with anti-TfR-1 antibody, and dT_F cells were 
slightly brighter when compared to dT cells (Figure 33). However, Total_F levels are 
not significantly up-regulated in dT_F cells, neither at the mRNA nor at the protein 
level as one would expect. In the case of GFP_T cells, very high levels of Total_T are 
detected, both at the mRNA and protein level; however, without any change in 
Total_F levels. These results indicate that even though many new receptors may be 
formed due to TfR-1 overexpression, ferritins are not present in higher amounts 
than in controls. TfR-1 overexpression in GFP_T cells was confirmed using 
immunofluorescence (Figure 33). At last, only in dT_F+GFP_T cells is overexpression 
detected for both Total_T and Total_F at the mRNA level. At the protein level, an 
increase in Total_T is present similarly to GFP_T cells, but for Total_F only a small 
up-regulation is observed. This suggests that it is only when TfR-1 and Fth-1 are 
overexpressed together that iron homeostasis is restored. 
The results obtained with the Ferrozine assay (Figure 34) confirm what was 
suggested and show that only when overexpressing both TfR-1 and Fth-1 in 
conjunction that it was possible to obtain a higher concentration of intracellular 
iron (2 mM), relative to Control cells. This may be the case as it might create a 
balanced iron system, introducing larger amounts of iron into the cell through the 
overexpressed TfR-1, and storing intracellular iron in a safe configuration in ferritin 
cages, promoted by the overexpression of Fth-1. To test if dT_F transduced cells 
were actually retrieving iron inside ferritin cages, these cells were deprived from 
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iron supplementation for a short time period (4 days). Then, the intracellular iron 
content of dT_F cells was compared to a non-supplemented control (untransduced 
cells) and no differences were found between the two conditions (data not shown). 
This suggests that iron may not be retrieved in ferritin cages for very long after iron 
supplementation is removed. Nevertheless, this assay was not performed for 
dT_F+GFP_T transduced cells, where a balanced iron system might have been 
restored. 
In terms of total iron content that mMSC are able to incorporate, both with 
Ferrozine assay and MR imaging of cell pellets (Figure 35, A), it was found that 
mMSC have an extremely high capacity for iron incorporation. For example, 
untransduced mMSC can accumulate up to 0.8 pg of iron per cell, when 
supplemented with 2 mM of iron. For this reason, when imaging compressed cell 
pellets previously supplemented with 0 mM (only untransduced cells), 0.2 or 2 mM 
of iron concentration, it was only possibly to determine T1 and T2 relaxation times 
for 0 and 0.2 mM conditions. However, at these iron concentrations, no significant 
difference was found between transduced cells, in agreement with the intracellular 
iron quantification obtained with the Ferrozine assay (Figure 34). Because the only 
statistically significant difference found was when dT_F+GFP_T cells were 
supplemented with 2 mM of iron, this concentration was then used to supplement 
cells prior to microinjection in chick embryos. 
At embryonic day 5 (E5), the identification of transduced cell clusters was 
straightforward for all conditions analysed and with both imaging platforms 
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(fluorescence microscopy and MRI) (Figure 36). Fluorescence microscopy allowed 
for the detection of cell clusters transduced with either GFP or dTomato genes, 
allowing for green and red fluorescence visualization, while MRI allowed for the 
detection of cell clusters based on contrast differences due to iron accumulation 
capacity of cells. At the same supplementation conditions of 2 mM of iron, controls 
(dT and GFP) were not distinctive from magnetic reporters of interest (dT_F, GFP_T 
and dT_F+GFP_T). Even though a significantly higher intracellular iron accumulation 
was found for dT_F+GFP_T, when imaged with MRI, this condition did not provide a 
definitive contrast in relation to the remaining transduction conditions. 
In summary, mMSC was used as a model stem cell line to evaluate the 
potential of TfR-1 and Fth-1, either used individually as magnetic reporter genes or 
in conjunction as a system to upload and store intracellular iron with a higher 
capacity than controls. It is clear that cell viability must be taken into consideration 
as it might reflect a disturbance promoted by the overexpression of a single gene 
involved in the iron metabolism. Also, because iron homeostasis is tightly controlled 
by the cell, the total levels TfR-1 and Fth-1 need to be determined and evaluated if a 
true overexpression is taking place. The results obtained with this study suggest 
that if a reporter system, like overexpression of TfR-1 and/or Fth-1, is to be used as 
a means of tracking mMSC through MRI, then 2 mM of iron might be too high 
supplementation conditions, since it completely overloads these cells and does not 
allow the reporter gene influence to take place. On the other hand, control mMSCs 
(untranduced, dT and GFP) appear to retain a very high concentration of iron by 
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itself creating very significant hypointense regions. These results suggest that for 
short-term cell tracking studies, it could be possible to detect mMSC with MRI in the 
absence of a contrast agent or reporter gene as long as the cells have previously 
been cultured in medium supplemented with iron. 
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5.4 SUPPLEMENTARY DATA 
 
Supplementary figure 3 – Representative differentiation pictures of Control, dT, GFP, dT_F, 
GFP_T and dT_F+GFP_T incubated with 0.2 mM of iron 24h post-transduction, along with a 
non-supplemented Control. Differentiation potential of these cells was directed towards 
the formation of osteocytes, adipocytes or chondrocytes (M&M, p.62). 
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Supplementary figure 4 – Representative western blot and correspondent total protein 
gels from Control, dT, GFP, ferritin heavy chain-1 (dT_F), transferrin receptor-1 (GFP_T) and 
dT_F+GFP_T transduced mMSC cells, iron supplemented since 24h after transduction. 
Orange rectangle highlights total TfR-1 (endogenous + viral, described as Total_T) protein 
expression, with a predicted molecular weight (MW) of 100 kDa; white rectangle 
corresponds to actin expression with 42 kDa and blue rectangle to Fth-1 
(endogenous + viral, Total_F) with 21 kDa. Sometimes another band is detected when 
targeting Fth-1, which may correspond to a post-translational modification of this protein. 
Protein quantification was normalized using total protein gels and confirmed using actin as 
a reference protein (M&M, p. 57). 
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CHAPTER 6 
MAGA AS A REPORTER GENE FOR MRI TRACKING OF CELLS 
6.1 INTRODUCTION 
MagA is a gene encoding for an iron transporter protein whose role in the 
formation of iron oxide crystals in magnetotactic bacteria has been extensively 
studied for many years, although no consensus exists on whether it is an essential 
gene for magnetosome formation (Nakamura et al., 1995b; Uebe et al., 2012). 
6.1.1 MagA gene as an MRI reporter gene 
MagA was first proposed as a possible MRI reporter gene in 2008. So far, 
only two research groups have explored its suitability as an MRI reporter. 
In the first study performed by Zurkiya et al., in 2008, MagA overexpression 
was conducted in a HEK 293FT cell line (Invitrogen, R700-07), and the authors 
concluded that the sole overexpression of MagA, a gene thought to be involved in 
the magnetosome formation, was sufficient to produce “magnetic nanoparticles” 
within the target cells (Figure 37), giving rise to a significant contrast in MRI (Zurkiya 
et al., 2008). 
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Figure 37 – Transmission electron microscopy (TEM) of HEK 293FT cells overexpressing 
MagA, where electron dense spots are visible (and highlighted in the inset) and have been 
suggested to correspond to iron oxide nanoparticles. Reproduced with permission from 
Zurkiya et al. (2008). 
Furthermore, the authors characterized the produced nanoparticles and 
suggested that these consisted mainly of magnetite (Fe3O4), the same component 
found in iron oxide magnetosomes of Magnetospirillum magneticum AMB-1 
bacteria (Zurkiya et al., 2008). In contrast, another study showed that the MagA 
gene is not crucial for magnetosome synthesis and neither is part of MAI, the 
cluster of genes related to the organelle’s formation and function (Uebe et al., 
2012). However, this does not exclude the fact that MagA is an iron transporter 
protein and could be used as a reporter gene, if it effectively aids in the 
accumulation of iron inside the cell. 
Six years later, Zurkiya et al., (2008) reported MagA inducible overexpression 
in mESC, controlled by a tetracycline (TET) response element. They observed an 
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increased contrast with MRI, and a longitudinal monitoring of engrafted stem cells 
was possible, but only when doxycycline (DOX) together with ferric citrate were 
supplemented in vitro (mESC in culture) or in vivo (mESC injected into mice). MagA 
expression did not appear to affect mESC pluripotency, but when assessing cell 
proliferation, there was a significant decrease in cell number of mESC-MagA when 
cells were exposed to high concentrations of DOX. This was not observed in control 
cells. In addition, cytotoxicity assays demonstrated that mESC-MagA were far more 
sensitive to the supplementation of DOX and ferric citrate than control cells. 
Nevertheless, this report was the first evidence of MagA being used an MRI reporter 
for a stem cell line (Cho et al., 2014). 
Goldhawk and co-workers have also explored the possibility of using the 
MagA gene as an MRI reporter (Goldhawk et al., 2009). Similarly to Zurkiya et al., 
they report that MagA overexpression resulted in iron accumulation in mammalian 
cells, producing “magnetosome-like particles”. Initially, a mouse neuroblastoma 
(N2A) cell line was used and transfected with a native MagA gene and an 
inactivating mutant, MagAE137V. Despite both conditions accumulating more 
intracellular iron than controls, in the MRI context, only cells expressing native 
MagA provided enough contrast for imaging. This report showed that 
overexpression of the MagA gene in this cell line did not adversely affect 
proliferation or viability (Goldhawk et al., 2009). More recently, in 2014, another 
study using MagA was reported by the same group, using a human 
breast/melanoma (MDA-MB-435) cell line. The relaxivity of cells expressing MagA 
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was compared to cells expressing a modified ferritin system, comprising of both 
subunits with iron responsive elements removed to allow constitutive expression. In 
this report, the tumour cell line expressing each reporter gene was transplanted in a 
mouse model and tumour growth was followed using MRI. It was concluded that 
both reporters enhance MR contrast relative to controls, with comparable results 
(Rohani et al., 2014). A second study involving the same experimental setup 
reported that both reporter systems increased the intracellular iron/zinc ratio by 
20-fold when supplemented with iron but the expression of the transferrin receptor 
decreased by 10-fold (Sengupta et al., 2014). 
Here, MagA gene is evaluated to assess its potential as a reporter for MRI 
tracking of cells. The integration ability of MagA was initially evaluated in three 
stem cell lines (mESC, mMSC, mKSC) and HEK 293T(N), already described by Zurkiya 
et al. (2008), to serve as a control cell line. HEK 293T(N) cells were also evaluated 
alongside CHO K1 cells, which have not previously been used for this purpose. The 
following parameters were compared: MagA transgene integration stability over 
passages and when exposed to different iron concentrations; the influence of MagA 
overexpression in iron homeostasis; and finally, iron accumulation capacity and 
suitability as an MRI reporter.  
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6.2 RESULTS 
6.2.1 Reporter gene integration in stem cell lines 
mESC, mMSC and mKSC cell lines, as well as HEK 293T(N), were transduced 
with lentiviral particles encoding for dT or dT_M (MagA), MOI=1 to evaluate MagA 
integration capacity in diverse cell lines. dT condition was performed to serve as a 
control and dT_M to evaluate MagA gene as a potential magnetic reporter. Three 
independent transductions were carried out for each condition and represent, 
therefore, three biological replicates (n=3). 
mESC (recently described in Cho et al. (2014)), mMSC and mKSC were 
transduced to evaluate MagA integration potential in a range of stem cells. 
HEK 293T(N) were also included to serve as a control cell line. RT-qPCR was used to 
evaluate dTomato/MagA gene expression over a period of 40 days. The cells were 
transduced at day 0 and RT-qPCR was performed at day 0 (before transduction), 2, 
4, 6, 8 for all cell lines and at day 10, 20, 30 and 40 for HEK 293T(N) and mESC. 
Human/mouse TBP/Tbp and GAPDH/Gapdh genes were used as reference genes to 
normalize Ct values obtained for dTomato and MagA genes and results are shown in 
Figure 38. 
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Figure 38 – RT-qPCR relative quantification of dTomato (A) and MagA (B) transgenes, 
evaluated in four dT_M transduced cell lines (MOI=1), including HEK 293T(N) as a reference, 
over a period of 40 days. Error bars represent SEM (n=3) (M&M, p.52). 
It is possible to observe that both transgenes are transcribed at very similar 
levels throughout the course of the study period for all cell lines, suggesting that the 
bicistronic expression is effective. As expected, at day 0, no expression of the 
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studied genes was found, showing that mRNA expression of the test genes that was 
observed on all other days was due to the transduction of dT_M. At day 2, there is a 
peak of expression of both genes in all cell lines, which correlates with the initial 
appearance of red fluorescence, followed by a gradual decrease until the end of the 
analysis. Two cells lines, HEK 293T(N) and mESC, were able to maintain dTomato 
and MagA mRNA levels during a time-period of 40 days, even though slowly 
decreasing their expression. This has also been observed when cells were followed 
up daily using fluorescent microscopy to investigate expression of dT protein 
(results not shown). However, for the other two cell lines, mMSC and mKSC, the 
experiment was stopped at day 8 because these cells were mostly dead, although 
expression levels were detected in the very few remaining. This suggests that MagA 
might have a toxic effect on these cells, either by cell death or decreasing their 
proliferation potential. To confirm this hypothesis, cells were again transduced with 
dT or dT_M (MOI=1) and their viability was assessed over a period of 8 days 
(Figure 39). 
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Figure 39 – Cell proliferation of HEK 293T(N), mESC, mMSC and mKSC during a period of 8 
days after being transduced with dT (A) or dT_M (B) lentiviral constructs. Data points are 
plotted in relation to control cells. The threshold line represents 50% of cell counts. Error 
bars represent SEM (n=3) (M&M, p.62). 
Figure 39 demonstrates that none of the cells have their viability or 
proliferation capacity impaired when transduced with dT. For dT_M transduced 
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cells, on the other hand, two cell lines, mMSC and mKSC, are not able to maintain 
proliferative capacity and fall to levels between 10-20% of controls. For this reason 
and together with the fact that mESC showed negligible levels of MagA expression 
from day 6 onwards (Figure 38), another cell line was evaluated for MagA 
integration potential, CHO K1. 
6.2.2 Reporter gene integration in CHO K1 cell line 
CHO K1 and HEK 293T(N) cells were transduced with dT or dT_M (MagA), 
with MOI=26 and MOI=5, respectively. Three independent transductions were 
carried out for each condition and represent, therefore, three biological replicates 
(n=3). MOIs were chosen in order to get a similar transgene expression level in both 
cell lines. Only HEK 293T(N) were possible to be FACS sorted for a high dTomato 
(and MagA) expressing population. FACS sorting in the same conditions was 
attempted on CHO K1 cells, but once these cells returned to in vitro culture 
conditions they failed to attach and did not survive. 
Once transduction was performed, dTomato/MagA gene integration was 
initially evaluated in both cell lines using fluorescence microscopy (Figure 40) and 
flow cytometry (Figure 41), which allow the visualization and measurement of red 
fluorescence, derived from the dTomato gene. 
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Figure 40 - Representative pictures of CHO K1 (A) and HEK 293T(N) (B) cells at P7 post-transduction, and Control cells (untransduced) at an equivalent 
passage. dT corresponds to dTomato transduced cells and dT_M to MagA transduced cells. All red fluorescent pictures were taken with the same exposure 
conditions. Scale bars correspond to 100 µm. 
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Figure 41 – Flow cytometry histograms (A) of CHO K1 and HEK 293T(N) cells, at P3 after transduction. Histograms show the number of events (cells) counted 
(y-axis) versus the fluorescence intensity (x-axis). Red fluorescence (RF) gate represents the dTomato-positive cell population plotted in (B).The Xmean (C) 
represents the mean fluorescence obtained from the gates region (RF cells). Error bars represent SEM (n=3). a.u.–arbitrary units; M&M, p.48. 
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Figure 40 and Figure 41 evaluate transgene expression, either by 
visualization or measurement of the red fluorescent cells. From these results it is 
clear that in relation to dT_M, transduction with dT results in a larger population of 
positive cells, which also tend to be brighter. The MOIs of 26 and 5 for CHO K1 and 
HEK 293T(N), respectively, were chosen in order for the cells to be comparable 
between each other. However, even though dT cells similarly express red 
fluorescence reaching almost 100% for both cell lines, the same is not true for 
dT_M, which is only expressed in about 40% of CHO K1, while in HEK 293T(N) cells, 
around 80% are positive (Figure 41, B). This difference probably has to do with the 
fact that HEK 293T(N) were sorted at P2 and CHO K1 cells were not, due to lack of 
cell survival, leading to a more diluted positive population. Also in this figure, the 
Xmean plot (Figure 41, C), which represents the cell’s fluorescence intensity, shows 
that in case of HEK 293T(N) cells, although the difference in the percentage of 
positive cells between dT and dT_M is only 20%, the brightness of the dT cells is 
much more intense than the dT_M cells. The same point is even more evident in the 
case of CHO K1 cells. Nevertheless, even though only half of CHO K1 cells are 
transduced with dT_M when compared with HEK 293T(N) cells, both have 
approximately the same fluorescence intensity (Xmean). This suggests that the 
dT_M positive population of both cell lines may be expressing dTomato/MagA 
genes at the same level at this point. 
To understand if the transgene expression levels in dT_M cells were stable 
over passages, mRNA from CHO K1 and HEK 293T(N) cells was quantitatively 
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evaluated by RT-qPCR at P1 and P3 after transduction. This is a direct and 
quantitative measurement of the transgene expression and it is shown in Figure 42. 
Pabpn1 and Vezt genes were used as a reference for CHO K1 cells and TBP and 
GAPDH genes were used as a reference for HEK 293T(N) cells. 
 
Figure 42 – RT-qPCR relative quantification of dTomato and MagA transgene expression at 
P1 and P3 in dT_M transduced CHO K1 cells or HEK 293T(N). For the evaluation of 
transgene expression over two passages, HEK 293T(N) cells were not FACS sorted. 
Expression values are plotted against P1. Error bars represent SEM (n=3) (M&M, p.52). 
As seen in Figure 42, for both cell lines, the expression of integrated genes 
decreases from P1 to P3. Also, both transgenes appear to decrease in the same 
ratio, which indicates the effectiveness of the bicistronic expression system. 
As previously done for stem cells, the viability was assessed for CHO K1 cells 
transduced with either dT or dT_M in two different time points, exactly 8 days after 
transduction (designated as P1) and three passages afterwards (P4). Results are 
displayed in Figure 43. 
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Figure 43 – Proliferation assay on dT and dT_M transduced CHO K1 cells at P1 and P4. Data 
points are plotted in relation to Control (untransduced) cells. Error bars represent SEM 
(n=3). A statistical difference is found in dT_M (P1) cells when compared to Control and dT 
cells of the same passage (M&M, p.62). 
Figure 43 shows a higher sensitivity of CHO K1 to dT_M than dT 
overexpression when compared to Control cells at P1, which is reflected by a lower 
absorbance of 30% in respect to untransduced controls. However, by P4, dT_M cells 
have recovered and returned to the proliferation capacity equivalent to Control and 
dT cells, which is possibly due to the decrease of MagA expression, as seen in 
Figure 42. 
6.2.3 Iron homeostasis 
To understand if the transgenes had an effect on cellular iron homeostasis, 
the expression of transferrin receptor-1 and ferritin heavy chain-1, which are known 
to be involved in this balanced pathway, were explored. To do this, Control, dT and 
dT_M cells were exposed to two iron concentrations of 0.2 and 2 mM alongside a 
non-supplemented Control (0 mM) for a period of 4 days. Transferrin receptor-1 
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(Total_T) and ferritin heavy chain-1 (Total_F) were evaluated at the mRNA level by 
RT-qPCR (Figure 44 A, C and Figure 45 A, C) and at protein level by WB 
(Figure 44 B, D, Figure 45 B, D and Supplementary figure 5). For RT-qPCR 
amplification, the reference genes used were the same as described previously. For 
WB detection, actin and total protein gels were used for data normalization. 
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Figure 44 – Relative quantification of transferrin receptor-1 (Total_T) expression obtained via RT-qPCR (A and C) and the respective protein levels as 
obtained via WB (B and D), when Control, dTomato (dT) and MagA (dT_M) transduced cells were exposed to different iron concentrations of 0, 0.2 and 
2 mM (Iron supplementation, p.50). Graphs A and B evaluate Total_T expression levels when each cell line is exposed to different iron concentrations and 
graphs C and D the difference between cell lines when exposed to the same iron concentration. Error bars represent SEM (n=3) (M&M, p.52 for RT-qPCR and p.57 for WB).  
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Figure 45 – Relative quantification of ferritin heavy chain1 (Total_F) expression obtained via RT-qPCR (A and C) and the respective protein levels as obtained 
via WB (B and D), when Control, dTomato (dT) and MagA (dT_M) transduced cells were exposed to different iron concentrations of 0, 0.2 and 2 mM ((Iron 
supplementation, p.50)). Graphs A and B evaluate Total_F expression levels when each cell line is exposed to different iron concentrations and graphs C and 
D the difference between cell lines when exposed to the same iron concentration. Error bars represent SEM (n=3); (M&M, p.52 for RT-qPCR and p.57 for WB). 
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Figure 44 shows the Total_T expression in two different scenarios, i.e., how 
transferrin receptors-1 levels change in response to differences in iron 
concentration within each cell type (A and B) and to different transgenes at a 
specific iron concentration (C and D). For the effect of iron concentration, the 
results obtained with mRNA (A) and protein (B) quantification show a regular 
pattern for all cell lines in the study, where a statistically significant decrease in the 
expression of Total_T is observed with increasing of iron concentrations, relative to 
a non-supplemented control. This is an expected result when the IRP/IRE regulatory 
system is considered; that is, an influx of iron should result in reduced expression of 
the transferrin receptor-1 (Figure 1). In the second part, to know if the transgenes 
influence Total_T at a set iron concentration, mRNA expression (C) and protein 
quantification (D) graphs show that there is no statistically significant differences 
between the different cell types (Control, dT and dT_M). However, although not 
statistically significant, dT and dT_M HEK 293T(N) cells have an increase in Total_T 
expression at 0.2 mM (relative to Control cells), both at the mRNA and protein level. 
More interestingly, for dT_M CHO K1 cells, when there is no iron present (0 mM), 
Total_T appears to have an up-regulation when compared to Control and dT, both 
at the mRNA and protein level. Once iron is introduced (0.2 and 2 mM), even 
though the mRNA is relatively stable between the different samples, at the protein 
level, Total_T expression is down-regulated for dT_M (comparatively to Control and 
dT), although those differences are not statistically significant. One hypothesis for 
these observations is that MagA might be acting like an iron transporter, possibly 
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introducing more iron inside the cell, and therefore, further down-regulating 
Total_T expression levels. 
Figure 45 evaluates Total_F, or ferritin heavy chain-1, expression levels 
under the same conditions. In contrast to the results observed regarding the 
transferrin receptor-1, the opposite trend in Total_F expression would be expected 
when the IRP/IRE regulatory system is considered. Panels A and B show an 
up-regulation of Total_F with increasing iron concentrations in all cell types, 
particularly at the protein level (relative to 0 mM). For the CHO K1 cells, an increase 
in Total_F expression is found at the mRNA level, in particular when iron is present 
at high concentrations (2 mM). Interestingly, at the mRNA level, HEK 293T(N) cells 
do not display an increase in Total_F expression and this may be explained by the 
readily available mRNA being translated into protein. At the protein level, both 0.2 
and 2 mM of iron increase Total_F expression in each cell line, reaching up to 5 to 
30-fold increase relative to a non-supplemented control. Finally, graphs C and D 
demonstrate if transgenes have some influence over Total_F expression. At the 
mRNA level, there is no evidence that dT or dT_M play a role when compared to 
Control cells, either for CHO K1 or HEK 293T(N). However, in HEK 293T(N) cells at 
the protein level, an up-regulation of Total_F expression is observed in dT_M cells, 
predominantly at low iron concentrations (0 and 0.2 mM). 
6.2.4 Reporter gene stability with iron supplementation 
To assess the effect of iron supplementation on the integration stability of 
dTomato and MagA transgenes, Control, dT and dT_M cells were exposed to iron 
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concentrations of 0, 0.2 and 2 mM for a period of 4 days. dTomato and MagA 
expression levels were then quantitatively measured by RT-qPCR and are displayed 
in Figure 46. The reference genes used here were the same as previously described 
for those cell lines. 
 
Figure 46 – RT-qPCR relative quantification of transgenes dTomato (A) and MagA (B) when 
dTomato (dT) and MagA (dT_M) transduced cells were exposed to 0, 0.2 or 2 mM of iron. 
Error bars represent SEM (n=3) (M&M, p.52). 
It was expected that dTomato and MagA expression would be stable in the 
presence of increasing iron concentrations. However, the results presented in 
Figure 46 demonstrate that for CHO K1 cells, dTomato expression in dT transduced 
cells was relatively stable, but in dT_M cells, there was statistically significant 
down-regulation of dTomato as well as MagA expression in the presence of 0.2 mM 
of iron. Similar results were obtained with CHO K1 cells when exposed to ten times 
more iron, but these results were not statistically significant. On the other hand, 
HEK 293T(N) cells appeared to up-regulate MagA (and dTomato) in the presence of 
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0.2 mM iron, with both dT and dT_M cells following the same trend. This suggests 
that the two MagA transduced cell lines react differently when exposed to iron. 
6.2.5 Intracellular Iron Uptake in vitro 
In the next experiments, the ability of dT_M cells to incorporate more iron 
than controls (Control, dT) was explored. To this end, the intracellular iron content 
of Control, dT and dT_M CHO K1 and HEK 293T(N) cells was measured in 
non-supplemented cells as well as in cells supplemented with 0.2 and 2 mM of iron. 
Results are displayed in Figure 47 where the intracellular amount of iron is plotted 
as a function of iron supplementation. 
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Figure 47 – Intracellular iron content of CHO K1 (A) and HEK 293T(N) (B) cells determined 
with the Ferrozine assay. Control, dTomato (dT) and MagA (dT_M) transduced cells were 
supplemented with different iron concentrations of 0, 0.2 and 2 mM for 4 days prior to 
measurement (Iron supplementation, p.50). Error bars represent SEM (n=3) (M&M, p.50). 
Graphs in Figure 47 show that in relation to CHO K1 cells, HEK 293T(N) cells 
have double the capacity to incorporate intracellular iron. At 0.2 mM of iron, for 
example, intracellular amounts can reach around 0.08 pg/cell for this cell line whilst 
CHO K1, at the same iron concentration, only incorporates about 0.04 pg/cell. In 
  
MAGA AS A REPORTER GENE FOR MRI TRACKING OF CELLS| 195  
terms of iron accumulation between Control and transduced cells, the results show 
that the expression of MagA in CHO K1 did not lead to an increase in intracellular 
iron; in fact, in the presence of 2mM iron, a small decrease was observed relative to 
Control and dT cells, though this was not significant. On the other hand, dT_M 
HEK 293T(N) cells have slightly higher levels of intracellular iron than controls 
(Control, dT) when cultured in the presence of 0.2 and 2 mM iron, but the 
differences are not statistically significant. 
To confirm the iron content in HEK 293T(N) cells, DAB-enhanced Prussian 
blue staining was performed on the different types of samples, in the presence of 0, 
0.2 and 2 mM of iron supplementation. Prussian blue forms a dark blue pigment in 
the presence of iron (Ludi, 1981), the intensity of which can be enhanced by DAB, 
resulting in the formation of a dark brown pigmentation. The results are displayed 
in Figure 48 in grey scale to facilitate comparison between conditions. 
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Figure 48 – Prussian blue and DAB staining of HEK 293T(N) Control, dTomato (dT) and MagA 
(dT_M) cells exposed to different iron concentrations of 0, 0.2 and 2 mM (Iron 
supplementation, p.50), M&M, p.51. 
The data in Figure 48 show the same trend as seen with the Ferrozine assay 
for intracellular iron determination; that is, cells with no iron supplementation have 
negligible iron staining and the staining intensity rises with increasing iron 
concentrations. Also, as seen with the Ferrozine assay dT_M cells cultured in the 
presence of 0.2 and 2 mM iron appear to have higher levels of intracellular iron 
when compared to controls (Control, dT). On the other hand, the staining in Control 
at 0.2 mM is less intense than expected, according to the data in Figure 47, where it 
should be around the same level of intracellular iron as dT 0.2 mM and instead it 
seems not much different than Control without any supplementation of iron. 
  
MAGA AS A REPORTER GENE FOR MRI TRACKING OF CELLS| 197  
Since MagA might be a suitable MRI reporter only for HEK 293T(N), next it 
was investigated if, as stated by Zurkiya et al. (2008) and Goldhawk et al. (2009), the 
overexpression of MagA did in fact lead to the production of magnetic 
nanoparticle-like structures. For this, dT_M and dT cells supplemented with 0.2 mM 
of iron for four days, along with a non-supplemented control (Control in 0mM) were 
analysed via TEM. 
 
Figure 49 – Electron microscopy images of HEK 293T(N) cells. (A) Control cells exposed to 
no iron supplementation and (B) dTomato (dT) and (C) MagA (dT_M) transduced cells 
supplemented with 0.2 mM of iron. Electron dense spots in A inside mitochondria and B 
and C are found in the cytoplasm. Scale bars: 200 nm; M&M, p.61. 
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Figure 49 displays representative pictures showing the presence of electron 
dense spots similar to those observed by Zurkiya et al. (2008) (c.f. Figure 37), 
although it is not possible to assess whether they correspond to iron or other 
electron dense structures. These spots where observed in all conditions tested 
either inside mitochondria (Figure 49, A) and/or spread in the cytoplasm 
(Figure 49, B and C). The approximate size of each electron dense spot was between 
5 and 8 nm, which is closely related to the average inner diameter of ferritin (8 nm), 
suggesting that the observed dark spots might be due to normal ferritins within a 
cell. With this method, no clear difference was seen between samples. 
6.2.6 MRI 
For MRI studies, transduced cells (dT and dT_M) supplemented with 0.2 and 
2 mM of iron, along with a non-supplemented control, were scanned using 
T2-weighed sequences. For this purpose, 107 cells were centrifuged at high speed to 
form a compact cell pellet and imaged via MR, where T1/T2 maps were produced 
for relaxivity measurements (Figure 50). 
  
MAGA AS A REPORTER GENE FOR MRI TRACKING OF CELLS| 199  
 
Figure 50 – MR imaging of cell pellets of CHO K1 (A,C and E) and HEK 293T(N) (B, D and F) 
cells. A and B are T2-weighted representative MR images obtained with  MRI of Control 
with no iron supplementation (0 mM), dTomato (dT) and MagA (dT_M) both supplemented 
with 0.2 and 2 mM of iron (Iron supplementation, p.50). Relaxation times T1 and T2 were 
quantified on a specific region of the cell pellet and represented in C-D and E-F, 
respectively. Error bars represent SEM (n=3) (M&M, p.65). 
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Figure 50 shows that only dT_M transduced HEK 293T(N) cells were able to 
produce a statistically significant (p=0,046) T2 shortening effect (graph F) with 
2 mM iron supplementation, when compared to its equivalent control (dT at 2 mM). 
This also can be perceptible in MRI image B, where dT_M at 2 mM is slightly darker 
than all other conditions. The same is not true for CHO K1 cells, in which there are 
no significant differences between dT_M and its controls. 
Then, 2x105 dT and dT_M cells were microinjected into the midbrain of the 
chick embryo at embryonic day 3 (E3). Both cell types were either incubated in 
normal cell culture conditions (0 mM) or supplemented with 2 mM of iron for 
3 days prior to injection. At E5, embryos were imaged with two complementary 
platforms: by fluorescence microscopy to detect red fluorescence derived from the 
dTomato gene, and by MRI transversal imaging, by observing electrodense spots 
derived from iron accumulation in transduced cells, which was influenced by 
extracellular iron supplementation or possibly due to MagA expression. Results are 
displayed in Figure 51. 
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Figure 51 – Fluorescence and MR imaging in CHO K1 (A, B, C and D) and HEK 293T(N) (E, F, 
G and H) cells, 2 days after injection in the midbrain of a chick embryo (E5). dTomato (dT) 
and MagA (dT_M) cells were injected with or without iron supplementation (2 mM of iron 
for 3 days) (Iron supplementation, p.50). In the fluorescence imaging panel, bright field (BF) 
and red fluorescence (RF) are projection images from the whole embryo; overlays are 
presented for both left and right views and were used as a reference guidance for MR 
imaging; scale bars correspond to 1 mm. In the MRI panel, anatomical images are displayed 
as transverse sections along the rostrocaudal axis of the embryo (left to right); 10 sections 
are displayed for each embryo, with the exception of D which has 12 images, to visualize 
the signal at the bottom of the neck. All images are representative from the results 
obtained and were equally processed with ImageJ software. Arrows indicate T2 shortening 
effect; b – bubble of air. Position of the embryo: F – front; B – back; R – right; L – left; 
number of biological and technical replicates is indicated in the table above (M&M, p.65). 
To identify if transduced cells integrated into chick embryo’s brain, first, 
bright field and fluorescence imaging were performed on whole embryos. Due to 
the presence of fluorescent reporters, transduced cell clusters were easily identified 
and located within the brain. This served as a guideline to identify hypointense cell 
clusters with MR imaging. Without this support, identifying cell clusters based only 
on anatomical images would have proven to be much more difficult. 
The fluorescence imaging panel in Figure 51 suggests that CHO K1 and 
HEK 293T(N) cells behave differently when introduced into the brain of the chick 
embryo. While CHO K1 cells appear to preferentially form clusters, HEK 293T(N) 
 Fluorescence Microscopy MRI 
Cell 
type 
Iron 
conc. 
Transduction 
condition 
Biological rep. 
(technical rep.) 
Iron 
conc. 
Transduction 
condition 
Biological rep. 
(technical rep.) 
CHO K1 
0 mM 
dT n=2 (5) 
0 mM 
dT n=2 (2) 
dT_M n=2 (2) dT_M n=2 (2) 
2 mM 
dT n=2 (6) 
2 mM 
dT n=1 (2) 
dT_M n=2 (4) dT_M n=2 (2) 
HEK 
293T(N) 
0 mM 
dT n=2 (3) 
0 mM 
dT n=2 (3) 
dT_M n=3 (5) dT_M n=1 (3) 
2 mM 
dT n=2 (4) 
2 mM 
dT n=2 (3) 
dT_M n=3 (7) dT_M n=2 (3) 
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cells appear to spread and engraft in several locations within the embryo. 
Transduced cells are also located in different regions apart from the brain, as seen 
in Figure 51, panel C. This might be due to either migration of cells to other parts of 
the body or more likely to the “leakage” of cells into the amniotic sac while injecting 
into the ventricle cavity, having then attached to the surface of the embryo. 
On what concerns the actual contrast obtained from the cells, in the case of 
CHO K1 (Figure 51, A, B, C and D), since the intracellular iron content results were 
not very promising, only two biological replicates were imaged for each condition. 
Comparing dT and dT_M cells exposed to the same iron concentration (0 or 2 mM), 
there does not appear to be any difference between control cells and those 
expressing MagA. Surprisingly, it was possible to detect hypointense regions 
corresponding to the location of fluorescent cells in embryos injected with cells that 
had been cultured in the absence of iron (panels A and B) However, the contrast 
intensity was noticeably stronger (i.e., more hypointense) in embryos injected with 
cells that had been cultured in the presence of iron (panels C and D). 
As for HEK 293T(N) (Figure 51, E, F, G and H), in all three biological 
replicates, for each set of embryos injected with non-supplemented dT cells (E), 
only one hypointense region corresponding to the location of fluorescent cells was 
detected with MRI. In contrast, in embryos injected with non-supplemented dT_M 
cells (F), all fluorescent cell clusters could also be detected via MR imaging 
(appearing as hypointense regions). These results imply that MagA overexpression 
in non-supplemented HEK 293T(N) cells may result in a higher contrast, and thus 
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facilitate detection with MRI. When iron supplementation was provided both to dT 
and dT_M cells, several of the red fluorescent cell clusters correlated with 
hypointense regions in MR images (G and H). However, MRI contrast of 
supplemented dT and dT_M clusters was very similar, suggesting that MagA 
transgene is not providing any advantage for these cells.  
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6.3 DISCUSSION 
In the studies described in the literature, MagA overexpression has been 
conducted in several cell lines and the main outcome is that the sole expression of 
this gene is sufficient to increase intracellular iron content, leading to a significant 
contrast when imaged with MRI (Goldhawk et al., 2009; Zurkiya et al., 2008). Not 
only is the cell line where MagA has been integrated important, but also the origin 
of this gene. Even though the MagA gene exists in different strains of magnetotactic 
bacteria, the specific organism from which MagA was cloned for those studies has 
not always been clear. Zurkiya et al. (2008) did not provide specific information 
about the bacterial strain used in their study, although they state that it was 
provided by L. Bertani [supposedly M. magnetotacticum MS-1 bacterial strain 
(GenBank AB001699.1)]. However, on several occasions throughout the 
introduction and discussion, the M. magneticum AMB-1 bacterial strain 
(GenBank D32253.1) is mentioned, leaving the reader with the impression that the 
MagA gene they used might have been cloned from this particular strain. On the 
other hand, in the first paper reported by Goldhawk et al. (2009), it specifically 
states that the strain used originated from AMB-1, and indicates that the previous 
study (Zurkiya et al., 2008) had used the MS-1 strain. Therefore, it is still unclear 
which bacterial strain was used in Zurkiya et al. (2008). Nevertheless, neither of the 
reports mentions the existence of mutations present in either strain. 
In this chapter, the MagA gene obtained from the magnetotactic bacterial 
strain MS-1, which has been deposited by L. Bertani in the Addgene repository was 
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used, supposedly the same as used by Zurkiya et al. (2008). The gene provided by 
Addgene had two noted missense mutations, altering amino acid coding in a 
non-conservative way. Also two novel silent mutations were identified by 
sequencing analysis and were not reported by Addgene. For more details, please 
see MagA gene sequence in Appendix I, p. 242. It is not known to which extent 
MagA gene properties were affected with these mutations and if it influenced the 
results presented here. MagA integration was firstly evaluated in several stem cell 
lines and then followed up in two cell lines: CHO K1 and HEK 293T(N) to assess 
MagA potential as an MRI reporter. 
In the first instance, dTomato and MagA transgene integration were 
analysed in dT_M transduced stem cells (mESC, mMSC and mKSC) over a time 
period. Following these cells by fluorescent microscopy and RT-qPCR (Figure 38), it 
was immediately clear that two types of cells were present: some that could not 
survive MagA expression for more than a few days (mMSC and mKSC) and others in 
which MagA appeared to have no obvious toxic effects (HEK 293T(N) and mESC) 
(Figure 39). With these results we may suggest that mMSC and mKSC decrease their 
proliferation capacity over time once MagA has been introduced, dying after 
approximately 8 days, at which point cells still showed acceptable levels of 
transgene expression. On the other hand, HEK 293T(N) and mESC survive over a 
period of 40 days, but the transgene expression was found to decrease with time. 
To some extent, this may be explained by the fact that not all cells were efficiently 
transduced and the non-transduced cells might proliferate at a higher rate. This 
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would dilute the overall amount of transgene in the sample, consequently leading 
to the decay in its expression levels as seen via RT-qPCR (Figure 38). In the case of 
mESC, mRNA transcript levels were nearly null from day 6 post-transduction and the 
encoded dTomato protein was practically undetectable using fluorescent 
microscopy. mESC have been shown to silence lentiviral vectors by epigenetic 
mechanisms, such as DNA methylation and chromatin silencing (Yao et al., 2004). 
Therefore, these cells were not chosen to evaluate MagA as a possible magnetic 
reporter. MagA integration was also unsuccessful in human MSC but successful in 
human ESC (data not shown). These results pose a limitation of using MagA as a 
reporter gene for MRI tracking of cells, as this system may not be suitable to use in 
all cell types. 
The CHO K1 cell line was then selected to evaluate MagA gene integration 
capacity, and later on, its potential as an MRI reporter was assessed alongside 
HEK 293T(N) cells. dTomato and MagA gene integration was initially assessed by 
fluorescence microscopy (Figure 40) and flow cytometry (Figure 41). When 
comparing cell types, dT fluorescence expression in CHO K1 cells was more intense 
than the same condition of HEK 293T(N) cells. This may be explained by the 
difference in the multiplicity of infection used (CHO K1 MOI=26 vs. HEK 293T(N) 
MOI=5), since both cell lines have similar transduction efficiency (3.2.4 Transduction 
efficiency between cell lines – Figure 9). Nevertheless, this difference was not 
observed for dT_M transduced cells where only about half of CHO K1 cells were 
transduced when compared with HEK 293T(N) cells. 
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dTomato and MagA transgene integration was then analysed in dT_M 
transduced CHO K1 and HEK 293T(N) cells by RT-qPCR and it was found that from 
passage 1 to passage 3 after transduction, transgene expression had decreased to 
about half (Figure 42). This might be due either to cell death of transduced cells, 
slower cell proliferation relative to non-transduced cells or even to repression or 
down-regulation of the integrated genes. Gene silencing has been widely studied 
over the years, particularly in stem cells, and it can be observed mainly in three 
different states: (i) a complete transcriptional silencing right after transduction; (ii) 
an effect known as variegation, where genetically identical cells may either express 
or silence the transgene; and (iii) extinction, in which a progressive silencing of the 
transgenes may be verified in long term cultures or during differentiation of cells 
(Ellis, 2005; Laker et al., 1998; Yao et al., 2004). More recently, it was reported that 
even the transduction process itself with HIV-based lentiviral vectors may induce 
profound epigenetic modifications in human hematopoietic stem cells (Yamagata et 
al., 2012). 
As previously seen for stem cells (Figure 39), CHO K1 viability is also affected 
by MagA integration, particularly 8 days post-transduction (Figure 43). However, 
this effect is not so dramatic and cells are able to recover up to levels comparable 
with controls. 
This overall evaluation of MagA transgene integration in the CHO K1 
demonstrates that only about half of dT_M CHO K1 cells are effectively transduced 
at P3, comparatively with dT_M HEK 293T(N) (Figure 41, B), even with the 
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multiplicity of infection being five times superior for CHO K1 cells. This evidence 
together with the decrease in viability/ proliferation (Figure 43) when exposed to 
MagA gene suggests that this transgene integration may also be causing certain 
toxicity in CHO K1 as seen in stem cell lines above (Figure 39), albeit to a lower 
extent. 
Next, it was essential to comprehend if MagA overexpression could be 
interfering with iron homeostasis. Figure 44 and Figure 45 demonstrate that cells 
reacted as expected to increasing iron concentrations. First, by down-regulating 
transferrin receptor-1 possibly by promoting mRNA cleavage as known from the 
IRP/IRE regulatory system (Figure 1) to block iron entering the cell. Second, by 
promoting Fth-1 mRNA translation process to occur in order to store intracellular 
iron present in excess. On the other hand, no statistically significant evidence was 
found that dT_M cells influence iron homeostasis. This influence would likely 
happen in two possible scenarios: i) if MagA overexpression was to produce 
“nanoparticles” or ferritin-like molecules accumulating intracellular iron, as 
proposed by Zurkiya et al. (2008) and Goldhawk et al. (2009); or ii) if MagA gene 
was to function as an iron transporter, as it was first described in magnetotactic 
bacteria (Nakamura et al., 1995a). In the first case scenario, if MagA expression in 
mammalian cells produced biomineralized iron “nanoparticles”, it would possibly 
harvest intracellular iron, leading to iron depletion, which would in turn up-regulate 
TfR-1 levels and down-regulate Fth-1 expression. On the other hand, it if functions 
as an iron transporter, just like in bacteria, introducing iron in an uncontrollable 
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fashion into the cells’ membranes (cytoplasmic, nuclear and/or mitochondrial), 
would be expected to lead to a decrease in TfR-1 expression and an increase in 
Fth-1. However, as seen in Figure 38, Figure 42 and Figure 46, to some extent, cells 
appear to be able to control overexpressed integrated genes. Perhaps this was the 
way cells found to maintain iron homeostasis since it is so important for cell 
survival. Therefore, this would explain why no evident differences of Total_T and 
Total_F were found in dT_M cells when compared to controls. It might also explain 
why some cells like mMSC and mKSC died and others survived. Hypothesizing a 
scenario where these non-surviving cells did not have any control over MagA 
transcription and translation processes, it would possibly lead to an uncontrollable 
deregulation in iron homeostasis, thus leading to cell death either by iron depletion 
or iron toxicity. An interesting case is observed in Cho et al. (2014), where 
increasing MagA transcription levels in TET controlled mESC-MagA are reported by 
qPCR, with the increase in doxycycline dosage. However, at the protein level, 
measured with western blot, the relative expression of MagA does not get affected 
with the same increase in doxycycline dosage. 
Even though the exact role of MagA when overexpressed in mammalian cells 
and its influence on the normal cellular mechanism is yet to be verified, it is of 
crucial importance to know if dT_M cells could in fact have an increase in the iron 
load capacity, relative to control cells. For this reason, quantitative and qualitative 
methods were performed to access the intracellular iron content. Ferrozine assay 
(quantitative) showed no differences between CHO K1 cells and very small iron 
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content increase in dT_M HEK 293T(N) cells (Figure 47). Equally, the qualitative 
method Prussian blue illustrated a higher iron accumulation capacity between 
different transduced and control HEK 293T(N) cells (Figure 48). Another qualitative 
method, TEM imaging, did not provide a great insight in terms of differences of iron 
content between HEK 293T(N) cell lines studied. The electron dense spots are 
assumed to be iron oxide crystals; however, without the means to identify the 
atoms present in these inclusions, there is a possibility that these spots are 
structures consisting of other elements of high atomic weight. Interestingly, TEM 
pictures shown in Figure 49 resemble the MagA-derived magnetic nanoparticles 
(Figure 37) presented in the study of Zurkiya et al. (2008), in which microanalysis 
showed that the particles consisted mainly of magnetite (Fe3O4), as seen within the 
magnetosomes of magnetotactic bacteria. 
Finally, MRI relaxivity studies performed on cell pellets showed that only 
when incubated with 2 mM, dT_M HEK 293T(N) cells provided sufficient contrast to 
be distinguished from control cells (Figure 50, B, D and F). On the other hand, 
embryo MRI scans indicated that only when cells were not iron supplemented that 
a distinct contrast was found between dT and dT_M (Figure 51, E-H), implying that 
MagA overexpression is somehow contributing to an increase in MRI contrast. Also, 
the T2 shortening effect of HEK 293T(N) cells implanted in the chick embryo is very 
similar, irrespective of iron supplementation, suggesting that supplementation 
previous to injection might not even be necessary for this cell line. In case of 
CHO K1 cells, MRI studies did not demonstrate a higher contrast capacity of dT_M, 
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relative to control cells (Figure 50, A, C and E; Figure 51, A-D). Nonetheless, in these 
cells the T2 shortening effect observed in embryo MRI scans is much more striking 
relative to HEK 293T(N), even though the same is not observed when measuring 
intracellular iron content (Figure 47) or in relaxivity studies performed on cell 
pellets (Figure 50). This might be due to the cluster formation observed in CHO K1, 
leading to a more intense loss of signal when imaged with MR, contrary to 
HEK 293T(N) cells which preferentially spread within the chick embryo brain. 
In summary, MagA gene overexpression in mammalian cells might be a 
useful reporter for MRI tracking, as seen here in HEK 293T(N) cells and in previous 
reports (Goldhawk et al., 2009; Zurkiya et al., 2008), but it is definitely dependent 
on the cell type used. Caution must be taken when introducing this bacterial gene, 
as it might promote a toxic effect on certain cell lines and/or disturb the cell’s iron 
equilibrium. For this reason, if using this gene as an MRI reporter, it is important to 
understand how it functions within the cell, and therefore, further work needs to be 
done.  
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6.4 SUPPLEMENTARY DATA 
 
Supplementary figure 5 – Representative western blots (A and B) and correspondent total 
protein gels (C and D) from Control, dTomato (dT) and MagA (dT_M) transduced CHO K1 (A 
and C) and HEK 293T(N) (B and D) cells, supplemented for 4 days with 0, 0.2 or 2 mM of 
iron. Orange rectangle highlights TfR-1 (or Total_T) protein expression, with a predicted 
molecular weight (MW) of 100 kDa; white rectangle corresponds to actin expression with 
42 kDa and blue rectangle to Fth-1 (or Total_F) with 21 kDa. Sometimes another band is 
detected when targeting Fth-1, which may correspond to a post-translational modification 
of this protein. Please note that because actin was not stable in different blots, particularly 
in the case of CHO K1 cells (A), protein quantification was normalized using only total 
protein gels for this cell line (M&M, p. 57). 
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CHAPTER 7 
GENERAL DISCUSSION AND CONCLUSION 
In the current work, reporter gene technology was evaluated as means to 
track cells within a model organism using MR imaging. This relied on the potential 
magnetic properties of specific genes, such as: i) transferrin receptor-1 (TfR-1), 
known to be an iron transporter located on the membrane of mammalian cells; ii) 
ferritin heavy chain-1 (Fth-1), an integral part of the ferritin complex which is 
responsible for storing intracellular iron in a safe configuration, and, iii) MagA, 
identified as an iron transporter in the membrane of magnetotactic bacteria and 
possibly involved in the formation of magnetosomes. The concept behind this work 
was that overexpression of any of these genes in a certain cell line would be 
sufficient to increase intracellular iron content and thus lead to a significant MRI 
contrast of these cells when compared to controls and to background levels. 
The work presented here was conducted by using a HIV-based lentiviral 
method to stably overexpress potential magnetic reporters (TfR-1, Fth-1 or MagA), 
along with fluorescent reporters (GFP and dTomato) in several established cell lines. 
Due to the lentiviral construct design, shown in Figure 5, Chapter 3, an internal 
ribosome entry site (IRES) was present between the magnetic and fluorescent 
reporters, allowing for bicistronic expression of both genes. TfR-1 was cloned into a 
GFP-containing lentiviral vector (green fluorescence), while Fth-1 and MagA were 
cloned into a dTomato-containing lentiviral vector (red fluorescence). When 
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integrated in specific cell lines, the presence of fluorescent reporters allowed for a 
longitudinal monitoring in vitro by fluorescence-based methods. However, this only 
allowed for verification of the expression levels obtained from fluorescent 
reporters. In some situations, even though cells were transduced with the same 
MOI, when comparing controls with target genes, for example GFP with GFP_T 
transduced in CHO K1 cells (Chapter 4) or in mMSC (Chapter 5), the control normally 
appeared with brighter fluorescence than the other transduction condition. This can 
potentially be explained by the fact that, within the lentiviral vector, the fluorescent 
reporter is located downstream of the IRES and is thus furthest from EF1-α 
promoter. In case of another gene of interest being present, the location of the 
fluorescent gene can influence this one to have weaker expression relative to the 
magnetic reporter, which in turn is located upstream of the IRES and is the first to 
be expressed by the promoter. Nevertheless, the only way to know if both 
integrated genes were being represented at the same level was to evaluate 
transgene expression by RT-qPCR. Results using this technique showed that for 
most transductions performed, the lentiviral system used here provided a robust 
bicistronic expression of both transgenes. 
An initial evaluation of the cell viability status a few days after transduction 
comprised both cell proliferation capacity and cell health and appeared to be 
decreased for all transduction conditions. This may not only be due to the 
transduction process itself or an influence derived from the integrated transgenes, 
as discussed on a case-by-case basis, but also due to the presence of the EF1-α 
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promoter. This promoter, present in all lentiviral constructs studied here, has been 
reported to transiently arrest the cell cycle at S phase in mesenchymal stem cells, 
when high MOIs of HIV-1 derived lentiviral preparations were used. However, the 
same publication also registered that, when EF1-α promoter was used, a significant 
increase in expression with advancing passages was observed and that transduced 
cells had the same differentiation capacity as untransduced cells (Lee et al., 2004). 
After analysing the overall transgene integration capacity and its effects on 
the viability status of a cell, the evaluation of how iron homeostasis is kept in 
response to the target transgene overexpression is also crucial. Taking a general 
overview of all results obtained in this study, some main points need to be taken in 
consideration. For instance, a balanced iron metabolism should always be a priority, 
confirming if cells are able to adjust its metabolic needs to the overexpression of 
iron related genes. This was observed when TfR-1 was overexpressed in CHO K1 cell 
line, in Chapter 4, where an internal increase of Fth-1 compensated TfR-1 
overexpression, maintaining an iron homeostasis state. However, in some cases this 
does not occur so easily, as observed when analysing mMSC overexpressed with 
Fth-1, in Chapter 5. Therefore, it is crucial to understand the impact on the cell’s 
normal behaviour, either when overexpressing a gene involved in the iron 
metabolism, such as TfR-1 or Fth-1, or when integrating a gene which may possibly 
disturb the normal iron metabolism, like MagA gene, studied in Chapter 6. In this 
case, there was no confirmation that iron homeostasis was adjusting to the new 
needs potentially promoted by MagA overexpression and therefore, the true 
  
GENERAL DISCUSSION AND CONCLUSION | 220  
function of MagA when overexpressed in mammalian cells remains elusive. 
In order to investigate the potential cause of toxicity in cells when transduced 
with MagA transgene, the surviving and non-surviving cell lines were compared side by 
side in culture. It was noticed that these two groups of cells performed different cellular 
respiration pathways and this could potentially be responsible for determining either 
cell death or cell survival. Even though all cell lines used in this work were cultured 
under glucose-containing medium, the surviving cell lines, such as HEK 293T(N), mESC 
and hESC, after a few days in culture turned the medium into a yellow colour. This was 
most likely due to a drop in pH caused by the secretion of lactic acid, a biowaste 
product from the glycolytic pathway (anaerobic respiration). On the other hand, 
non-surviving cells, like mMSC, hMSC and mKSC, although metabolites are also secreted 
into the culture medium, the colour always remained the same, even after long periods 
of time, indicating there were no changes in the pH. In this case, cells might 
preferentially use oxidative phosphorylation (aerobic respiration) to meet their energy 
needs. In order to understand if the cellular respiration pathways had any influence on 
the survival of some cell lines in detriment of others, a hypothesis was approached to 
try to explain why cells who most likely use of mitochondria for oxidative 
phosphorylation, fail to survive after MagA transduction. The hypothesis contemplated 
that the lack mitochondrial function of these cells after MagA transduction might 
potentially be the underlying reason for the non-survival. Therefore, 
glucose-deprivation experiments (substituting glucose with galactose) were performed 
to one cell line from each group (mESC and mKSC). The production of energy through 
the glycolytic pathway under galactose-supplemented conditions, rather than glucose, 
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yields no net ATP and therefore cells are forced to use the oxidative phosphorylation 
pathway to produce energy. For both cell lines, mKSC and mESC, an obvious decrease in 
proliferation was immediately detected when comparing galactose-supplemented 
media with normal media conditions (data not shown). This was somewhat expected 
since not only the cells probably need some time to adjust to the new metabolic 
conditions, but also it is known that oxidation phosphorylation pathway requires more 
time for energy production, not allowing such a fast growth rate. However, the fact that 
mESC, when transduced with MagA, were not able to proliferate under aerobic 
conditions (data not shown) provides some insight of a possible mitochondrial 
functional loss after MagA gene was introduced. Nevertheless, further work needs to 
be done to understand the reason for toxicity upon MagA integration in some cell lines 
in detriment of others. 
The capacity of cells transduced with magnetic reporters to retain more iron 
than controls was evaluated by measuring the intracellular iron content of each cell, 
using a Ferrozine assay. GFP_T transduction into CHO K1 cells (Chapter 4) promoted 
a higher intracellular iron accumulation relative to untransduced and GFP control 
cells; however, when GFP_T viral particles were transduced in mMSC (Chapter 5) 
the same results were not observed. While CHO K1 cells were transduced with 
MOI=100, mMSC had only MOI=50. This might partially explain why TfR-1 
overexpression led to an iron content increase in some cell lines but not others. 
Also, in CHO K1 cells, iron homeostasis adjusted to GFP_T integration, promoting an 
increase in Fth-1 mRNA/ protein levels, indirectly meaning that the number of 
ferritins available increased due to the sole overexpression of TfR-1. This potentially 
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led to more iron entering the cell due to high numbers of receptors available, and 
clustering in ferritins in a safe configuration. 
An interesting observation between all these studies was the variation of 
iron accumulation capacity amongst the different cell lines studied. All cell lines 
were incubated with 2 mM of iron for a period of 4 days prior to measurement. The 
CHO K1 cell line has the least retention capability, with only 0.1 pg/cell, similarly to 
HEK 293T(N) cells with 0.13 pg/cell, but greatly surpassed by mMSC, with 
0.78 pg/cell. These values refer to untransduced cells only. In a work published by 
Heyn et al., (2003), calculations of the minimum amount of iron needed for MRI 
detection of a single cell lead to a conclusion that for 100x100x200µm (2nL) voxel 
resolution, using a 1.5 T MRI with a 3DFIESTA pulse sequence, the range would have 
to be between 1.4 and 3 pg/cell (Heyn et al., 2003). Although MR imaging 
conditions were different for the present study, and cells were not detected on a 
single basis but rather as a cluster, it is good to take into consideration that the 
influence magnetic reporter genes may possibly have on iron acquisition into cells is 
very likely to be on the borderline for minimum MRI detection capacity. 
When analysing cell pellets with MRI, the results show that MRI contrast is 
dependent not only on the overexpressed transgene as desired, but very much 
influenced by the cell type and iron supplementation conditions used. The fact that 
mMSC have such great iron retention aptitude, makes it possible for them to create 
markedly increased MRI contrast when supplemented with iron, without the further 
need of contrast agents or magnetic reporter genes. 
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To further complete this study, magnetic target genes and respective 
controls were injected into the midbrain of an E3 chick embryo. Up to now, no 
other research study has investigated the potential of MRI reporter genes using the 
chick embryo in ovo as a model organism. At embryonic day 5, embryos were 
harvested and imaged both with fluorescence microscopy and MRI. In terms of the 
fluorophores chosen for this study, GFP and dTomato, the best to use particularly in 
an in vivo setting was dTomato, created by Shaner et al. (2004). While eGFP (Cubitt 
et al., 1999) produces a green fluorescence protein with an excitation peak of 
488 nm, dTomato gene gives rise to a red fluorescence protein with an excitation 
peak of 554 nm. The longer excitation wavelength makes dTomato produce less 
phototoxicity and penetrate deeper into the tissue (Shaner et al., 2007), 
circumventing more efficiently the biological tissue autofluorescence than eGFP. 
In conclusion, the field of magnetic reporter genes is yet to be fully explored. 
While other MRI imaging systems require exogenous contrast agents, such as 
SPIONS, magnetic reporter gene technology would allow for long-term MRI cell 
tracking studies, without signal dilution upon cell division or false positive signalling. 
The promise of a global magnetic reporter gene for MRI tracking of any cell type 
might never come to a reality, as one needs to evaluate on a case-by-case basis, if a 
certain reporter gene is influencing the normal behaviour of a specific cell line. A 
pitfall of using reporter genes for cell tracking is the low sensitivity when compared 
to exogenous agents such as SPIONS (Vande Velde et al., 2011). However, studies 
have reported adverse effects on cell differentiation when exposed to particles such 
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as SPIONs (Chen et al., 2010). Furthermore, the inevitable dilution over time of 
these particles does not allow a longitudinal tracking study over the course of weeks 
or months (Taylor et al., 2014). An alternative approach would be to join together 
both tracking methods, combining the high sensitivity of SPIONs in early tracking 
studies to precisely determine the location of cell engraftment, allied with the 
magnetic reporter gene technology for long-term monitoring. Possibly the magnetic 
nanoparticle dissolution with time would allow for sufficient iron dispersion to be 
taken up by complexes such as ferritins, whose numbers may be increased due to 
overexpression of TfR-1, as seen in Chapter 4, or perhaps of Fth-1, as described by a 
number of previous studies (Cohen et al., 2005; Deans et al., 2006; Genove et al., 
2005). Another setback is the necessity to use a retroviral system to stably 
introduce and overexpress magnetic reporters of interest. This has long been 
known to pose potential risks, such as insertional mutagenesis, and may not be 
applicable in the clinical setting. For this reason, increasing research on gene 
integration directed targeting is being explored, aiming to avoid the random 
insertion pattern, typical of virus-based integration systems (Nielsen et al., 2009; 
Qasim et al., 2010; Qi et al., 2013). Also, several studies are testing the efficacy and 
safety of non-viral DNA transfer systems, creating the next generation of gene 
delivery tools (Yin et al., 2014). 
Other reporter genes with potential MRI contrast properties may also be 
explored for cell tracking purposes. One example is the divalent metal transporter, 
DMT-1, known to be involved in the uptake of manganese and recently presented 
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as a novel reporter for manganese-enhanced MRI, or MEMRI (Bartelle et al., 2012). 
Another protein yet to be explored as a magnetic reporter is Scara5+, initially 
reported by Jiang et al. (2006) as a class A scavenger receptor. Later it was 
identified by Li et al. (2009) to be expressed in the mesenchymal, stromal and 
capsule compartments of the embryonic kidney, serving as an 
endocytosis-mediated receptor of extracellular ferritin, representing therefore a 
mechanism for non-transferrin iron delivery. This protein could potentially be used 
in other cell types to introduce ferritin complexes into the cell, allowing for 
intracellular iron accumulation in a safe configuration and contributing to a 
significant increase in contrast with MRI. Therefore, reporter gene technology may 
one day be a robust system for tracking of cells. 
At last, from the three magnetic reporters for MRI cell tracking investigated 
in this study, TfR-1 proved to be a suitable reporter in the CHO K1 cell line 
(Chapter 4), particularly when used with low iron supplementation conditions. 
However, the same suitability was not verified for mMSC (Chapter 5). In fact, for 
this particular cell line, none of the reporter genes investigated promoted a contrast 
difference using MRI, neither when TfR-1 and Fth-1 were overexpressed 
independently or in conjunction. Also, as described in Chapter 6, stem cell lines 
failed to incorporate MagA gene (mKSC, hMSC, mMSC) or decreased its expression 
levels to null a few days after transduction (mESC). The product derived from MagA 
overexpression in mammalian cells and potential cytotoxicity remains unknown. 
Nevertheless, this system does not appear to be adequate for stem cell studies, but 
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rather for other cell lines, perhaps with a more robust iron metabolism, easily 
adjusting its needs. As previously stated in the study of Zurkiya et al. (2008), the 
MagA gene provided a distinct contrast with MRI in HEK 293T(N) cells and when 
iron supplementation was not provided. Even though the same was not observed 
for CHO K1 cell line, the potential use of MagA (or TfR-1) without any iron-related 
supplementation conditions would provide a useful advantage for long-term 
tracking of cells. 
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APPENDIX I 
CDNA SEQUENCES 
CAGACGTTCTCGCCCAGAGTCGCCGCGGTTTCCTGCTTCAACAGTGCTTGAACGGAACCCGGTGCTCG
ACCCCTCCGACCCCCGCCGGCCGCTTCGAGCCTGAGCCCTTTGCAACTTCGTCGTTCCGCCGCTCCAG
CGTCGCCACCGCGCCTCGCCCCGCCGCCACCATGACCACCGCGTCTCCCTCGCAAGTGCGCCAGAACT
ACCACCAGGACGCGGAGGCTGCCATCAACCGCCAGATCAACCTGGAGTTGTATGCCTCCTACGTCTAT
CTGTCTATGTCTTGTTATTTTGACCGAGATGATGTGGCTCTGAAGAACTTTGCCAAATACTTTCTCCA
CCAATCTCATGAGGAGAGGGAGCATGCCGAGAAACTGATGAAGCTGCAGAACCAGCGAGGTGGCCGAA
TCTTCCTGCAGGATATAAAGAAACCAGACCGTGATGACTGGGAGAGCGGGCTGAATGCAATGGAGTGT
GCACTGCACTTGGAAAAGAGTGTGAATCAGTCACTACTGGAACTGCACAAACTGGCTACTGACAAGAA
TGATCCCCACTTATGTGACTTCATTGAGACGTATTATCTGAGTGAACAGGTGAAATCCATTAAAGAAC
TGGGTGACCACGTGACCAACTTACGCAAGATGGGTGCCCCTGAAGCTGGCATGGCAGAATATCTCTTT
GACAAGCACACCCTGGGACACGGTGATGAGAGCTAAGCTGACTTCCCCAAAGCCACGTGACTTTACTG
GTCACTGAGGCAGTGCATGCATGTCAGGCTGCCTTCATCTTTTCTATAAGTTGCACCAAAACATCTGC
TTAAGTTCTTTAATTTGTACCATTTCTTCAAATAAAGAATTTTGGTACCC 
Mus musculus Ferritin heavy chain-1 mRNA (NM_010239.2). Grey area represents the 
untranslated regions (5’ UTR and 3’ UTR) and the light area the coding sequence of the 
Fth-1 mRNA. Note that within the 5’ UTR, an iron responsive element is represented in 
blue. ATG and TAA in red correspond to the start and stop codons, respectively. The 
sequence in green is an Fth-1 native Kozac sequence. The underlined nucleotides 
correspond to the primer specific region used to amplify the cDNA sequence. 
GTGCGGAAGGAAGTGACGTAGATCCAGAGGGCCGGCCGGGGGGTGGGGCCGAGCTATAAGCTTTGGGT
GGGAGGCAGCGCTGCCTTCAGAAGGCGTGCGGAGCGCGGGCTGCTGCATTGCGGACTGTAGAGGCGCT
TCCTAGTACTCCCTTGTAGCAGCTGAGAATGATGGATCAAGCCAGATCAGCATTCTCTAACTTGTTTG
GTGGGGAACCATTGTCATACACCCGGTTTAGCCTTGCTCGGCAAGTAGATGGAGATAACAGTCATGTG
GAGATGAAACTGGCTGCAGATGAAGAAGAAAATGCCGACAATAACATGAAGGCTAGTGTCAGAAAACC
CAAGAGGTTTAATGGAAGACTCTGCTTTGCAGCTATTGCACTAGTCATTTTCTTCTTGATTGGATTCA
TGAGTGGCTACCTGGGCTATTGTAAGCGTGTAGAACAAAAAGAGGAGTGTGTGAAACTGGCTGAAACG
GAGGAGACAGACAAGTCAGAAACCATGGAAACAGAGGATGTTCCTACATCATCTCGCTTATATTGGGC
AGACCTCAAAACACTGTTGTCAGAGAAGTTGAACTCCATAGAGTTTGCTGACACCATCAAGCAGCTGA
GCCAGAATACATACACTCCTCGTGAGGCTGGATCTCAAAAAGATGAAAGTCTTGCCTATTATATTGAA
AATCAGTTCCATGAATTTAAATTCAGCAAAGTCTGGCGAGATGAACACTATGTGAAGATTCAAGTGAA
AAGCAGCATTGGTCAAAACATGGTGACCATAGTGCAGTCAAATGGTAACTTAGACCCAGTGGAGTCTC
CCGAGGGTTATGTGGCATTCAGTAAACCTACAGAAGTTTCTGGTAAACTGGTCCATGCTAATTTTGGC
ACTAAAAAGGACTTTGAAGAACTAAGTTATTCTGTGAATGGATCTTTAGTGATTGTTAGAGCAGGGGA
AATTACTTTTGCAGAAAAGGTTGCAAATGCCCAAAGCTTTAATGCAATTGGTGTCCTCATATACATGG
ACAAGAATAAATTCCCCGTTGTTGAGGCAGACCTTGCACTCTTTGGACATGCTCATCTAGGAACTGGT
GATCCATACACACCTGGCTTTCCTTCTTTCAATCATACTCAGTTTCCGCCATCTCAGTCATCAGGGTT
GCCTAATATACCTGTGCAAACAATCTCAAGAGCTGCTGCAGAAAAGCTATTTGGAAAAATGGAAGGAA
GCTGTCCTGCTAGATGGAACATAGATTCTTCATGTAAGCTGGAACTTTCACAGAATCAAAATGTGAAG
CTCATTGTGAAAAACGTACTGAAAGAAAGAAGAATACTTAACATCTTTGGAGTTATTAAAGGTTATGA
GGAACCAGACCGTTATGTTGTAGTAGGAGCCCAGAGAGACGCTTTGGGTGCTGGTGTTGCGGCGAAGT
CCAGTGTGGGAACAGGTCTTCTGTTGAAACTTGCCCAAGTATTCTCAGATATGATTTCAAAAGATGGA
  
APPENDIX I | 243  
TTTAGACCCAGCAGAAGTATAATCTTTGCCAGCTGGACTGCAGGCGACTTTGGAGCTGTTGGTGCCAC
TGAGTGGTTGGAGGGATACCTTTCATCTTTGCATTTAAAAGCTTTCACTTATATTAATTTGGATAAAG
TTGTCCTTGGTACTAGTAACTTCAAAGTTTCTGCCAGCCCCTTATTATATACACTTATGGGAAAGATA
ATGCAAGATGTAAAGCATCCAGTTGATGGAAAATCTCTATATAGAGACAGCAATTGGATTAGCAAAGT
TGAGAAACTTTCCTTTGACAATGCTGCATATCCTTTCCTTGCATATTCTGGAATCCCAGCAGTTTCTT
TTTGTTTTTGTGAGGATGCAGACTATCCTTATTTGGGCACTAGATTGGATACCTATGAGGCATTGACT
CAGAAAGTTCCTCAGCTCAACCAAATGGTTCGTACAGCAGCGGAAGTGGCTGGTCAGCTCATTATTAA
ACTTACCCATGACGTTGAATTGAACCTGGACTATGAGATGTATAACAGCAAACTACTGTCATTTATGA
AGGATCTGAACCAGTTCAAAACAGATATCAGGGATATGGGTCTAAGTCTACAGTGGCTGTATTCCGCT
CGTGGAGACTACTTCCGTGCTACTTCTAGACTAACAACTGATTTTCATAATGCTGAGAAAACAAACAG
ATTTGTCATGAGGGAAATCAATGATCGTATTATGAAAGTGGAGTATCACTTCCTGTCGCCCTATGTAT
CTCCAAGAGAGTCTCCTTTCCGACATATCTTCTGGGGCTCTGGCTCTCACACTCTCTCAGCTTTAGTG
GAGAACTTGAAGCTTCGTCAAAAAAATATTACTGCTTTTAATGAAACCCTCTTCAGAAACCAGTTGGC
CCTGGCTACTTGGACTATTCAGGGAGTCGCAAATGCCCTCTCTGGTGACATTTGGAATATTGACAATG
AGTTTTAAATGTAACATGCATAATTAAATAAGAGCAGGGTAGTCTGTTTCTAGACTTGTGTTGGTTGT
GCTAAATTTTCATTAGAGCTCTAAAATCTAATGTTAAAATTCTACCCAATCATCTAATGTCTTAGGCA
GCAGCTTTTAGTGCGGGGTTGGACCTACACTTCAAGTACAATGGATAACACTTTCCATGTTTGTGATA
TCTTCTCAGATTATCTTTAAAATTTTTGAGTCCTTTGTAATAACTTCCTCTTTGCTTCATGGTCATGA
AAATGTCAGAACCAGTTGTAAGAACAATGCTATATGTCCTGAGGGCATTAACTAGTGTCTTTTGAGGT
AGGAGAAAGAGTGTGCTTGTGGAGGGTCAACGTGGTAGTTGGGTAGTTGGAGATTGCCCCGTCTCCAT
CTGATCTTCCATTGAGCTGTATGCCCTTAAGGATGTAGCTGGTTTGCATTTCCCTAAATTAGACAGTA
ACTTTCAGAAGAGATGGAACTTGTTTTCTTGCCAGCAAGGTTGAAAATAGGTCCTTAGCTGGACCAAT
TTGTCTGTTTACAGGAATAAGTAAGGCCTTACTGGTTAACCTTGGTGTTCTTTATGATGAGACCAGAA
GCCAAAGACCTCAAGTTTTCTCTCCTCTTGGCATCTGCCCTATAGTCTTTAGTTCTTTGTTTTTATTT
TGTTTTTCTTTTTTTCCCAACATTTTCTGAAAAAGAACAAGTTTTAGACTCAATTTGTCAGACTTGAA
AAGAACACACTGCCAAGTTTTGGCCAAAGTGTTAGTCTTCAGGAAAGCTTTCTATCATTTTGGCACTG
AGATATTTATTGTTTATTTATCAGTGACAGAGTTCACTATAAATAGTGTTGTTTTTTTTTTATATATA
GAAGATAATTATCGGAAGCAGTGCCTTCCATAATTATGACAGTTATACTGTCGTTTTCTTTTAATAAA
AGCAGCATCTGCTAATGAGACCCACAGATACTGGAAGTTTTGCACTTATGGTCAGCACTTGCAACTTT
AGGAAGGAAGAATGCCACAATCCAAATAATATGAGCTAGAAGAGGATTGGGTTAAATAAGAGATTCCT
AATTGAGTTGGGGAAAAAAATGATAGTTTTCCTAAGTGCAGTGAGTTGTGGCCAAGTTAAATGTCATT
TAAAGGCTATGGTAGTACTTACATCTACAAAATTTTACAGCTCAATTTATTCAAGATGTAACTCAAAA
TCAATTTTGCAAAATTTCCAGTACCTTTGTCACAAACTTAACTCACATTATCGGGAGCAGTGTCTTCC
ATAATGCATAAAGAACAAGGTAGTTTTTGCCTACCACAGTGTCTATATCGGAGACAGTGATCTCCATA
TGTTACACTAAGGGTGTACGTAATTATCGGGAACAGTGTTTCCCATAATTTTCTTCATGCAATGACAT
CTTCAGAGCTTGAAGATCGTTAGTATCTAACATGAATTCCTAACTTCCTGTAGCTCCTTAGTTTTAGT
TGCAAAAAACATTTGTGGTCATTGAGCATTTGGTGGGTAAAATCAACTGCTGTAAAATCATTACTTCC
AAGATCCTTTTTTAAAATGTGGGTATTTTGTTATCTCTGGTTTATGGAATAAAAGCATACGTTTATAA
TGTTTGCTGGTGACAAAGGAATTTAACTATCTCCCTTTATTTGCATGTTACATGTTATTTCCTAAATG
TAGTTCTTAGAAGTTTGAATTCATTTTTGGTTTTTGGGAGGGTAGAAAGTAGAGAATAATGGGTGTTG
GGAAGACAAAGCTTGCAAAAGGATCTTTATGTACCTGCTCATCACTATGGTGGCTATGAATTATGTAG
GTAATGAGCAAGATCACATTAACAAAGACTAGTTAACCATCATTACGCATCTAATCAGTTTTGCCATG
GGGTCAGTTCAAAGCTGCCACCTGAGAATGTCACTAGGCTCTCAGGGTCTTGGCACCACTCGCCCAAG
TTATATCCACCAGATTATTTTGAGCCTCACTGAGTTGTTTTGCTACTCAGTCCCTTCAGTCTTCACAG
TGTTTCTCTTGTACCAGTATGAGTATCACCGTGCATAATGGGATTCCAAGTCTTGAATGAAGGCATGC
ATTTTACATAGACGTCTCTGTGAAATAACCTTTGTTGTAAGTGGTGTTTCCAGTCAAAGCAGTAAGTT
GGTAAGGTTTAGTCTTGGGTGAAATGTGGATCTGAGTAATAAGTAGCTTCTGCTACTTATCAGGTTAT
TGTTGGTTAAAATGTAGATTTTGAAGATAAAAATAGATCTTTTGTCATGACTCACTGCTAGAATTTGC
ATGACCTTTACTGTGTTAGCTTTTGAATGCCTTTTGGTTTGGACTTGCCAACCTATACTGTCTTTGCT
GAAATGCCCTTATAAATGTATACAGCTGGTATGTAACAATGTGAAGATTCCTTACCTGACTTAATAAA
ATACTTCGATAATACTGAAAAAAA 
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Mus musculus Transferrin Receptor-1 mRNA (NM_011638.4). Grey area represents the 
untranslated regions (5’ UTR and 3’ UTR) and the light area the coding sequence of the 
TfR-1 mRNA. Note that within the 3’ UTR, five iron responsive elements are represented in 
blue. ATG and TAA in red correspond to the start and stop codons, respectively. The 
underlined nucleotides correspond to the primer specific region used to amplify the cDNA 
sequence. 
CGTCGAGGTCATCGAAAGACGGGGGCGTCTCGTGGTCAGCCATAGGTCAGTCCTCGAAATCCCCCTTC
TGGCGCTTTGGTGCCAAAAGCGCGGGCACCATAAGGTCTGGACCCACCCGTGTCAAGGACTCAAACCG
GCGAAGCCAACACGCTGAATTGCATTGGTGAATCAGGGGGTTTGCGGGGTCGCGCCATGCCGGATGCT
GCGTTGCGGCAAGATTCTTCCCACCCAAGGGGGTGGCGTCAGGTGGGATTCGGCCACCGATCGCTTAT
CCCCATTTCCGTCCCGATGATTTTCCGCCCCCCTCCAGCCGCCTCACTCTTGCAACATCCGCACTTTA
GACCGTGGGCTGCCTTCGTGTTAAGAACGTGCCATGGACCTGCATCATCCCGAACTGACCTATGCCGC
CATCGTCGCCCTGGCCGCCGTTCTGTGCGGCGGGCTGATGACGCGCCTCAAGCAACCGGCCATCGTCG
GCTATATCCTGGCCGGGGTGGTGCTGGGCCCCAGCGGCTTCGGGCTGGTGAGCAACCGCGACGCCGTG
GCCACCCTGGCCGAGTTCGGCGTGCTGATGCTGCTCTTCGTCATCGGCATGAAGCTGGACATCATCCG
TTTTCTCGAAGTGTGGAAGACGGCGGTCTTCACCACCGTTTTGCAGATCGCGGGCTCCATCGGCACGG
CGCTGCTGCTGCGCCACGGTTTGGGCTGGAACCTGGGGCTGGCGGTGGTGCTGGGCTGCGCCGTGGCG
GTGTCGTCCACCGCCGTGGTGATCAAGGTGCTGGAATCCTCGGGCGAGTTGGAAACGCCGGTGGGGCG
CACCACGCTGGGCATCCTGATTGCCCAGGACATGGCGGTGGTCCCCATGATGCTGGTGCTGGAATCCT
TCGAGACCAAGGTGTTGCTGCCCGCCGATCTGGCCCGCGTGATCCTGTCCGTGCTGTTCCTGGTGCTG
CTGTTCTGGTGGCTGTCCAAGCGCCGTATCGACCTGCCGCTGACCTCCCGGCTGTCGCGGGATTCCGA
TCTGGCCACCCTTTCCTCCCTGGCCTGGTGCTTTGGCACGGCGGCCATTTCCGGGGTGCTGGACCTGT
CGCCCGCCTATGGCGCCTTTCTGGGCGGCGTGGTGCTGGGCAATTCCGCCCAGCGCGACATGCTCTTG
AAGCGCGCCCAGCCCATCGGCAGCGTGCTGTTGATGGTGTTCTTCCTGTCCATCGGGTTGCTGCTTGA
TTTCAAGTTCATCTGGAAGAATCTGGGCACCGTTCTCACTCTTTTAGCCATGGTGACGCTGTTCAAGA
CGGCGCTGAACGTCGCCGCGCTGCGTCTGGCGCGTCAGGACTGGCCCAGCGCTTTCCTGGCCGGGGTG
GCCCTGGCCCAGATCGGCGAGTTCTCGTTTTTGCTGGCCGATACCGGCAAGGCGGTTAAGCTGATCAG
CGCCCAGGAGACCAAGCTGGTGGTGGCGGTCACCGTGCTGTCCCTGGTGTTGTCGCCCTTCTGGCTGT
TCACCATGCGGCGTATGCATCGGGTGGCGGCGGTGCATGTCCATTCGTTCCGCGAATTGGTCTCGCGG
CTTTACGGCGACGAAGCCCGCACCGCGCGGCGGGCCCGCACCCTGGTGCGGCGGGGCTCTTGGAGGGA
TGATCACAATGCCGGACCTGGCACTGGAATCTGAGATCGGGGGCATCGTCTGCGGCATCGACGA 
Magnetospirillum magnetotacticum MS-1 Strain MagA insert sequence (1696 bp) 
originally in pCR2.1 vector (Invitrogen), Addgene, 21751. Grey area represents the genomic 
DNA surrounding the MagA gene (light area). ATG and TGA correspond to the start and stop 
codons, respectively. The underlined nucleotides correspond to the primer specific region 
used to amplify the current gene. In green, C is a mismatch from G-C and G is a new 
insertion, identified by sequencing analysis and not previously reported by Addgene. These 
mutations are silent and do not affect the amino acid coding sequence. In red, two 
missense mutations reported by Addgene, led to amino acid substitutions, S94L and P390S. 
These substitutions are not conservative and the influence it may have of normal gene 
coding of MagA in unknown. 
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APPENDIX II 
BUFFERS, SOLUTIONS, MEDIA, OTHER MATERIAL 
Molecular Biology Manufacturer, catalogue number 
2-propanol Sigma, I9516 
Accuzyme™ DNA Polymerase Bioline, BIO-21051 
Agarose Helena Biosciences, 8201-07 
BIOTAQ™ DNA Polymerase (5U/µl)    Bioline, BIO-21040 
Calf Intestinal Alkaline Phosphatase, 
10,000units/ml 
NEB, M0290S 
Chloroform Sigma, C2432 
dNTP Set Bioline, BIO-39025 
Ethanol Sigma, E7023 
Fast SYBR® Green Cells-to-CT™ Kit Life Technologies, 4402956 
FlashGel® Recovery Kit Lonza, 57050 
FlashGel® System Lonza, 57067 
HyperLadder™ I Bioline, BIO-33026 
HyperLadder™ IV Bioline, BIO-33030 
LB-Agar MERCK, 1.10283.0500 
Minielute PCR Purification Kit Qiagen, 28004 
Molecular biology water Lonza, 1315 
One Shot® Stbl3™ Chemically Competent 
E. coli 
Invitrogen, C7373-03 
Phenol: Chloroform: Isoamyl alcohol 
(25:24:1) 
Sigma P3803 
QIAprep® spin miniprep kit QIAGEN, 27104 
QIAquick gel extraction kit QIAGEN, 28706 
Random hexamers QIAGEN, 79236 
RQ1 DNase 10x reaction buffer Promega, M198A 
RQ1 DNase Stop Solution Promega, M199A 
RQ1 RNase-Free DNase Promega, M6101A 
Sodium acetate Sigma, S5636 
SuperScript™III Reverse Transcriptase Invitrogen, 18080-044 
SYBR® Safe DNA gel stain Invitrogen, S33102 
T4 DNA Ligase (1U/µl) Roche, 10481220001 
TOPO TA Cloning Kit Invitrogen, K4650-01 
TRIzol® Reagent Invitrogen, 15596-026 
X-gal (5-Bromo-4chloro-3-indolyl-β-D-
galactopyranoside) 
Calbiochem, 203782 
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Restriction enzymes  
BamHI  NEB, R0136S 
EcoRI-HF™ NEB, R3101S 
Hind III NEB, R0104S 
Stu I NEB, R0187S 
Xba I Promega, R618A 
Xho I NEB, R0146S 
Cell Culture Manufacturer, catalogue number 
1-thyoglycerol Sigma, M6145 
2x HEPES Sigma, 515588 
Alizarin Red S Sigma, A5533 
Aspirator tube assembly for calibrated 
microcapillary pipettes 
Sigma, A5177 
Bright Cryo-m-Bed embedding medium Bright instruments, 53581-1 
Calcium Chloride 2.5 M Solution - 5 ml Sigma, C2052 
Cell Counting Kit-8 Solution Sigma, 96992 
Corning® bottle-top vacuum filter system Sigma, CLS430767 and CLS430769 
Corning® Costar® cell culture plates – 
6-well, flat bottom 
Sigma, CLS3516 
Culture slides tissue culture 8-well VWR, 734-0089 
Deoxyribonuclease I from bovine 
pancreas 
Sigma, D5025 
DMEM: F12 (1:1) medium Lonza, 12-719 
DMSO Sigma, D2650 
DMEM Sigma, D6546 
Dulbecco’s Phosphate Buffered Saline Sigma, D8537 
Fast Green FCF Sigma, F7258 
Foetal Calf Serum  PAA Laboratories, A15-609 
Formaldehyde Solution Thermo Scientific, 28908 
Leukaemia Inhibitor Factor  Merck Millipore, LIF2010 
L-glutamine 200mM Sigma, G7513 
Minimum Essential Medium Eagle (MEM) Sigma, M5650 
Oil-red-O Sigma, O0625 
PES filter (0.22µm) MILLEX-GP, SLGP033RS 
PES filter (0.45µm) Sartorius Stedim, 16555 
Polybrene Sigma, H9268 
Safranin-O Sigma, S2255 
Sodium Pyruvate  Sigma, S8636 
Triton X-100 Sigma, T-8787 
Trypan Blue Solution  Sigma, T8154 
Ultracentrifuge tubes, Thinwall, UltraClear Beckman Coulter, 344058 
  
APPENDIX II | 247  
Cell Culture mediums: 
Cell culture medium A 
Fetal Calf Serum 10%  
L-glutamine 1% Filter with Corning® bottle-top vacuum 
filter system Made in DMEM  
Cell culture medium B   
Fetal Calf Serum 10%  
L-glutamine 1%  
1-thyoglycerol 100 mM  
LIF 1.5 U Filter with Corning® bottle-top 
vacuum filter system Made in DMEM  
Cell culture medium C 
Fetal Calf Serum 10% Filter with Corning® bottle-top 
vacuum filter system Made in DMEM: F12  
Freezing medium   
Fetal Calf Serum 30%  
DMSO 10%  
Made in DMEM  Filter with 0.22 µm PES filter 
Osteogenic induction media   
Dexamethasone 100 nM  
2-phospho-L-ascorbic acid 
trisodium salt 75 µM  
β-Glycerol phosphate 10 mM  
Fetal Calf Serum 10%  
Made in MEM  Filter with 0.22 µm PES filter 
Adipogenic induction media   
Dexamethasone 100 nM  
IBMX 500 nM  
Indomethacin 50 µM  
Bovine pancreas insulin 175 nM  
Fetal Calf Serum 10%  
Made in MEM  Filter with 0.22 µm PES filter 
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Chondrogenic induction media  
TGFβ3 10 ng mL
-1  
BMP7 100 ng mL-1  
Dexamethasone 100 nM  
2-phospho-L-ascorbic acid 
trisodium salt 50 µM  
Proline 40 μg mL-1  
Sodium pyruvate 1 mM  
Insulin-transferrin-selenium  1% (v/v)  
Made in DMEM  Filter with 0.22 µm PES filter 
Intracellular Iron Uptake: 
Iron supplements  Manufacturer, catalogue number 
Ferric citrate 0.2/2 mM Sigma, F3388 
Human holo-transferrin 
100 µg/ml 
(1.28 mM) 
Sigma, T0665 
L-ascorbic acid 50 µM Sigma, A4403 
Iron measurement   
Potassium permanganate  Sigma-Fluka, 60459 
Iron Standard for AAS  Sigma-Fluka, 16596 
Ferrozine reagent 
  
Ammonium acetate 5 M Sigma, A1542 
Ascorbic acid 2 M Sigma, A0278 
3-(2-Pyridyl)-5,6-diphenyl-
1,2,4-triazine-p,p′-disulfonic 
acid monosodium salt 
hydrate 
6.5 mM Sigma, 160601 
Neocuproine 15,4 mM Sigma, N1501 
Prussian Blue   
Iron stain kit  Sigma, HT20 
4% potassium ferrocyanide 
solution 
50% Sigma, HT20-1 
4% hydrochloric acid 50% Sigma, HT20-2 
DAB enhancement solution   
DAB 0.025% Sigma, D8001 
Hydrogen peroxide 0,005% Sigma, H3410 
Made in PBS   
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Immunofluorescence and Western Blot Manufacturer, catalogue number 
Dako Fluorescence Mounting Media Dako, S3023  
Pierce™ BCA Protein Assay Kit Thermo Scientific, 23225 
NuPAGE LDS Sample buffer (4x) Life Technologies, NP0007 
NuPAGE Reducing Agent (10x) Life Technologies, NP0009 
XCell SureLock Electrophoresis Life Technologies, EI0001 
MOPS Running Buffer (20x) Life Technologies, NP0001 
NuPAGE Antioxidant Life Technologies, NP0005 
NuPAGE® Novex® 4-12% Bis-Tris Protein Gel Life Technologies, NP0336 
Odyssey Protein Molecular Weight Marker Licor, 928-40000 
Immobilon®-FL Transfer Membranes (PVDF) Millipore, IPFL 10100 
NuPage Transfer Buffer (20x) Life Technologies, NP0006 
Sponge pad Life Technologies, EI9052 
XCell II Blot Module Life Technologies, EI9051 
Odyssey® Blocking Buffer Licor, 927-40000 
Western Blot Solutions: 
Lysis Buffer for protein extraction 
Tris-HCl (pH 7.5) 50 mM  
EDTA 1 mM  
EGTA 1 mM  
Sodium orthovanadate 1 mM  
Triton X-100 1%  
Sodium pyrophosphate 5 mM  
Sodium B-glycerophosphate 10 mM Aliquot and store at -20 oC 
Phosphatase inhibitor 1% 
Add fresh to complete solution 
Protease inhibitor cocktail 1% 
 
Transfer buffer 
NuPage Transfer Buffer (20x) 1x  
Methanol 10%  
Made in distilled water  Add 1% NuPage Antioxidant at time of use 
Other Solutions: 
10x TAE  
NaCl 48.4 g 
Glacial Acetic Acid (17.4M) 11.4 ml 
EDTA 3.7 g 
H20 Up to 1L 
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PBS 
NaCl 8 g  
KCl 0.2 g  
Na2HPO4 dibasic 1.44 g  
KH4PO4 monobasic 0.24 g  
H20 Up to 1 L Adjust to pH 7.4-7.6 
20% (w/v) Sucrose Solution   
Sucrose 20%  
Sodium Chloride 0.1 M  
Sodium Chloride 0.001 M Make in distilled water and Filter with 
0.22 µm PES filter HEPES 0.02 M 
4% (v/v) formaldehyde  
16% Formaldehyde Sol. 10 ml 
PBS 30 ml 
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APPENDIX III 
PLASMID MAPS 
 
Restriction map of pCR®II-TOPO® Vector. Sequence of the multiple cloning site is 
annotated (TOPO TA Cloning Kit, Invitrogen). 
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Lentiviral plasmid map of pHIV-dTomato (Addgene, 21374). Key features are annotated in 
the map. 
 
Lentiviral plasmid map of pHIV-eGFP (Addgene, 21373). Key features are annotated in the 
map. 
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2nd generation packaging vector, psPAX2 (Addgene, 12260). One of the elements used to 
cotransfect a producer cell line, together with transfer (pHIV-dTomato/ pHIV-eGFP) and 
envelope (pMD2.G) plasmids in a 2nd generation HIV-based lentiviral system. 
 
2nd generation envelop vector, pMD2.G (Addgene, 12259). One of the elements used to 
cotransfect a producer cell line, together with transfer (pHIV-dTomato/ pHIV-eGFP) and 
packaging (psPAX2) plasmids in a 2nd generation HIV-based lentiviral system. 
